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ABSTRACT 
 
The peripheral nerve disorder Guillain-Barré syndrome (GBS) accounts for the most 
common cause of acute acquired paralysis in the Western World. Circulating anti-
ganglioside antibodies (Abs) are  considered important mediators  of this disease. 
Research conducted in a mouse model of GBS has the revealed the neuromuscular 
junction (NMJ) as a potential site of anti-ganglioside Ab-binding, due to this structure 
lying outside the blood-nerve-barrier. The ganglioside composition of the neural and 
glial components of the NMJ determines which of these structures are bound and in 
the following subjected to complement-mediated injury. 
Some patients suffering from the acute motor axonal neuropathy (AMAN) forms of 
GBS  recovery  very  rapidly  from  paralysis;  it  has  been  proposed  that  in  these 
patients  the  injury  was  restricted  to  the  distal  motor  axons  and  nerve  terminals 
(NTs), which are able to regenerate over a short time-frame. To test this hypothesis, 
the mouse model of GBS was combined with in and ex vivo imaging of the NMJ in 
the ventral neck muscles of mice expressing cytosolic fluorescent proteins in their 
axons (cyan fluorescent protein: CFP) and Schwann cells (green fluorescent protein: 
GFP). 
Following confirmation of the stability of NMJs in these mice over time, optimisation 
of in vivo imaging procedures and determination of the most advantageous Abs for 
these kinds  of investigations, 45 mice were subjected to  a single in vivo  topical 
application of anti-ganglioside Ab followed by  a  source  of complement. Group A 
(n=15) received Ab that selectively bound to the NTs, group B (n=15) received Abs 
that bound both to the NTs and the perisynaptic Schwann cells (pSCs) and group C 
(control  animals;  n=15)  only  received  complement.  Evolution  of  the  injury  was 
documented  by  in  vivo  imaging,  and  following  euthanasia  the  muscles  were 
reimaged ex vivo both quantitatively and qualitatively, either immediately, or after 1, 
2, 3 or 5 days of regeneration (each n=3 per group). 
Within 15 minutes of complement application, a rapid loss of CFP overlying the NMJ 
could be seen; in group A, the GFP signal remained unchanged, whereas in group B 
the GFP signal was also lost. In group C no changes to either CFP or GFP were 
observed. At 24h, 6% of the superficial NMJs in group A and 12% of the NMJs in 
group B exhibited CFP; the CFP-loss extended proximally until the axons formed 
little  bundles.  In  both  groups,  CFP  returned  within  the  next  five  days  (group  A: 
93.5%, group B: 94%; p=0.739), with the recovery of CFP being preceded by a 
return of GFP-positive cells overlying the NMJ in group B. Both in groups A and B,       iii 
the pSCs exhibited processes which extended beyond the normal NMJ boundaries 
and very occasionally accompanied by axonal sprouts. This behavior was similar to 
that of pSCs challenged by traumatic denervation of their NMJ, albeit the changes 
observed in the Ab-mediated injury were lower in frequency and less dramatic when 
compared to those observed following traumatic denervation. The rate of motor NT-
regeneration corresponds well to rates observed following the application of spider 
or snake toxins, which mediate selective injury to the NTs. 
Auxiliary investigations revealed that the loss of CFP at the NMJ correlated with a 
loss  of  axonal  architectural  proteins  (neurofilament  (NF)  heavy  and  light)  and  a 
return  of  CFP  at  the  NMJ  was  accompanied  by  a  return  of  NF  heavy. 
Ultrastructurally, the injured NTs resembled NTs undergoing degeneration following 
a traumatic denervation of the endplate and following five days of regeneration, the 
NMJs exhibited a physiological morphology. 
The  results  described  above  indicate  that  following  a  single  anti-ganglioside  Ab-
mediated  and  complement-mediated  attack,  independent  of  whether  there  are 
healthy and mature pSCs overlying the NMJ, the murine NT is capable of recovering 
its  architectural,  axolemmal  and  ultrastructural  integrity  very  rapidly.  This  data 
supports  the  notion  that  an  equivalent  mechanism  may  account  for  the  rapid 
recovery seen in some clinical cases of AMAN.        iv 
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1. INTRODUCTION 
1.1 Guillain-Barré syndrome (GBS) 
1.1.1 Epidemiology 
Guillain-Barré syndrome (GBS) stands for a group of acute peripheral neuropathies, 
which together account for the most common cause of acute acquired paralyis in the 
Western World  since  the  eradication  of  polio  (Hafer-Macko  et  al.,  1996a;  Hahn, 
1998). The incidence for acquiring GBS, which can occur at any age (Hahn, 1998), 
but affects more males than females (Hughes et al., 1999; Sejvar et al., 2011), lies 
at one to four cases per 100 000 (Hughes et al., 1999; Yu et al., 2006) with the 
lifetime likelihood for an individual to acquire the disease resting at 1:1000 (Willison, 
2007). Roughly 20% of patients affected die or remain disabled within one year of 
disease onset (Willison, 2007). In 2/3 of the patients, the onset of GBS is anteceded 
by an acute infectious illness of the either the gastrointestional or respiratory system 
(Hahn,  1998).  The  most  common  microorganisms  linked  to  GBS  include 
Campylobacter (C.) jejuni (13% to 66% of cases), Cytomegalovirus (5% to 22%), 
Mycoplasma pneumoniae (5%) and Epstein-Barr virus (1% to 3%) (Hughes et al., 
1999; Ogawara et al., 2000; Yu et al., 2006). 
 
1.1.2 Aetiology and anti-ganglioside antibodies 
GBS and its variant forms are considered an auto-immune mediated neuropathy 
with  both  humoral  and  cell-mediated  immune  factors  contributing  to  the  disease 
process (Ariga & Yu, 2005). The antibodies (Abs) observed in high titres in GBS-
patients are anti-ganglioside Abs (Yu et al., 2006) and were first demonstrated in the 
late 1980s (Ilyas et al., 1988). Gangliosides are complex glycosphingolipids found 
within  cells  and  on  cell  membranes  throughout  the  body  but  in  a  higher 
concentration on neural and glial tissue (Hamberger & Svennerholm, 1971). There 
are a number of different gangliosides which are distinguished from one another by 
the number and location of sialic acid residues attached to a neutral sugar backbone 
(Fig.1) (Svennerholm, 1963). 1. Introduction    2 
 
Fig.1: Schematic overview of the synthesis and composition of gangliosides (adapted 
from (Plomp & Willison, 2009)). Mice lacking GD3-Synthase do not express and b- and c-
series gangliosides (orange box), whereas mice lacking GalNAc-Transferase do not express 
any complex gangliosides (green box) at all. 1. Introduction    3 
Gangliosides  are  not  distributed  evenly  throughout  the  organism  and  their 
composition varies depending which structures they are located on. Investigations 
conducted in human, mouse and rat peripheral nerves, nerve roots and dorsal root 
ganglia  revealed  a  preferential  staining  of  anti-GD1a  Abs  for  myelinated  motor 
nerves (compared to myelinated sensory nerves) in cross- and transverse sections 
of nerve roots and sciatic nerves (De Angelis et al., 2001; Gong et al., 2002). In 
contrast  to  this,  anti-GM1  Abs  bind  both  myelinated  motor  and  sensory  nerves 
(Gong et al., 2002) with ultrastructural studies confirming binding sites both on the 
nodal axolemma and the paranodal areas of Schwann cells (SCs) (Sheikh et al., 
1999a). The extraocular nerves (cranial nerves (CNs) III, IV and VI) and the optical 
nerve contain high levels of GQ1b (Chiba et al., 1997). The function of gangliosides 
is diverse and is hypothesized to range from cell development, signal transduction 
and  receptor  function  to  cell-cell  interactions  (Plomp  &  Willison,  2009;  Zeller  & 
Marchase, 1992). 
Depending on the screening method and the patient groups/ ratio of GBS-subtypes 
under investigation (see below), the incidence of anti-ganglioside Abs found in GBS-
patients ranges from 38% to 60% (Alaedini et al., 2002; Caudie et al., 2002; Matà et 
al.,  2006;  Meena  et  al.,  2010;  Yu  et  al.,  2006).  The  patterns  for  the Ab-binding 
specificities vary between the different subtypes of GBS assessed (Caudie et al., 
2000).  Good  correlations  are  observed  between  anti-GQ1b  Abs  and  the  GBS-
subtype Miller-Fisher syndrome and anti-GM1/GD1a Abs and motor axonal forms of 
GBS, in the latter especially after preceding C. jejuni infections (Ariga & Yu, 2005; 
Caudie et al., 2002; Ogawara et al., 2000; also see 1.1.3) Nevertheless, controversy 
surrounds the importance of these Abs for two reasons: firstly, depending on the 
detection  assay  anti-ganglioside  Abs  are  detected  (Matà  et  al.,  2006),  are  not 
detected in relevant titres (Vincent, 1998) or are not detected at all in control sera or 
sera  of  patients  suffering  from  other  neurological  diseases  (Ilyas  et  al.,  1988; 
Alaedini et al., 2002). Secondly, despite high Ab-titres being frequently observed at 
onset  of  the  disease  and  a  reduction  or  even  loss  of  titres  observed  during 
progression of the disease (Ariga & Yu, 2006), it is not quite clear whether the Abs 
themselves  are  responsible  for  induction  of  the  disease  or  merely  should  be 
considered  as  generated  secondarily  to  nerve  damage  (Hughes  et  al.,  1999). 
However,  considering  plasmapheresis  and  the  application  of  intravenous 
immunoglobulin improve the symptoms of GBS-patients (van Doorn et al., 2010; 
Walgaard et al.,  2011),  it can  be surmised that anti-ganglioside Abs are directly 1. Introduction    4 
involved  in  the  pathogenesis  of  GBS  (Ariga  &  Yu,  2005).  Furthermore,  patients 
suffering  from  GBS-forms  associated  with  a  C.  jejuni-infection  often  exhibit  Abs 
against GM1 or GQ1b (Willison & Yuki, 2002; Yuki et al., 1993; Yuki et al., 1994), 
which - in addition to GT1a, GD3, GM2, GM3, GD1a and GD1b - share a structural 
homology with oligosaccharide side chains of C. jejuni surface lipopolysaccharides 
(Ang et al., 2002; Aspinall et al., 1994; Gilbert et al., 2000; Guerry et al., 2002; 
Prendergast et al., 1998) (Fig.2). Thus, an Ab-mediated attack of the pathogens also 
leads to production of Abs against the body’s own structures, rendering this situation 
one of molecular mimicry (Yu et al., 2006). This principle has also been proven in 
mice following an immunisation with C. jejuni preparations (Goodyear et al., 1999) 
and further indicates that the anti-ganglioside Abs are not produced secondary to 
nerve injury, but bear a more striking role in this group of peripheral nerve disorders. 
At the same time, however, only about one in a thousand cases of symptomatic C. 
jejuni-enteritis is followed by GBS, indicating that other factors, such as host factors, 
must contribute to the disease susceptibility (Hahn, 1998; Hughes et al., 1999; Yu et 
al., 2006). 
 
Fig.2: Examples for the homology between Campylobacter jejuni oligosaccharide (OS) 
side-chains and gangliosides. 1. Introduction    5 
1.1.3 Subtypes (Fig.3) 
There are a number of subtypes for GBS. These comprise the axonal forms, acute 
motor axonal neuropathy and acute motor and sensory axonal neuropathy, which 
are  more  common  in  central  America,  China,  Japan  and  India,  and  the 
demyelinating  form,  acute  inflammatory  demyelinating  polyradiculoneuropathy, 
which is the predominant form in North America and Europe (Hughes et al., 1999). 
The demyelinating type of GBS was considered the only form of GBS up until the 
late 1980s when the axonal variants were “discovered” (Feasby et al., 1986). 
In addition to these two major types, there also are regional variants of GBS, such 
as Miller-Fisher syndrome, and forms frustes, like acute oropharyngeal palsy; these 
can remain localised or develop into full-blown GBS at a later time-point (Hughes et 
al., 1999; Willison, 2005). 
 
1.1.3.1 Acute motor axonal neuropathy (AMAN) 
AMAN-patients  exhibit  paralysis,  which  may  be  that  widespread  that  they  are 
required to be ventilated artificially (McKhann et al., 1993). In electrophysiological 
investigations,  reduced  or  absent  distally  evoked  compound  muscle  action 
potentials are noted, whilst the nerve conduction velocities and the action potentials 
of the sensory nerves remain normal (Hahn, 1998; McKhann et al., 1991). These 
findings indicate a selective axonal injury to the peripheral motor nerve fibres. 
The convalescence of AMAN-patients seems to occur in two subgroups: one which 
exhibits a rapid improvement within the first two to four weeks after onset of disease, 
and another, in which recovery is prolonged and the patients are unable to walk 
independently at six months after disease onset (Hiraga et al., 2005; Kuwabara et 
al., 1998a; Ogawara et al., 2000). 
Necropsies  of  AMAN-patients  reveal  minimally  inflammatory  Wallerian-like 
degeneration of the motor nerve fibres more pronounced in the ventral roots than 
the peripheral nerves, indicating that the initial lesion is to be found in the spinal 
roots. Demyelination of the axons remains an exception (Griffin et al., 1995). 1. Introduction    6 
 
Fig.3:  Schematic  overview  of  the  two  main  forms  of  GBS,  the  axonal  and  the 
demyelinating form. In both forms the Abs bind very proximal or distal areas of the PNS, 
areas where there is no blood-nerve barrier. In the axonal form, anti-ganglioside Abs bind 
directly to the axolemma of the nerve roots and NTs, whereas in the demyelinating form it is 
surmised that the Abs bind the outer surface of the myelinating SCs. Following activation of 
the complement system, this in turn leads to degeneration of proximal and distal axons with 
minimal demyelination and cell infiltrates in the axonal form, whereas in the demyelinating 
form extensive demyelination with a mononuclear infiltrate of cells is observed. In severe 
cases the demyelinating form is accompanied by secondary axonal degeneration. 1. Introduction    7 
Ultrastructural investigations of the nodes of Ranvier (NoR) at early stages of AMAN 
reveal a lengthening of the node with a local accumulation of neurofilaments in the 
axon  and  macrophages  overlying  the  node.  In  more  advanced  stages  the 
macrophages had moved into the paranodes and the internodal space, distorting 
both axon and myelin sheath and leading to shrinking of the axon (Griffin et al., 
1996b).  At  nodes  not  yet  undergoing  degeneration,  complement  products  are 
visualised at the nodal axolemma, whilst immunoglobulin-deposits can be seen on 
the internodal axolemma (Hafer-Macko et al., 1996a). 
In  some  necropsies,  the  pathological  changes  to  the  nerve  roots  and  proximal 
peripheral nerves are not sufficient to be commensurate with the degree of paralysis 
observed (Griffin et al., 1995; McKhann et al., 1993). At the same time, the very 
extensive motor fibre degeneration observed in many necropsies is not compatible 
with  the  rapid  recovery  described  above  (Griffin  et  al.,  1995;  Ho  et  al.  1997b). 
Potential  explanations  for  a  rapid  recovery  include  a)  distal  demyelination,  b)  a 
reversible conduction-block along motor axons and c) degeneration restricted to the 
very  distal  motor  nerve  (Griffin  et  al.,  1995;  Ho  et  al.,  1997b;  Kuwabara  et  al., 
1998a)  with  the  investigation  of  muscle-nerve  biopsies  obtained  from  a  rapidly 
recovering  AMAN-patient  providing  evidence  for  the  third  hypothesis  (Ho  et  al., 
1997a).  
Anti-GM1  and  anti-GD1a  are  the  circulating  Abs  predominantly  found  in  AMAN-
patients (Kaida et al., 2000; Press et al., 2001; Willison, 2005).  
 
1.1.3.2 Acute motor and sensory neuropathy (AMSAN) 
AMSAN-patients exhibit paralysis, paresthesia and sensory loss with the occasional 
involvement of CNs. Both the compound motor and sensory action potentials are 
reduced, whilst conduction velocities remain preserved (Feasby et al., 1986; Griffin 
et al., 1996a), indicating an axonal injury to both motor and sensory fibres. Recovery 
is slow and often incomplete (Feasby et al., 1986; Griffin et al., 1996a). 
In necropsies of AMSAN-patients an additional involvement of the sensory fibres 
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both  dorsal  and  ventral  nerve  roots,  minimal  inflammatory  Wallerian-like 
degeneration  of  the  axons  is  observed.  Additionally  (and  equivalent  to  AMAN), 
macrophages are present within the periaxonal space of many myelinated fibres and 
only very rarely demyelination is seen (Griffin et al., 1995, 1996a). 
In AMSAN-patients, the predominant Abs found also are anti-GM1 Abs (Kuwabara 
et al., 1998b), indicating that these Abs might play a pivotal role in axonal damage 
(Hughes et al., 1999).  
1.1.3.3 Acute inflammatory demyelinating polyradiculoneuropathy (AIDP) 
AIDP is the most common form of GBS in the western countries (85-90%; Hahn, 
1998). Clinically, AIDP-patients exhibit weakness, which progresses to paralysis and 
can require artificial ventilation. Paresthesia also is a common complaint (Asbury et 
al.,  1969).  In  electrophysiological  investigations,  decreased  conduction  velocities 
and conduction blocks are noted (Hughes et al., 1999), indicating that this disorder 
is based on demyelination of the axons. The lesions can occur at any site of the 
nerve, i.e. predominantly proximal or distal or both, and can involve both motor and 
sensory nerves, also including autonomic nerves (Asbury et al., 1969; Hughes et al., 
1999). 
AIDP is considered a self-limiting disease. Once the immune-reaction has come to a 
halt,  the  nerves  remyelinate  promptly,  which  leads  to  a  complete  recovery. 
Additional  axonal  injury,  however,  complicates  recovery  and  can  lead  to  lasting 
deficits (Hahn, 1998). 
Histologically,  a  mononuclear  inflammatory  infiltration  is  observed.  This  is 
predominantly lymphocytic in character, however, a macrophage component is also 
noted. The myelin sheaths form ovoids and are phagocytosed. In the severe cases, 
the axonal continuity is interrupted and Wallerian degeneration can be seen (Asbury 
et al., 1969). Detailed investigations conducted on tissues of three subjects suffering 
from the early stages of AIDP revealed complement products on the outer surface of 
SCs and vesicular changes of the myelin, starting from the outer layer. At later time-
points, macrophages and  extensive  lymphocytic infiltrates  were observed (Hafer-
Macko et al., 1996b). These findings lead to the hypothesis, that in (at least some 
cases) of AIDP the abaxonal SC plasmalemma serves as a target for circulating 1. Introduction    9 
Abs, which then leads to the formation of a complement on these structures and 
vesicular  changes  to  myelin  beginning  at  the  outer  surface  (Hafer-Macko  et  al., 
1996b; Willison & Yuki, 2002). 
A  common  Ab  found  in  AIDP-patients  remains  to  be  discovered  (Hughes  et  al., 
1999); in these patients often a variety of anti-ganglioside Abs, such as anti-GM1, -
GM2, -GM3, -GD1a, -GD1b, -GT1b and -GQ1b Abs, are detected (Alaedini et al., 
2002; Matà, 2006; Meena et al., 2010). 
 
1.1.3.4 Miller-Fisher syndrome (MFS) 
MFS accounts for roughly 5-10% of GBS cases observed (Willison & Yuki, 2002). 
Clinically, MFS-patients exhibit a characteristic triad of ophthalmoplegia, ataxia and 
areflexia  and  serologically,  anti-GQ1b  Abs  can  be  found  in  96%  of  MFS-cases 
(Hahn, 1998), rendering these Abs a reliable serologic marker. As described above, 
GQ1b  is  strongly  expressed  on  the  extraocular  nerves,  which  accounts  for  the 
ophthalmoplegia observed. Additionally, serum obtained from MFS-patients binds to 
cells in the molecular layer of the cerebellum (Kornberg et al., 1996), which could 
account for the ataxia observed. 
In  general,  MFS  is  benign.  Therefore,  histological  investigations  have  only  been 
carried out in the cases which graduated to full-blown GBS. In these, pathological 
investigations have revealed a multifocal inflammatory process in the line with AIDP 
(Hughes et al., 1999). 
 
1.1.4 Models 
1.1.4.1 Spontaneous models 
There are a number of naturally occurring animal diseases, which are considered 
spontaneous  models  for  GBS.  These  include  acute  canine  polyradiculoneuritis 
(ACP, also known as Coonhound paralysis), Marek’s disease in chicken (Stevens et 1. Introduction    10 
al., 1981) and an acute paretic syndrome in juvenile White leghorn chicken (Bader 
et al., 2010). Whilst ACP most accurately replicates the various features found in in 
the different types of GBS, i.e. axonal (motor and sensory) and demyelinating forms 
with varying  cellulary  infiltrates (Cummings &  Haas,  1967; Northington & Brown, 
1982), both avian peripheral nerve disorders seem to resemble the demyelinating 
form of GBS more closely. 
1.1.4.2 Experimental allergic neuritis (EAN) 
Early artificially induced models for GBS were based on the observations made in 
AIDP and therefore primarily focussed on the immune-mediated demyelination of 
peripheral nerves. A widely applied model was (and still is) experimental allergic 
neuritis  (EAN),  which  was  first  described  by  Waksman  and  Adams  in  1955. 
Experimental  allergic  neuritis  is  primarily  carried  out  in  Lewis  rats  or  other 
susceptible rat strains. 
Rats are actively immunised with purified myelin or myelin components, such as P0 
protein,  P2  protein,  myelin  basic  protein  or  myelin-associated  glycoprotein.  The 
immune-reaction is orchestrated by activated T-cells, which cross the blood-nerve 
barrier (BNB) and induce a generized invasion of T-cell and macrophages into the 
peripheral  nervous  system  (PNS)  (Maurer  &  Gold,  2002).  Clinically  and 
electrophysiologically,  the  rats  closely  resemble  AIDP-patients.  Histological 
investigations carried out in acute EAN reveal an infiltration of the nerve roots and 
peripheral nerves with macrophages and lymphocytes, which closely resemble the 
changes  seen  in  AIDP.  Furthermore,  primary  demyelination  of  the  nerves  is 
observed, which can be associated with axonal damage (Maurer et al., 2002). In 
addition  to  an  induction  by  active  immunisations,  EAN  can  also  be  induced  by 
adoptive transfer of T-cells specific for P2 peptides, P0 or P2 peptides (Maurer et 
al., 2002). It could be shown that following the induction of EAN by adoptive transfer 
of specific T-cells the BNB is compromised. The systemic application of unspecific 
immunoglobulin (Ig) leads to local accumulations of Igs in nerve roots (Hadden et 
al., 2002). 
Similar  to  EAN  in  rats,  murine  EAN  can  reliably  be  reproduced  by  actively 
immunising susceptible mouse strains (SJL/L mice) with purified peripheral nerve 
myelin (Xia et al., 2010). 1. Introduction    11 
Interestingly,  in  rabbits  EAN  can  also  be  induced  by  active  immunisation  with 
galactocerebroside (GalC), which is a glycosphingolipid with a galactose unit, thus 
very similar to a ganglioside. Galactocerebroside is a major component of central 
nervous system (CNS) and PNS myelin (Linington & Rumsby, 1980; Ranscht et al., 
1987). During development of the PNS and CNS and before myelin is formed, GalC 
is expressed on the surface of myelin-forming cells; the application of anti-GalC Abs 
during this time inhibits the formation of peripheral myelin (Ranscht et al., 1987). 
Later  in  life,  GalC  is  expressed  on  the  surface  of  oligodendrocytes  and  both 
myelinating and non-myelinating SCs (Jessen et al., 1985). In GalC-EAN, quite a 
length of time after the GalC-immunisations have taken place, the rabbits exhibit 
paralysis,  ataxia  and  decreased  responses  to  pinpricks  (Saida  et  al.,  1981). 
Histologically,  demyelinative  lesions  of  the  PNS  are  observed.  These  are  more 
frequent in proximal sites when compared to distal sites and are accompanied by an 
infiltration of phagocytic mononuclear cells, which are mainly macrophages. Only 
very few lymphocytic infiltrates are noted, and no changes to the CNS are observed 
(Saida  et  al.,  1981). Weeks  before  clinical  and  electrophysiological  changes  are 
noted,  circulating  anti-GalC  Abs  and  deposits  of  anti-GalC  Abs  at  the  PNS-
predilection sites are detected (Maurer & Gold, 2002). Systemic transfer of rabbit 
anti-galactocerebroside  serum  with  high  Ab-titres  into  rats  does  not  induce  any 
clinical  or  histological  changes  (Hahn  et  al.,  1993),  whereas  the  intraneural 
application of anti-GalC serum into rat sciatic nerves produces focal demyelination 
in the rats, which is accompanied by an invasion of phagocytic mononuclear cells. 
However,  SC  damage  and  disruption  of  myelin  occur  prior  to  the  invasion  of 
macrophages,  and following additional  investigations  which  were  associated  with 
heat-treatment of the serum and pretreatment of nerves with complement-activating 
factors, it was surmised that demyelination and SC-injury are Ab- and complement-
mediated (Saida et al., 1979; see also 1.1.5). Additionally, the application of rabbit 
anti-GalC serum into EAN-rats induced by adoptive transfer of sensitised T-cells 
very much exacerbates the demyelinating changes observed in mild EAN and the 
application  of  anti-GalC-serum  into  rats  where  the  BNB  has  been  openend 
unspecifically,  results  in  mild  demyelination;  however,  no  clinical  changes  are 
observed (Hahn et al., 1993). Thus, the investigations conducted in EAN (especially 
with the combination of rat and rabbit EAN) have revealed the potentially synergistic 
roles of T-cells and Abs in demyelinating GBS. 
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1.1.4.3 Models based on anti-ganglioside antibodies 
Following the detection of anti-ganglioside Abs in GBS-patients (Ilyas et al., 1988), 
models  for  GBS  were  expanded  to  include  the  immunisation  with  gangliosides. 
Interestingly, here the results vary widely between the species immunised and Ab-
responses are not necessary accompanied by clinical and histological changes. 
Rabbits have repeatedly been actively immunised with gangliosides, which in some 
cases  has  also  lead  to  GBS-like  clinical,  serological  and  histological  changes 
(Kusunoki et al., 1996; Moyano et al., 2008; Nagai et al., 1976; Susuki et al., 2007; 
Thomas et al., 1991; Yuki et al., 2001). Depending on the gangliosides applied, the 
rabbits  exhibit  ataxia  (Kusunoki  et  al.,  1996),  reduced  compound  muscle  action 
potentials (Thomas et al., 1991) and weakness (Moyano et al., 2008) leading to 
respiratory paralysis (Yuki et al., 2001). Histologically, Wallerian-like degeneration of 
axons is observed in the PNS. Demyelinative lesions are minimal and no invasions 
of mononuclear cells are seen (Kusunoki et al., 1996; Thomas et al., 1991; Yuki et 
al., 2001). In summary, these results correspond most accurately with the clinical 
and histological observations made in the axonal forms of GBS. 
In mice and rats, active immunisation with the ganglioside GM1 readily leads to T-
cell  independent  anti-GM1  Ab  titres  (Freimer  et  al.,  1993;  Ilyas  &  Chen,  2007). 
Interestingly,  however,  the  animals  do  not  exhibit  any  clinical  or  pathological 
changes (Ilyas & Chen, 2007). Whether this is due to immunisation protocols or 
differences in species and strain susceptibility, remains to be elucidated (Willison & 
Yuki, 2002). Additionally, the degree to which the BNB is permeable seems to play a 
role  in  the  development  of  Ab-mediated  neuropathy  (Sheikh  et  al.,  2004)  which 
makes sense considering the conclusing reached in EAN-experiments regarding a 
potentially  synergistic  role  for  T-cells  and  Abs  in  demyelinating  GBS.  Research 
conducted on endothelial cells of endoneurial origin, however, has shown that these 
cells  express  GM3,  GM1,  GD1a, GD1b and  GT1b  (Kanda et al., 1997) and the 
examination  of  nerve  samples  from  patients  suffering  from  autoimmune 
demyelinative neuropathy and exhibiting antiglycosphingolipid Abs reveals a loss of 
tight junctions between endothelial cells. Thus, it is surmised that circulating anti-
ganglioside  Abs  of  the  required  specificity  can  mediate  a  loss  of  BNB-integrity, 
which might in turn permit the Igs to enter the endoneurial space (Kanda et al., 
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Passive immunisations of mice with gangliosides have been fruitful and have yielded 
a plethora of information regarding possible pathophysiological events in GBS and 
potential  treatments.  Most  of  these  investigations  have  been  conducted  on  the 
neuromuscular junction (NMJ) or the distal motor nerves as these sites lie outside 
the BNB (Olsson, 1968) and therefore clearly provide an excellent target for anti-
ganglioside  Abs,  both  under  clinical  and  experimental  circumstances  (Ho  et  al., 
1997a;  Plomp  &  Willison,  2009).  The  application  of  mouse  monoclonal  anti-
ganglioside Abs has been carried out both in in vivo (application of Abs to living 
animals)  and  ex  vivo  systems  (application  of  Abs  to  muscle-nerve  preparations) 
(Bullens et al., 2002; Goodfellow et al., 2005; Halstead et al., 2004, 2005a, 2005b, 
2008b;  McGonigal  et  al.,  2010;  O'Hanlon  et  al.,  2001;  2003;  Paparounas  et  al., 
1999). The advantages of the in vivo system are that the whole organism is involved 
and,  potentially,  regenerative  processes  can  also  be  observed.  However,  the 
systemic in vivo application of anti-ganglioside Abs is relatively difficult to regulate 
and maintain, due to the foreign Ab being degraded and cleared from the system. 
Thus, the obvious advantages of an ex vivo application of Abs include the ease in 
regulating the dose and reproducibility of investigations. However, here a limited 
“life”-span  of  the  tissue  preparations  provides  a  time  barrier  for  extended 
investigations  and,  obviously,  no  insights  can  be  gathered  on  regenerative 
processes. 
Similar to the conclusions reached in EAN regarding the pathomechanisms of GalC-
Abs,  the  actions  of  anti-ganglioside  Abs  are  also  complement-dependent  (see 
1.1.5). Following the in or ex vivo application of murine anti-ganglioside Abs in mice 
or mouse tissue, clear Ab-deposits are observed at the site of interest, the NMJ. 
However, only very sparse deposits of mouse complement can be detected and no 
pathophysiological changes are observed in the structures bound by Abs or in the 
behaviour of the mice (Willison et al., 2008; see also 3.3.2). Considering it could be 
demonstrated  in  additional  investigations  that  the  mouse  monoclonal  anti-
ganglioside  Abs  are  able  to  activate  mouse  complement,  it  was  surmised  that 
complement-inhibitory factors, such as protectin (CD59a), decay accelerating factor 
(DAF1)  or  Factor  H  are  present  at  the  area  of  interest.  Protectin  is  easily 
demonstrated at the NMJ and factor H can be stained for at the NMJ when activated 
complement is present. Following experiments with CD59a/DAF1 double knock-out 
mice, it is hypothesised that the endogenous mouse complement fails to generate 
pathological  changes  at  the  Ab-binding  site  due  to  an  inability  of  the  mouse 1. Introduction    14 
complement to follow thought the entire complement cascade and produce MAC 
(see 1.1.5). 
One final caveat must be noted regarding the use of any artifical models, especially 
those  concerned  with  the  induction  of  specific  Abs  and  based  on  antigen/Ab 
interactions.  The  expression  (amount  and  localisation)  of  the  Ab-targets,  i.e.  the 
antigens, might vary between the species the experiments are conducted in and 
when comparing species under investigation and humans. Interestingly enough, in 
many studies conducted with anti-ganglioside Abs, good correlations were achieved 
between the experimental subjects and humans. Anti-GD1b Abs, for example, are 
associated both in rabbits (Kusunoki et al., 1996) and humans (Caudie et al., 2002; 
Wicklein et al., 1997) with pure ataxic sensory neuropathies, whilst anti-GM1 Abs 
are linked with weakness and a loss of compound muscle action potentials both in 
rabbits (Yuki et al., 2001) and in humans (Caudie et al., 2002; Willison, 2005). In 
contrast  to  this,  the  extent  of  the  expression  of  sulphated  glucuronyl  glycolipids 
(components of peripheral nerves), however, varies between animal species (Ilyas 
et  al.,  1986)  and  this  is  surmised  to  be  the  reason  why  following  an  active 
immunisation with these glycolipids an ataxic sensory neuronopathy can be elicited 
in cats, but not in rabbits and rats (Ilyas et al., 2008). Following the immunisation, 
the rabbits exhibit mild clinical changes but not pathology, whereas rats exhibit large 
Ab-titres but no clinical or pathological abnormalities. Interestingly, the pathological 
changes  observed  in  the  cats  do  not  quite  correlate  with  changes  observed  in 
humans suffering from the same Abs and clinical symptoms (Ilyas et al., 2008). This 
stresses the fact that all animal models remain to be a model and do not necessarily 
replicate  all  the  events  taking  place  in  the  “original  disease”,  but  only  can  give 
potential explanations for disease pathophysiology and progress. Regarding the use 
of anti-ganglioside Abs it needs to be stressed that characterisation of ganglioside 
distribution profiles and antiganglioside Ab-binding patterns is essential before the 
interpretation of results. 
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1.1.5 Anti-ganglioside Ab-mediated pathophysiology 
Investigations conducted in mice following the application of anti-ganglioside Abs 
and an external source of complement have shown that following the binding of the 
anti-ganglioside  Abs  to  neural  (motor  nerve  terminal;  NT)  and  glial  (perisynaptic 
SCs; pSC) structures at the NMJ, the complement system is activated (Fig.4), which 
then leads to a formation of the membrane attack complex (MAC) and injury of the 
structures bound (Halstead et al., 2004, 2005b). The application of anti-GT1a Abs 
combined  with  a  source  of  complement  leads  to  a  selective  injury  of  the  NTs, 
whereas the application of anti-GD3-Abs combined with a source of complement 
preferencially  induces  pSC  injury  (Halstead  et  al.,  2005b;  for  more  detailed 
information see chapter 3.3.1). Membrane attack complexes are a the complement 
factors C5b, C6, C7, C8 and C9 combined (see Fig.4) of which the C5b-7 complex 
mediates the binding to the cell membrane bound by Ab. Association of C8 to the 
C5b-7 complex leads only to unstable pore formation on the membrane, whereas 
the binding of one C9 to a C5b-8 complex rapidly leads to a transformation of C9 
and  an  incorporation  of  up  to  16  molecules  of  C9  into  the  final  complex.  C9 
polymers consisting of more than 6 C9 molecules form a tubular structure with an 
external diameter of 20 nm, an internal diameter of 5 nm and a height of 15 nm. The 
functional size of a MAC-pore is between 1 and 11 nm; the more C9 molecules are 
incorporated into the complex, the bigger the pore (Tegla et al., 2011). 
The  presence  of  C1q  and  C4  indicates  that  the  classical  complement  activation 
pathway is in operation in the murine model of GBS, while the alternative pathway 
can  be  ruled  out  as  a  primary  source  of  MAC  due  a  Ca
2+-dependency  of  the 
process.  The  lectin  pathway  cannot  be  excluded  (Halstead  et  al.,  2004).  In  the 
absence  of  C6  (which  prevents  the  formation  of  MAC),  only  further  upstream 
components of the complement cascade such as C3c can be detected; there are no 
MAC-deposits  and  neither  functional  nor  morphological  changes  to  the  NTs  are 
observed (Halstead et al., 2004). Similar observations are made in the absence of 
C7  and regarding an injury  to the pSCs (Halstead  et al.,  2004). The addition of 
Eculizumab or rEV576, which both bind to C5, thus preventing the formation of C5a 
and C5b and effectively stopping the complement cascade at this level, completely 
prevent the deposition of MAC and the occurrence of morphological and functional 
changes  to  the  neural  and  glial  structures  of  the  NMJ,  while  once  again  further 
upstream complement components (C3c) are still readily detected (Halstead et al., 1. Introduction    16 
2008a, 2008b). The application of the complement inhibitor APT070 leads to the 
same results (Halstead et al., 2005a). 
Investigations  conducted  at  the  NoR  confirm  the  observations  made  at  the  NT. 
Following the application of anti-ganglioside Abs, IgG- and complement-deposits are 
observed (McGonigal et al., 2010; Paparounas et al., 1999). Here, the application of 
the complement-inhibitor Eculizumab together with the source of complement, leads 
to a protection of the nodal proteins, including the sodium channel Nav1.6, and a 
preservation of the sodium current upon perineural recordings (McGonigal et al., 
2010).  The  finding  that  MAC  plays  a  major  effector  role  in  this  model  for  anti-
ganglioside  Ab-mediated  injury  correlates  well  with  the  localised  IgG  and 
complement  activation  products  demonstrated  at  the  NoR  and  also  on  the 
axolemmal surface in AMAN patients (see 1.1.3.1) (Hafer-Macko et al., 1996a). 
The  deposition  of  MAC  (pores)  on  the  axonal  and  glial  surface  leads  to  an 
uncontrolled influx of ions, small molecules and water into the NT and pSCs along 
the diffusion gradient (Acosta et al., 1996; Morgan et al., 1986). This includes all 
ions,  however,  especially  the  passive  influx  of  Ca
2+,  possibly  exacerbated  by  a 
breakdown or reversal of the Na/Ca exchanger (LoPachin & Lehning, 1997), which 
has been shown to be specifically concentrated at the presynaptic NT (Luther et al., 
1992),  leads  to  a  massive  increase  in  intraaxonal  Ca
2+.  This  in  turn  has  many 
effects, such as the overload and disruption of mitochondria, metabolic depletion 
due to an increased expenditure of energy to maintain the ionic gradients, and the 
activation of a number of Ca
2+-dependant proteases (Morgan et al, 1986). Recent 
research  has  attributed  the  mitochondria  a  pivotal  role  in  the  process  of  nerve 
degeneration  (Barrientos  et  al.,  2011).  One  of  the  Ca
2+-dependant  proteases  is 
calpain,  and  neurofilament  (NF),  which  stabilises  the  axonal  cytoskeleton  and 
determines its caliber (Schlaepfer, 1987), acts as a substrate for calpain (Chan & 
Mattson, 1999).  
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Fig.4: Activation of the complement system following the binding of anti-ganglioside 
Abs on target structures. 
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1.1.6 Anti-ganglioside Ab-mediated pathology 
Following the application of anti-ganglioside Abs and a source of complement, a 
loss  of  NF  (both  phosphorylated  and  un-phosphorylated)  (O'Hanlon  et  al.,  2001, 
2003)  and  β-tubulin, swollen mitochondria (with abnormal or  absent  cristae) and 
decreased amounts of vesicles located to the pre-synaptic active zone are seen 
(Goodfellow et al., 2005; Halstead et al., 2005b; O'Hanlon et al., 2001). Additionally, 
the presence of pSC processes invading the synaptic cleft or even “wrapping” the 
NT  can  be  observed  (Halstead  et  al.,  2005b;  O'Hanlon  et  al.,  2001,  2003). 
Application  of  the  calpain-inhibitor  AK295  (or  other  calpain-inhibitors)  leads  to  a 
preservation of NF-heavy (McGonigal et al., 2010; O'Hanlon et al., 2003) 
Perisynaptic SCs, when targeted by anti-ganglioside Ab and complement-mediated 
injury, exhibit a nuclear uptake of Ethidium, swollen and electron-lucent cytoplasm, 
damaged organelles, fragmented processes and perinuclear cell bodies (Halstead et 
al.,  2004,  2005b).  Ethidium  is  a  nuclear  marker  whose  cellular  ingress  und 
subsequent nuclear binding indicates a loss of the cell membrane integrity. 
 
1.1.7 Anti-ganglioside Ab-mediated clinical and electrophysiological changes 
Mice supplied systemically with anti-ganglioside Abs and a source of complement 
exhibit acute respiratory problems with a decrease in tidal volumes and respiratory 
rate. This is accompanied by a decrease in grip strength (Halstead et al., 2008b). 
Electrophysiological investigations conducted at the NMJ reveal an initial massive 
increase  of  miniature  endplate  potentials,  followed  by  a  block  of  synaptic 
transmission due to an inability to release acetylcholine (Goodfellow et al., 2005; 
Halstead et al., 2008b; Plomp & Willison, 2009); these changes have been attributed 
to dysfunction of the motor NTs, as acute injury to the pSCs alone does not seem to 
affect the electrophysiologic properties of the NMJ (Halstead et al., 2005b). At more 
proximal  sites,  a  complete  loss  of  the  perineural  K
+  and  Na
+  flow  is  observed 
(McGonigal et al., 2010). 
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1.2 The neuromuscular junction 
Over the last century, the vertebrate NMJ has been closely examined in many of its 
aspects  including  structure,  function,  development,  maintenance  and  plasticity, 
which renders the NMJ the most thoroughly investigated synaptic structure (Balice-
Gordon, 1997a; Sanes & Lichtman, 1999). The reasons for these rigorous efforts lie 
in the fact that the NMJ was and still is considered a fairly simple, large, and easily 
accessible model system for synapses (Astrow et al., 1994, 1998; Lampa et al., 
2004;  Patton,  2003;  Ribchester,  2009;  Rochon  et  al.,  2001;  Sanes  &  Lichtman, 
1999; Wigston,  1990)  especially  when  compared  to  those  located  in  the  central 
nervous system (Balice-Gordon, 1997b; Lu & Lichtman, 2007). However, in recent 
years, research on the NMJ in its own right has been driven forward, after it was 
shown that the architecture and composition of the NMJ is compromised in various 
congenital myasthenic syndromes (Hughes et  al.,  2006).  Furthermore, the motor 
NTs are the first areas to degenerate in dying-back neuropathies (Luo & O’Leary, 
2005;  Saxena  &  Caroni,  2007)  such  as  amyotrophic  lateral  sclerosis  (Dadon-
Nachum et al., 2011) and acrylamide intoxication (Jennekens et al., 1979), and are 
targeted by a number of bacterial, spider and snake toxins (Cull-Candy et al., 1976; 
Dixon & Harris, 1999; Duchen et al., 1981; Duchen & Strich, 1968; Duchen & Tonge, 
1973; Gopalakrishnakone & Hawgood, 1984; Hucho, 1995). In addition to this, the 
different  structures  of  the  NMJ  also  pose  as  targets  for  auto-antibody-mediated 
attacks  in  Lambert-Eaton  myasthenic  syndrome,  myasthenia  gravis  and  possibly 
also acquired neuromytonia (Hughes et al., 2006; Vincent, 2008). 
 
1.2.1 Research carried out on the NMJ: tools, techniques and sites 
Progress in research on the NMJ has largely been determined by the tools available 
(Hughes  et  al.,  2006;  Sanes  &  Lichtman,  1999).  The  first  descriptions  of “nerve 
endings”  date  back  to  1836,  however,  it  was  only  Doyere,  in  1840,  who  first 
described that the nerve terminates on the muscle (and does not form an arc which 
runs back to the CNS as a sensory fibre as surmised in the earlier descriptions) (Lu 
& Lichtman, 2007). These investigations triggered numerous studies of motor NTs in 
varies species, one of the most complete being published by Kuehne in 1887, who 
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axonal  branches  (Lu  &  Lichtman,  2007).  Subsequent  development  of  the  silver-
staining technique was employed by researchers such as Retzius, Cajal and Tello. 
However,  it  was  Paul  Ehrlich,  who  already  in  1886  introduced  the  vital  dye 
methylene blue (Lu & Lichtman, 2007). Development of the electron microscope in 
the 1950s made it possible to examine the structures involved more closely (Lu & 
Lichtman,  2007;  Ribchester,  2009),  whereas  advances  in  modern  biological 
technologies  at  the  end  of  the  20
th  century  facilitated  the  isolation  of  individual 
molecules involved in signaling (Sanes & Lichtman, 1999). In recent years, strong 
progress was made both in imaging techniques and fluorescent probes binding to 
various  components  of  the  NMJ.  These  include  the  NT-stains  4-(4-
diethylaminostyryl)-N-methylpyridium  iodide,  RH  795,  tetanus  toxin  and  FM1-43, 
calcein  blue  acetoxymethyl  ester  which  labes  the  pSCs,  various  lectins  such  as 
peanut agglutin, which label the synaptic basal lamina, and α-bungarotoxin (BTx) 
which  selectively  binds  to  the  nicotic  acetylcholine  receptors  (nAChRs),  the 
muscular  component  of  the  NMJ  (also  see  1.2.3)  (Astrow  et  al.,  1998;  Balice-
Gordon,  1997b;  Betz  et  al.,  1992;  Magrassi  et  al.,  1987;  O'Malley  et  al.,  1999). 
Especially  the  “construction”  of  transgenic  animals,  which  express  fluorescent 
proteins in neurons/axons and various glial cells, such as SCs (Feng et al., 2000; 
Livet et  al.,  2007; Zuo et al., 2004) has proven  extremely helpful in this kind of 
research (Hayashi et al., 2008; Lichtman & Sanes, 2003; Magill et al., 2007, 2008).  
Investigations  of  the  NMJ  have  been  conducted  in  various  different  sites  and 
animals.  The most  popular  sites  include the  sartorius  (Herrera  et  al.,  1990)  and 
cutaneous  pectoris  muscle  (Georgiou  &  Charlton,  1999)  in  the  frog,  the 
sternocostalis (Kemplay & Stolkin, 1980), bulbocavernosus (Lubischer & Bebinger, 
1999),  soleus  (Lubischer  &  Thompson,  1999),  gastrocnemius  (Ma  et  al.,  2002; 
Mehta et al., 1993) and extensor digitorum longus muscle (Love & Thompson, 1998) 
in  the  rat,  and  the  levator  auris  longus  (Rochon  et  al.,  2001),  gluteus  (Balice-
Gordon,  1997b),  soleus  (Fahim  et  al.,  1983;  Wigston,  1989),  gastrocnemius 
(Wigston, 1990), extensor digitorum longus (Fahim et al., 1983), flexor digitorum 
brevis (Halstead et al., 2004), bulbocavernosus (Balice-Gordon, 1997b), triangularis 
sterni (Bishop et al., 2004; Goodfellow et al., 2005; Kerschensteiner et al., 2008), 
diaphragm (Bullens et al., 2002; Halstead et al., 2004; O'Hanlon et al., 2001) and 
sternomastoid muscle in the mouse (Balice-Gordon, 1997b; de Paiva et al., 1999; 
Lichtman  et  al.,  1987;  O'Malley  et  al.,  1999;  Rich  &  Lichtman,  1989b). 
Developmental stages examined reach from embryos, over neonates  to adult  or 1. Introduction    21 
senile individuals (Balice-Gordon, 1997b; Fahim et al., 1983; Love & Thompson, 
1998; Trachtenberg & Thompson, 1996). 
All  mammalian  muscles  listed  above  share  two  traits,  namely  that  their  muscle 
fibres, physiologically, are singly innervated by only one axon and that their NMJs 
exhibit an en plaque morphology. These features are the norm in the mammalian 
muscle,  however,  amphibian,  reptile,  avian  and  some  mammalian  muscles  also 
have muscles fibres, which are multiply innervated and exhibit en grappe synapses 
(Morgan & Proske,  1984; Hughes  et al., 2006). En  plaque  endplates,  which  are 
found  mostly  on  mammalian  twitch  muscle  fibres,  are  about  50  µm  in  diameter 
(Hughes et al., 2006) and physiologically are clustered in a central endplate band 
across the muscle (Sanes & Lichtman, 1999). In contrast to this, en grappe endings 
are found on tonic or intermediate muscle fibres, exhibit a smaller diameter of only 
10 to 16 µm and usually are dispersed along the entire length of individual muscle 
fibres (Hughes et al., 2006). The latter fibres, unlike twitch muscle fibres, do not 
respond  to  a  single  neural  input  with  a  single  action  potential,  but  rather  are 
activated by a passive spread of depolarisation from multiple nerve endings, which 
results  in  continuous  contractions  lasting  over  time  (Hughes  et  al.,  2006).  In 
mammals,  muscle  fibres  of  the  extraocular,  laryngeal,  intrinsic  ear  and  tongue 
muscles  as  well  as  the  intrafusal  fibres  found  in  muscle  spindles  contain  multi-
innervated  fibres  with  both  en  plaque  and  en  grappe  endings  (Matthews,  1981; 
Morgan  &  Proske,  1984;  Subramani  et  al.,  1986;  Hughes  et  al.,  2006).  In  the 
following all information is related to en plaque NMJs. 
 
1.2.2 Formation and maturation of the NMJ 
During the first postnatal weeks all mammalian en plaque NMJs share a elliptical 
plaque-like appearance and are multiply innervated (Ma et al., 1999). Their shape, 
however, becomes more distinguished over the next few weeks due to changes in 
input, so that mature NMJs have been likened to the form of pretzels, with each 
NMJ exhibiting a distinct and individual appearance and supplied by a single axon 
(Bishop  et  al.,  2004;  Sanes  &  Lichtman,  1999).  During  further  growth  of  the 
organism the NMJs have been described not to change anymore in their geometry 
and shape, only in size (Balice-Gordon, 1997a, 1997b; Kang et al., 2007; Lichtman 1. Introduction    22 
et  al.,  1987;  Lubischer  &  Bebinger,  1999;  Powell  et  al.  1982;  Son  et  al.,  1996; 
Wigston, 1990). A mature NMJ physiologically persists for life, remodeling of small 
areas,  however,  can  be  observed  and  attributed  to  changes  in  input  or  activity 
(Wigston, 1990). In general, the extent of NMJ remodeling seems to rely on the age, 
species and muscle observed. 
Frog NMJs seem to undergo a lot more changes when compared to NMJs of young 
adult  (three  to  six-month  old)  mice  (Herrera  et  al.,  1990;  Wigston,  1990).  The 
sternomastoid muscle in such mice exhibits hardly any changes when  examined 
over a period of three to  six months (Lichtman  et  al.,  1987; Sanes &  Lichtman, 
1999), whereas approximately one seventh of NMJs in the gastrocnemius muscle 
(Wigston, 1990) and close to half of the NMJs in the soleus muscle in mice undergo 
significant remodelling in the same period of time (Wigston, 1989). The reason for 
these discrepancies in observations might lie in the different approaches applied for 
these  studies,  i.e.  the  application  of  presynaptic  (Lichtman  et  al.,  1987)  or 
postsynaptic  dyes  (Wigston,  1989)  or  both  (Wigston,  1990).  Alternatively,  the 
amount of fast- and slow-twitch muscle fibres per muscle has been proposed to play 
a role, too (Wigston, 1990). Muscles containing mostly fast-twitch fibres, like the 
sternomastoid,  the  bulbocavernosus  and  gastrocnemius  muscles  in  the  mouse, 
exhibit  less plasticity  (changes)  when  compared  to those consisting to a greater 
degree of slow-twitch fibres, like the soleus muscle (Wigston, 1990). In embryonic 
and young adult mice up to 3 months of age, NMJs can further be divided into “fast 
synapsing” and “delayed synapsing” NMJs, which is independent from which kind of 
muscle fibres these are located on, but nevertheless has an impact on the stability 
of  the  different  neuromuscular  components  during  synaptogenesis  and  following 
toxin- and denervation-induced paralysis (Pun et al., 2002; Santos et al., 2003). A 
drastic  increase  of  instability  of  synapses  has  been  reported  once  mice  have 
reached the age of one year. This instability becomes quite marked at an age of 18 
to 20 months, so that 24- to 36-month-old mice exhibit significant losses both in pre- 
and postsynaptic components of the NMJ even in the otherwise relatively stable 
sternomastoid muscle (Balice-Gordon, 1997a, 1997b). Other researchers report an 
increase  in  the  number  of  intrasynaptic  nerve  branches  in  association  with  an 
increased number of primary clefts on the postsynaptic sites in 29-month-old mice, 
rendering the pre-and postsynaptic apparatus observed a lot more complex than 
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1.2.3 Anatomy of the NMJ (Fig.5) 
The NMJ is a tripartite synapse consisting of a) a presynaptic component, the motor 
NT,  b)  a  postsynaptic  component,  the  nAChRs,  and  c)  glia,  the  pSCs  (Balice-
Gordon, 1997b; Feng & Ko, 2007; Hughes et al., 2006; Ribchester, 2009; Sanes & 
Lichtman,  1999).  Recent  research  has  provided  mounting  evidence  of  a  fourth 
component of the NMJ, a fibroblast-like cell, which lies outside the synaptic basal 
lamina, caps the NMJ in total and thus has been named ‘kranocyte’ (Court et al., 
2008; Ribchester, 2009; Fig. 5C). 
The  motor  NT  is  polarised  (Patton,  2003),  with  most  of  the  synaptic  vesicles 
clustered in that half of the terminal which faces the muscle. The ab-junctional half 
mostly  incorporates  mitochondria,  which  provide  the  energy  for  neurotransmitter 
synthesis and release (Sanes & Lichtman, 1999), and also buffer intracellular Ca
2+ 
(Hughes et al., 2006). The synaptic vesicles, which have an approximate diameter 
of 30-50 nm and are filled with the neurotransmitter acetylcholine (ACh), are once 
again concentrated in so-called active zones (Patton, 2003) and are associated with 
voltage-dependant K- and Ca
2+-channels (Hughes et al., 2006; Sanes & Lichtman, 
1999). Following the arrival of an action potential at the NT, Ca
2+ enters the NT and 
leads to a marked increase of the local Ca
2+-concentration. This triggers the fusion 
of the synaptic vesicles with the preterminal axonal membrane, thus resulting in the 
release of ACh into the synaptic cleft. Additionally, to being Ca
2+ -dependent, this 
process also relies on various SNARE (soluble NSF (N-Ethylmaleimide-Sensitive 
Factor) Attachment Protein receptor) -proteins associated with both the presynaptic 
NT membrane and the vesicle membranes (Hughes et al., 2006). Other molecular 
structures  on  the  NT  surface  feature  the  α-latrotoxin  receptor  (Lelyanova  et  al., 
2009), which mediates the binding of the black widow spider venom, A2A adenosine 
receptors  (Baxter  et  al.,  2005)  and  gangliosides,  which  act  as  receptors  for  the 
neurotoxins tetanus toxin and botolinum toxin (van Heyningen, 1974; see also 3.5.4) 
Once released, the ACh transverses the short synaptic cleft, which is roughly 50 to 
80 nm wide (Hughes et al., 2006; Yamagata et al., 2003), thus about two to three 
times  wider  than  the  average  interneuronal  synaptic  cleft  (Patton,  2003),  and  is 
taken up by the nAChRs. These nAChRs are ligand-gated ion channels (Hughes et 
al.,  2006)  and  are  located  on  the  postsynaptic  membrane.  The  postsynaptic 
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and is organised in about 1 to 2 µm deep junctional folds, the secondary synaptic 
folds. The nAChRs are located at a concentration of more than 10,000 per µm
2 
(Hughes  et  al.,  2006;  Sanes  &  Lichtman,  1999)  in  direct  apposition  with  the 
presynaptic active zones at the crest and partly down the sides of the secondary 
folds,  whereas  Na-channels  are  located  in  the  depths  of  these  folds  (Sanes  & 
Lichtman, 1999). 
 
Fig.5: The neuromuscular junction. A schematic overview; B NMJ in a mouse expressing 
cyan fluorescent protein (CFP; blue in composite image) in its axons and green fluorescent 
protein (GFP; green in composite image) in its SCs. Additionally, the nicotinic acetylcholine 
receptors are stained with rhodamine-conjugated bungarotoxin (BTx; orange in composite 
image). C Location of the kranocyte (stained with anti-GM1 Ab; orange in composite image) 
in relation to the nerve terminals (CFP; blue in the composite image) and pSCs (GFP; green 
in the composite image). Scale bars: 20 µm. 1. Introduction    25 
Located within the synaptic cleft, and extending into the junctional folds, is the basal 
lamina which ensheaths every muscle fibre. The composition of this is similar to 
other basal laminae in the body, namely collagen IV, laminin, entactin, perlecan and 
fibronectin  (Patton,  2003).  In  addition  to  these,  however,  further  molecules  like 
acetylcholinesterase  (Hughes  et  al.,  2006;  Sanes,  1995)  for  the  clearance  of 
neurotransmitter (Patton, 2003) and agrin and neuregulin, two molecules important 
for postsynaptic differentiation and the clustering of nAChRs (Martin, 2003;Sanes & 
Lichtman,  1999),  can be found. Generally,  it is  assumed that the synaptic basal 
lamina  in  its  unique  composition  of  molecules  organises  and  maintains  the 
architectural  specialisation  of  the  pre-  and  postsynaptic  components  of  the  NMJ 
(Patton, 2003).  
On top of the NT the pSCs are situated, isolating the NMJ from the environment 
(Sanes  &  Lichtman,  1999).  Physiologically,  each  NMJ  (both  in  mammalian  and 
amphibian  organisms)  is  associated  with  between  three  and  five  pSCs  (Auld  & 
Robitaille, 2003; Hughes et al., 2006; O'Malley et al., 1999). This number seems to 
be relatively tightly regulated and depends on the endplate size (Love & Thompson, 
1998; Lubischer & Bebinger, 1999; Zuo et al., 2004) Unlike the preterminal SCs, 
which wrap themselves around to the motor axons and produce myelin, the pSCs do 
not produce any myelin and only cap the NT with their cell bodies and processes 
(Balice-Gordon, 1996).  
The apposition between pSCs and NTs is estimated to approximately 10-20 nm and 
no basal lamina intervenes (Griffin & Thompson, 2008). In the amphibian NMJ, the 
processes  of  pSCs  invade  the  synaptic  clefts  (Auld  &  Robitaille,  2003;  Griffin  & 
Thompson, 2008), whereas in mammalian NMJs the synaptic basal lamina inhibits 
the pSCs from doing so (Sanes & Lichtman, 1999). Invading processes can only be 
seen  at  mammalian  NMJs  under  pathological  conditions,  such  as  following  NT 
degeneration (Manolov, 1974; Miledi & Slater, 1970; Winlow & Usherwood, 1975), 
and habitually are observed in the mouse model of GBS described above (Halstead 
et al., 2004; O'Hanlon et al., 2001). In the event of a genetic deficiency for synaptic 
acetylcholinesterase or after chronic administration of anti-acetylcholinesterase, the 
pSCs also extend processes into cleft; this is seen as compensatory mechanism to 
reduce the amount and duration of ACh in the cleft during synaptic activity (Hughes 
et  al.,  2006).  In  general,  pSC  processes  have  been  described  as  very  dynamic 
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1.3 Schwann cells 
1.3.1 Origin 
Both myelinating and non-myelinating SCs arise from the neural crest, together with 
a  variety  of  other  neural  and  non-neural  cells,  such  as  neurons  (for  sensory, 
sympathetic  and  enteric  ganglia),  melanocytes,  satellite  cells,  endoneurial 
fibroblasts  (Joseph  et  al.,  2004)  and  endocrine  cells.  Neural  crest  cells  of  the 
cephalic  domain  of  the neural crest  even give rise to mesenchymal cells, which 
eventually  will  form  cartilage,  bone,  dermis,  connective  tissue  in  muscles  and 
glands, meningeal cells and adipocytes (Dupin et al., 2007; Le Douarin et al., 2008). 
The differentiation of multipotent neural crest cells seems to be strongly determined 
by the environment into which these cells migrate (Dupin et al., 2007) and once 
these cells  have reached  post-migratory  stages, they are fairly  restricted in their 
developmental  potential.  Various  experiments,  however,  in  which  neural  crest 
derived cells were removed from their differentiated tissues and subjected to a new 
environment, have exhibited a reversal of differentiation programmes and recovery 
of multipotential properties in these cells. In addition to this, pluripotent progenitors 
for glia, autonomic neurones and myofibroblasts and also a distinct line of bipotent 
cells,  yielding  myofibroblasts  and  glia,  have  been  shown  to  be  capable  of  self-
renewal (Dupin et al., 2007; Stemple & Anderson, 1992). 
 
1.3.2 Differentiation and maturation 
Differentiation  of  the  neural  crest  stem  cells  to  SCs  occurs  in  two  steps  during 
embryonic  development.  In  mice,  SC  precursors  have  been  formed  from  neural 
crest stem cells around embryonic day (E) 12/13 (Jessen & Mirsky, 2005). These 
then develop into immature SCs, which are present around E15/16 until the time of 
birth  (Jessen  &  Mirsky,  1999;  Woodhoo  &  Sommer,  2008).  Schwann  cell 
proliferation  rates  are  their  highest  during  the  immature  SC  stage  (Woodhoo  & 
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Both SC precursors and peripheral axons traverse the body together on their way to 
connect the periphery with the central nervous system, with the axons leading the 
way (Koirala et al., 2003). At this stage of development, the SC precursors are likely 
to provide trophic support for the sensory and motor neurons, in addition to being 
essential for the development of the normal nerve fasciculation (Jessen & Mirsky, 
2005). At the same time the SC precursors are dependant on neuregulin which is 
produced  by  the  axons  (Birchmeier  &  Nave,  2008;  Jessen  &  Mirsky,  1999)  and 
binds to ErbB receptors on the SCs (Hayworth et al., 2006). Differentiation of the 
immature  SCs  into  myelinating  and  non-myelinating  forms  seems  to  depend  on 
which axons they randomly have been associated with; SCs associated with single 
large diameter (> 1 µm) axons turn into myelinating SCs (Jessen & Mirsky, 2005) 
and this, in addition to the thickness of myelin produced by the SC, once again is 
mediated  by  neuregulin  (Birchmeier  &  Nave,  2008).  Following  nerve  injury,  both 
mature myelinating and non-myelinating SCs revert to a phenotype similar to that of 
immature SCs. Schwann cells precursors can (in vitro) be persuaded to form other 
neural  crest  derivatives.  Only  the  transition  from  SC  precursor  to  immature  SC 
seems to be irreversible (Jessen & Mirsky, 2005). This then means that once the 
neural crest cell has differentiated into a SC precursor, it will become a (myelinating 
or  non-myelinating)  SC.  There  is  not  clear  evidence  for  the  persistence  of  a 
precursor population in mature nerves (Jessen & Mirsky, 1999) 
Denervation of the NMJ in the first two weeks of life results in the pSCs undergoing 
apoptosis and this loss  extends  along the efferent axon  into the myelinating SC 
population. Application of glial growth factor, a member of the neuregulin family, 
prevents the apoptosis in vivo (Trachtenberg & Thompson, 1996), further indicating 
the dependency of SC to axons in this stage of development. During the maturation 
of SCs in the early postnatal life, however, the SCs establish an autocrine survival 
mechanism  which  renders  them  independent  from  axonal  neuregulin-production 
(Jessen & Mirsky, 1999). 
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1.3.3 Perisynaptic Schwann cells 
1.3.3.1 Distribution 
At  birth,  no  or  only  one  pSC  body  can  be  found  on  most  rat  NMJs  (Love  & 
Thompson,  1998).  This  one  pSC  forms  a  loose  cap  over  multiple  axonal  bulbs 
(Hirata  et  al.,  1997),  whereas  in  the  adult  only  one  pSC  is  responsible  for  one 
terminal bouton (Sanes & Lichtman, 1999). Neuromuscular junctions with no visible 
pSC  body  are  covered  by  processes  extending  down  from  cells  located  on  the 
preterminal axon (Love & Thompson, 1998). 
The most dramatic increase of pSCs occurs during the first two weeks of life in rats 
(Love & Thompson, 1998). The increase in pSC number is attributed to migration (at 
least for the first pSC), followed by a considerable rate of mitosis. Two- to four-
month-old rats exhibit two to four pSC bodies at each NMJ (Hirata et al., 1997; Love 
& Thompson, 1998) and over the next year only one or two pSCs are added to each 
NMJ (Love & Thompson, 1998). Reportedly, up to nine pSC bodies per NMJ can be 
counted in young adult rats and mice (O'Malley et al., 1999; Reynolds & Woolf, 
1992). Mitosis of pSCs, however, is  not seen  under physiological circumstances 
(Love & Thompson, 1998) and the number of pSCs in adult NMJs is remarkably 
stable (O'Malley et al., 1999). 
In general, large NMJs are associated with more pSCs than small NMJs (Love & 
Thompson, 1998; Lubischer & Bebinger, 1999) and shrinkage of endplates due to 
muscle fibre atrophy or gradual decrease of nAChRs in old individuals is associated 
with loss of pSCs (Lubischer & Bebinger, 1999; Sanes & Lichtman, 1999). 
 
1.3.3.2 Function 
Despite numerous studies trying to elucidate the role of the pSCs at the NMJ, not 
much  is  know  regarding  their  regular  function,  especially  in  mammals  (Griffin  & 
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It  has  been  shown,  however,  that,  like  glial  cells  at  central  nervous  system 
synapses, pSCs can detect neuronal activity at the NMJ. They respond to release of 
neurotransmitter from the motor NT with a rise in intracellular Ca
2+ derived from 
internal stores (Georgiou et al., 1994; Jahromi et al., 1992; Rochon et al., 2001), 
which in the frog in turn potentiates the release of neurotransmitter probably via 
second  messager-cascades  (Castonguay  &  Robitaille,  2001).  Additionally,  it  has 
been shown that frog pSCs can influence synaptic efficacy via G-protein signaling, 
which  are  linked  downstream to  purinergic,  adenosine  and  peptidergic  receptors 
(Robitaille, 1998). In mice, the increase of intracellular pSC Ca
2+ levels is mediated 
both  by  muscarinic  AChR  and  adenosine  A1  receptors  (Rochon  et  al.,  2001). 
Extracellular  Ca
2+  negatively  affects  the  pSCs  to  respond  to  the  release  of 
neurotransmitters (Rochon et al., 2001). Following denervation of NMJ or electrical 
stimulation of pSCs, frog pSCs also seem to be able to release ACh (Bevan et al., 
1973; Dennis & Miledi, 1974). The ACh-release following stimulation of the pSCs is 
Ca
2+-independent, relatively “explosive” and accompanied by an extensive changes 
of the pSC-morphology (Dennis & Miledi, 1974). 
Selective ablation of frog pSCs from the NMJ acutely does not seem to affect NMJ 
structure and function, whereas loss of pSCs for one week or more, results in the 
NTs retracting from the NMJ and a reduction in synaptic transmission (Reddy et al., 
2003). 
In addition to the functions described above, a role for the pSCs in “pruning” of 
neonatal multiple innervation of NMJs (Hirata et al., 1997; Love & Thompson, 1998), 
clustering  of  nAChRs  (Koirala  et  al.,  2003)  and  phagocytosis  of  cell  debris 
(Reynolds & Woolf, 1992) have been described. 
 
1.3.3.3 Perisynaptic Schwann cells and NMJ denervation 
As indicated above, denervation of motor endplates in neonatal rats results in the 
pSCs  undergoing  apoptosis,  as  at  that  stage  these  cells  are  still  trophically 
dependant  on  axons  (Lubischer  &  Thompson,  1999;  Trachtenberg  & Thompson, 
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Denervation of mammalian NMJs after that age, however, induces pSCs to change 
from a steady into a reactive form. These changes are mediated by an autocrine 
neuregulin  signaling  pathway  (Hayworth  et  al.,  2006)  and  result  in  the  pSCs 
extending processes towards neighbouring NMJs (Reynolds & Woolf, 1992), which 
then form an extensive interconnecting network (Son et al., 1996). This process is 
preceded by proliferation and spreading of the kranozytes capping the NMJ (Court 
et  al.,  2008).  The  reactive  forms  of  pSCs  themselves  display  characteristics  of 
earlier developmental stages (Son et al., 1996) and once reinnervation is complete, 
the pSC processes are withdrawn (Reynolds & Woolf, 1992). 
In  completely  denervated  muscles,  regenerating  axons  extend  towards  the 
periphery  along  the  bands  of  Büngner  until  they  reach  an  endplate.  Due  to  the 
network of pSC processes between the endplates, however, the axons often do not 
stop  there,  but  continue  growing  along  the  intercalating  pSC  processes  to  other 
NMJs (Son & Thompson, 1995b). This is the basis for (muscle) fibre type clustering 
after reinnervation and also often leads to multiple innervation of individual muscle 
fibres (Son & Thompson, 1995b; Son et al., 1996). Only once the endplates have 
regained innervation, some pSCs can undergo mitosis (Love & Thompson, 1998). 
In  partly  denervated  muscles,  the  pSC  processes  extending  from  denervated 
endplates preferentially contact still innervated endplates (Love & Thompson, 1999), 
induce the intact NTs there to grow and then guide the motor sprouts towards “their” 
denervated motor endplate, so that these motor axons end up providing innervation 
to another NMJ in addition to their original endplate (Son & Thompson, 1995a). In 
addition to inducing axonal growth, processes extending from denervated endplates 
also induce pSC mitosis on innervated NMJs (Love & Thompson, 1998; Lubischer & 
Thompson, 1999). 
The event of mitosis in adult pSCs, therefore, seems to require two prerequisites. 
Firstly, a preceding denervation at the same or a different site, and secondly, axon-
pSC  contact.  The  latter  further  implies  that  a  nerve-derived  factor  probably  is 
necessary  to  induce  mitosis.  Several  signaling  molecules,  including  neuregulin, 
platelet-derived growth factor, fibroblast growth factor and calcitonin gene-related 
peptide have been proposed to be responsible for this (Love & Thompson, 1998). In 
addition to this, reactive pSCs might also be responsible for providing the stimulus, 
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experiments indicated a role for neuregulin signaling in inducing pSC mitosis (and 
migration (Trachtenberg & Thompson, 1997)) at NMJs; the source of this, however, 
remains to be determined (Hayworth et al., 2006).  
 
1.3.3.4 Markers 
The most commonly used SC probe is S100, which labels both myelinating and non-
myelinating SCs (Koirala et al., 2003); in mouse SC precursors low levels of S100 
might be detected with increasing sensitivity of the assay (Jessen & Mirsky, 2005). 
In general, S100 proteins are Ca
2+ binding proteins and act primarily as intracellular 
Ca
2+ receptors, some, however, also extracellularly. There are roughly 16 different 
S100 proteins (Zimmer et al., 1995), of which S100B is commonly used as a marker 
for glial cells (Zuo et al., 2004). S100B has been described to play a role in cell-cell 
communication,  cell  structure,  growth,  metabolism  and  intracellular  signal 
transduction (Zimmer et al., 1995). Interestingly, in frogs, myelin associated proteins 
P0 and myelin-associated glycoprotein also label both myelinating SCs and pSCs 
(Georgiou & Charlton, 1999). All non-myelinating SCs can be labelled with Abs to 
glial fibrillary acidic protein (Jessen & Mirsky, 2005) and the cell-surface glycoprotein 
CD44 (Gorlewicz et al., 2009); peanut agglutin and mAb 2A12 specifically label the 
external surface of frog (and in the case of mAB 2A12 also avian) pSCs (Astrow et 
al., 1998), but unfortunately not mammalian pSCs (Koirala et al., 2003). However, 
Calcein blue,  a cell permanent dye  has recently been used to  label mammalian 
pSCs in vivo (O'Malley et al., 1999). 
LNX1 is an ubiquitin kinase which is specifically localised to mouse pSCs (compared 
to myelinating SCs). The expression of this protein is at its maximum roughly at 
postnatal week two to three and then persists in adults. Following denervation, it 
cannot  be  stained  for  anymore  (Young  et  al.,  2005).  In  direct  contrast  to  this, 
semaphorin  3A  is  predominantly  expressed  in  the  pSCs  of  postnatal  developing 
(until day 21) and denervated muscles and here selectively in pSCs of type IIb/x 
(fast-fatigable)  muscle  fibres  (De  Winter  et  al.,  2006).  The  monoclonal  Ab  4E2, 
which recognises a truncated nestin protein (Kang et al., 2007), weakly stains rat 
myelinating SCs, whereas pSCs do not exhibit any levels of immunoreactivity at all. 
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become strongly nestin immuno-positive until reinnervation of the NMJ has occurred 
(Astrow et al., 1994; Kang et al., 2007). Similarly, the blockade of nerve activity (or 
nerve transection of the efferent) results in the up-regulation both of glial fibrillary 
acidic protein (Georgiou et al., 1994), which might be important in inducing process 
extension (Love & Thompson 1998), growth-associated-protein (GAP) -43, which 
coincides  with  the  onset  of  process  extension  (Woolf  et  al.,  1992)  and  the  low-
affinity nerve growth factor receptor p75 (Reynolds & Woolf, 1992). 
Thus,  the  markers  for  semaphorin  3A,  nestin,  glial  fibrillary  acidic  protein 
(upregulated), p75 and GAP-43 indicate the reactive state of pSCs. 
 
1.3.4 Schwann cells as targets in pathological processes 
Myelinating SCs are affected by a number of hereditary demyelinating disorders. 
These include Charcot-Marie-Tooth disease and the lysosomal storage diseases, 
globoid cell and metachromatic leukodystrophy (Scherer & Wrabetz, 2008; Suzuki, 
2003).  Additionally,  these  cells  can  suffer  from  metabolic  disturbances,  such  as 
oxidative  stress  after  ischemia-reperfusion  injury  to  the  peripheral  nerve  in  both 
normal  (Iida  et  al.,  2004)  and  diabetic  peripheral  nerves  (Wang  et  al.,  2005). 
Intoxications  with  lead  (Powell  et  al.,  1982),  galactose  (Mizisin  &  Powell,  1993), 
bortezomib  (Shin  et  al.,  2010)  and  disulfiram  (Filosto  et  al.,  2008)  also  result  in 
changes observed in myelinating SCs. 
Additionally,  myelinating  SCs  are  presumed  to  be  directly  targeted  by 
Mycobacterium leprae in the peripheral neuropathy leprosy (Spierings et al., 2000) 
and  diphtheria  toxin  following  the  infection  with  Corynebacterium  diphteriae 
(Morgan-Hughes,  1968).  Immune-mediated  attacks  on  myelinating  SCs  are 
observed in paraproteinaemic neuropathies, lymphomatous neuropathies (Kelly & 
Karcher,  2005)  and  the  demyelinating  form  of  GBS,  CIPD  (Glass  &  Cornblath, 
1994). 
However, regarding pSCs posing as specific (and sole) targets in disease, the anti-
ganglioside  Ab-mediated  injury  described  above  seems  to  account  for  the  only 
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1.4 In vivo imaging 
In vivo imaging of synapses was pioneered in the 1980s, with the report of Purves 
and colleagues of imaging dendrites of sympathetic neuron in the cranial cervical 
ganglion probably being the first of its kind (Purves & Hadley, 1985). Following the 
development of dyes suitable to stain NTs reliably (see 1.2.1), this technique was 
subsequently applied to image NMJs in living mice (Kasthuri & Lichtman, 2004). In 
addition to single in vivo investigations, it now has become possible to monitor the 
same  NMJ  repeatedly  over  a  period  of  time  (Lichtman  et  al.,  1987; Lichtman  & 
Sanes, 2003), which has yielded invaluable information on development, stability 
and plasticity of synapses (Balice-Gordon, 1997b; Balice-Gordon & Lichtman, 1993; 
Lichtman & Sanes, 2003; Magrassi et al., 1987; Walsh & Lichtman, 2003). 
The  prerequisites for  the  sites  used for  in  vivo  imaging  include  ease  of  access, 
location  of  endplate  band  and  flatness.  Thus,  the  muscles  preferentially  used  in 
mice  comprise  the  sternomastoid,  lateral  gastrocnemius,  soleus  and  gluteus 
muscles (Balice-Gordon, 1997a, 1997b; Lichtman et al. 1987; O'Malley et al., 1999; 
Rich & Lichtman, 1989b; Wigston, 1989, 1990). 
 
1.4.1 Sternomastoid muscle 
The sternomastoid muscle (SM) acquires its motor innervation by the spinal part of 
CN XI, whose combined motor pool for SM, cleidomastoid muscle and trapezius 
muscle lies in the caudal medulla and C1 to C3. Sensory innervation is provided 
from the cervical plexus (C1 to C6) (Fitzgerald et al., 1982; Gottschall et al., 1980). It 
has, however, very recently been reported, that additional motor innervation to the 
SM might be supplied by ventral roots of the first few spinal nerves (Ullah et al., 
2007).  
Both medullary and spinal cervical components of CN XI exit the skull via the jugular 
foramen and run caudal under the digastric muscle, medial to the SM and lateral to 
the  truncus  vagosympathicus  together  with  CN  XII.  Cranial  nerve  XI  then  turns 
towards lateral, passing under the cleidomastoid muscle. On the lateral side of this 
muscle the innervation for the trapezius muscle branches off and the rest of the 1. Introduction    34 
nerve is divided up into a branch for the cleidomastoid muscle and a branch for the 
SM. The latter enters the SM from underneath in the middle of the muscle and is 
distributed throughout the middle of the muscle belly in a single endplate band. This 
endplate band lies in the mid-region of the muscle (Lichtman et al., 1987) and runs 
from caudomedial to craniolateral (when the mouse lies in dorsal recumbency). All 
muscle fibres of the SM pass the entire length of the muscle without interruption 
(Zenker et al., 1990). The SM itself consists of two parts, but predominantly is a fast-
twitch muscle  in  rats  and mice  (d'Albis et al., 1988;  Kemp  et al.,  2009). On the 
lateral side, there is a main white component with fibre types IIa (intermediate) and 
IIb (fast), whereas on the medial side a smaller red component with fibre types I 
(slow twitch) and II (fast) can be found (Gottschall et al., 1980). The fibre types do 
not seem to exert any influence on the size of the individual NMJs (Zenker et al., 
1990).  
 
1.4.2 Gastrocnemius muscle 
The gastrocnemius muscle is innervated by tibial nerve which enters the muscle 
from dorsal (Popesko et al., 1992). On the lateral gastrocnemius muscle (used for in 
vivo investigations (Wigston, 1990)) a short endplate band runs obliquely on the 
distal half of the lateral head close its border with the tibia. 
The  mouse  and  rat  lateral  gastrocnemius  muscle  is  predominantly  a  fast-twitch 
muscle (90%) with the surface area containing only fast-twitch fibres (Gillespie et al., 
1987;  Wigston,  1990),  whereas  in  human  subjects  this  muscle  seems  to  be 
predominantly slow-twitch (Shorey & Cleland, 1988). 
 
1.4.3 Soleus muscle 
Innervation to the soleus muscle is provided by a branch of the tibial nerve, which 
enters the soleus muscle in its proximal third from dorsal (Popesko et al., 1992). 1. Introduction    35 
The endplate band of the soleus muscle extends diagonally on its caudal aspect 
from proximo-lateral to distal-medial. In rats, mice and humans, the predominant 
fibre types in the soleus muscle are slow (I) and intermediate types (IIa) (d'Albis et 
al., 1988; Gillespie et al., 1987; Jaweed et al., 1975; Kemp et al., 2009; Shorey & 
Cleland, 1988). 
 
1.4.4 Gluteus muscle 
The gluteus muscle is innervated by two branches of the sciatic nerve, the rostal 
and caudal gluteal nerves, and its endplate band runs in a craniocaudal direction 
(Lampa et al., 2004). 
Both in rat and mouse, the gluteus muscle is a predominantly fast-twitch muscle 
(Armstrong & Phelps, 1984; Lampa et al., 2004). 
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1.5 Aims 
The  aim  of  my  doctoral  research  project  was  to  combine  the  already  well-
established mouse model of GBS with an in and ex vivo imaging system of the 
murine NMJ and exploit this paradigm to investigate acute injury and regeneration of 
neural and glial structures targeted in GBS. 
The  successful  establishment  of  an  in  vivo  imaging  system  not  only  allows  to 
monitor and document acute dynamic changes to the neural and glial components 
of the NMJ following anti-ganglioside Ab and complement-mediated injury in real 
time, but also to highlight the progress and recovery of individual NMJs over time. 
This system then can also be used to investigate potential therapies for GBS, in 
addition  to  exploring  basic  neurobiological  questions  on  the  relationship  of  the 
neural and glial components of the NMJ with one another. Due to the possibility of 
multiple reimaging sessions, the number of experimental subjects required to obtain 
the information desired can be greatly decreased. 
Within this investigatory paradigm, my investigations sought to address the following 
hypotheses:  
1.  Following an in / ex vivo application of anti-ganglioside Ab and complement, 
differential (neural and or glial) patterns of injury can be observed depending 
on the binding specificity of the anti-ganglioside Ab applied. 
2.  Injury  restricted  to  the  distal  motor  nerves  and  NTs  can  be  observed 
following the application of anti-ganglioside Abs which specifically bind to the 
NTs, and a source of complement. 
3.  Following a single anti-ganglioside Ab and complement-mediated injury, the 
distal  motor  nerves  and  NTs  can  rapidly  recover  their  physiological 
morphology. 
4.  The  rate  of  NT  recovery/regeneration  is  decreased  in  the  event  of  a 
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5.  Similar to amphibian NTs, mammalian NTs are also dependant on pSCs. 
Thus,  morphological  changes  to  the  NTs  can  be  observed  following  a 
prolonged (one week or more) loss of pSCs. 
To ensure reliability and reproducibility of the investigations and to eliminate any 
artificial changes in this system, my experiments were conducted in a hierarchical 
fashion and included a number of control and supplementary investigations. 
These included to  
·  confirm  stability  of  the NMJ  over  time  in  the mice  aspired  to  use  for  the 
imaging investigations (chapter 3.1) 
·  optimise  in  vivo  imaging  technique  to  eliminate  any  manipulation  and 
imaging-induced changes (chapter 3.2) 
·  determine most advantageous anti-ganglioside Abs for in vivo investigations 
(chapter 3.3)  
·  ensure that results acquired from the different muscles can be extrapolated 
to one another and that muscles used for investigations are able to exhibit 
the properties required (chapter 3.4) 
Once these prerequisites were established, the in and ex vivo regeneration studies 
were to be conducted.  
In  these  investigations,  the  focus  lay  on  the  rate  of  distal  motor  nerve  and  NT 
regeneration following anti-ganglioside Ab and complement-mediated injury (chapter 
3.7). To examine the role of the pSCs in NT recovery/regeneration, a concomitant 
injury of the pSCs was carried out (also chapter 3.7).  
In addition to the in vivo experiments, a number of ex vivo auxiliary investigations 
were  carried  out  to  elucidate  the  meaning  of  the  loss  of  intracytosolic  axonal 
fluorescent proteins in the injury paradigms applied and to facilitate the interpretation 
of the results achieved (chapter 3.6). 1. Introduction    38 
Out  of  line  with  the  rest  of  the  investigations,  a  result  achieved  in  the  primary 
investigations, namely the physiological and rapid uptake of anti-ganglioside Ab into 
the NT, was further explored in a side-study (chapter 3.5). 
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2. GENERAL MATERIALS AND METHODS 
2.1 Experimental animals 
2.1.1 Wildtype (WT) fluorescent mice 
All  experiments  were  conducted  in  fluorescent  B6.Cg-Tg(Thy1-CFP/S100B-GFP) 
mice, which express intracytosolic cyan fluorescent protein (CFP) in their peripheral 
motor and sensory axons (Feng et al., 2000) and intracytosolic green fluorescent 
protein (GFP) in their Schwann cells (Zuo et al., 2004). These double-fluorescent 
mice  were  generously  supplied  to  us  by  Dr  W.  Thompson  (Austin,  TX,  USA), 
however now are also commercially available as individual lines through Jackson 
(Bar  Harbor,  ME,  USA).  The  description  of  these  lines  on  the  “The  Jackson 
laboratory  site”  (http://jaxmice.jax.org/)  indicates  that  the  double-fluorescent  mice 
are on a mixed B6/DBA background and are - at least for the expression of GFP - 
supplied as homozygous mice. To increase the number of experimental subjects 
available, male double-fluorescent mice were also outbred with conventional DBA 
females. All F1-offspring of these matings where also double-fluorescent, indicating 
that the founder line must be homozygous for the expression of both GFP and CFP. 
Heterozygous F1 mice were crossed to acquire single-fluorescent (GFP or CFP) 
mice. 
All  offspring  (both  homozygous  and  heterozygous)  were  investigated  for  the 
inheritance of transgenes by phenotyping ear-punches from 21 day-old mice. For 
this, the skin of the two sides of the ear was gently pulled apart and coverslipped 
with  Citifluor  antifade  (Citifluor  Products,  Canterbury,  UK)  with  the  inner  side 
upwards.  The  samples  were  then  examined  under  a  fluorescence  compound 
microscope (see 2.3.4 for details) for the occurrence of GFP in adipocytes and CFP 
in axons/neurons. 
In our particular strain of mice, the expression of CFP is observed in all peripheral 
motor axons; this lies in contrast to other strains of these mice, where only a subset 
of  motor  axons  exhibit  fluorescent  proteins  (Beirowski  et  al.,  2004;  Feng  et  al., 
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The  GFP  signal  intensity  is  proportional  to  the  activity  of  the  S100B-promotor, 
however, GFP can also persist in these cells over some time even when the S100B-
promotor is inactive. Myelinating SCs exhibit a lower level of GFP intensity when 
compared to pSCs (Magill et al., 2007). 
Both homozygous or heterozygous mice were used for experiments; occasionally 
only single-fluorescent (only CFP or GFP) mice were required. 
 
 
2.1.2 Knock-out (KO) fluorescent mice (see Fig.1) 
GalNac-Transferase  knock-out  (GM2KO)  mice  do  not  express  any  complex 
gangliosides,  whilst  at  the  same  time  expressing  higher  levels  of  the  simple 
gangliosides GM3, GD3 and GT3 (Takamiya et al., 1996). 
GD3-Synthase KO-mice (GD3KO) do not express any gangliosides of the b- and c-
series, but express gangliosides of the a-series at higher levels when compared to 
WT mice (Kawai et al., 2001; Okada et al., 2002). 
Both  of  these  strains  are  viable  and  do  not  appear  to  have  any  very  obvious 
morphological, behavioural and electrophysiological changes (Bullens et al., 2002; 
Kawai et al., 2001; Okada et al., 2002; Takamiya et al., 1996). The homozygous 
male  GM2KO-mice,  however,  are  sterile  and  other  investigators  report  subtle 
changes to the myelination of axons and increased axonal degeneration both in the 
CNS and PNS of these mice (Sheikh et al., 1999b). 
Both strains of KO-mice were crossed with fluorescent mice to obtain both single-
and double-fluorescent KO-mice. Inheritance of the transgenes was confirmed by 
PCR (kindly carried out by Dr Denggao Yao) and phenotyping of earsamples (see 
2.1.1). 
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2.1.3 Knock-in-knock-out fluorescent mice (PLP-transgenic (Tg-) mice) 
In GM2KO-mice, GalNac-Transferase was reintroduced by linking this enzyme to a 
proteolipid  protein  (PLP)-promotor.  PLP  and  its  smaller  isoform  DM20  are 
expressed in oligodendrocytes, SC precursors, olfactory ensheathing cells and also 
some non-glial cells (cardiomyocytes and cells of the thymus) (Griffiths et al., 1998). 
This  means  that  in  these  mice  only  the  cells  listed  above  should  be  able  to 
synthesise and thus exhibit complex gangliosides.  
To obtain (single- and double-) fluorescent PLP-Tg-mice, fluorescent GM2KO-mice 
were crossed with non-fluorescent PLP-Tg mice. Due to sterility of the homozygous 
male GM2KO-mice (see 2.1.2), no backcrossing was carried out. Inheritance of the 
required transgenes was confirmed by PCR (kindly carried out by Dr Denggao Yao) 
and phenotyping of earsamples (see 2.1.1). 
 
2.1.4 Age and sex 
All  experiments  were  carried  out  in  male  and  female  ten-  to  14-week-old  mice 
unless stated otherwise. 
 
2.1.5 Procedures 
All procedures described were carried out in accordance with UK home office and 
local (University of Glasgow) guidelines.  
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2.2  In  vivo  exposure  and  imaging  of  the  sternomastoid  (SM)  and 
sternohyoid (SH) muscles 
2.2.1 Preparation of the mouse, surgical approach and intubation 
All mice were induced in an anaesthetic box (Fig.6A), which was flooded with 4% 
isoflurane (IsoFlo®, Abbot, Kent, UK). Following tolerance, the mice were supplied 
with buprenorphine (Vetergesic®, Reckitt Benckiser, Hull, UK; 0.05 mg/kg s.c) and 
0.5  ml  Glucose-saline  (Baxter,  Thetford,  UK;  s.c.)  before  being  transferred  to  a 
padded  metal  plate,  positioned  in  dorsal  recumbency  and  maintained  on  2% 
isoflurane with a mouse mask. Body temperature was kept physiological by placing 
the mice in a bubble-wrap “sleeping-bag” and supplying them with heated hot water 
bottles (tied-off glove-fingers filled with warm water). All surgical procedures were 
monitored with the help of an anaesthesia protocol (Table 1). 
As a next step, the ventral neck area from the area of the chin to the rostral area of 
the  sternum  were  depilated  (Fig.6B;  Veet  ®,  Renckitt  Benckiser,  Hull,  UK)  and 
cleaned with 70% alcohol. Following a midline incision, the bilateral submandibular 
salivary glands were separated and retracted carefully, and the SM and SH exposed 
(Fig.6C). 
The  surgical  area  was  covered  in  sterile  Ringer’s  solution  (Vetivex  9,  Dechra, 
Shrewsbury, UK; approximate ionic content: 147 mM Na, 4 mM K, 2.25 mM Ca, 
155.5 mM Cl) and the mice were intubated with a 18G (green) or 20G (pink) ventflon  
(Vasofix®, Braun, Melsungen, Germany) under visual guidance and connected to a 
rodent  ventilator  (Harvard  Apparatus,  Edenbridge,  Kent,  UK).  All  mice  were 
ventilated at 110 breaths per minute and 0.1 ml volume per 10g (i.e. 0.3 ml for a 30g 
mouse). 
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Table 1: Anaesthesia protocol 
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Fig.6:  In  vivo  imaging.  A  mouse  being  induced  in  an  anaesthesia  box  flooded  with 
isoflurane;  B  mouse  maintained  under  anaesthesia  with  an  isoflurane  mask  and  being 
depilated for surgery; C SM and SH following a midline incision in the ventral neck area and 
retraction of skin and salivary glands; D, E mouse placed under the microscope for in vivo 
imaging; F: map to depict location of NMJs imaged; G: mouse sutured up following imaging 
and ready for recovery. 
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2.2.2 In vivo imaging 
Prior to imaging the skin surrounding the surgical area was retracted in four points 
(caudal-left and -right and rostral-left and -right) to create a trough. Then the SH and 
SM were covered with 0.4 ml of sterile Ringer’s solution containing rhodamine- or 
Cy5-conjugated  BTx  (Molecular  Probes,  Eugene,  OR,  USA)  for  10  minutes. 
Following a wash with Ringer’s solution, the trough was filled with Ringer’s solution 
and  the  mice  transferred  to  the  imaging  microscope  (Fig.6D,  E),  which  was  an 
epifluorescence microscope (Leica DMI4000B, Leica, Wetzlar, Germany) fitted with 
the appropriate filters to detect cyan, green, red and purple fluorescence (see Table 
2) and connected to a computer via camera (Leica DFC 350 Fx, Leica Wetzlar, 
Germany). Images were acquired with the help of Leica Application Suite (Version 
2.5.0 RI, Leica Microsystems CMS GmbH, Switzerland). 
Following orientation at a total magnification of x100 (numerical aperture (NA) 0.3), 
superficial  NMJs  of  the  SH/SM  were  imaged  at  x400  (NA  0.8),  taking  care  to 
minimise the exposure of the tissue to light. The localisation of the NMJs imaged 
was depicted by maps drawn which highlighted the main structures of the muscle 
(Fig.6F). Individual NMJs were identified by their distinct BTx-signal. 
Fluorochrome  TRITC  GFP  CFP  Cy5 
Excitation range  Green  Blue  Violet / blue  Red 
Excitation filter  BP 546/12  BP 470/40  BP 436/20  BP 620/60 
Dichromatic mirror  565 nm  500 nm  455 nm  660 nm 
Suppression filter  BP 600/40  BP 525/50  BP 480/40  BP 700/75 
 
Table 2: Filter sets for Leica DMI4000B (in vivo imaging). All values for bandpasses (BP) 
are given in nm. 
 
2.2.3 Recovery 
All  mice  recovered  received  a  skin  suture  (single  sutures  Fig.6G,  6-0  Vicryl, 
Ethicon®,  Johnson  &  Johnson,  Livingston,  UK),  a  single  dose  of  carprofen 
(Rimadyl®, Pfizer, Kent, UK; 5 mg/kg s.c.) and another dose of Glucose-saline (0.5 2. General Materials and Methods    46 
ml, s.c.). They were then transferred to a padded cage in an incubator (27ºC) for 24 
hours and fed with soft mouse chow and babyfood (egg custard with rice, Heinz, 
Hayes, UK). Over the next five days (or until sacrificed), the mice were monitored 
regarding  abnormalities  in  weight,  appearance  of  the  suture,  general  mentation, 
appetite, grooming, urination and defecation. 
2.2.4 Sacrifice 
In the event of a terminal anaesthesia, mice received an intraperitonaeal dose of 
pentobarbital  (Euthatal®,  Merial  Animal  Health  Ltd,  Harlow,  UK;  pentobarbital 
sodium  200  mg/ml;  0.3  ml  per  mouse).  The  muscles  were  then  processed  and 
imaged as described in 2.3. 
 
 
2.2.5 Reconstruction of images acquired in vivo (Figs.7, 8) 
For  reconstructing  the  images  a  combination  of  ImageJ  (Version  1.38,  NIH, 
Bethesda, MD, USA; http://rsb.info.nih.gov/ij/) and Adobe Photoshop CS (Version 
8.0,  Adobe  Systems  Europe  Limited,  Edinburgh,  UK)  were  used.  Some  macros 
used in ImageJ (“MinMax” and “deblurrr single stack”) were generated in-house by 
Mr Peter Humphreys; the commands for these are included in the Appendix. 
As a first step, all clear images showing a part of or the entire the NMJ (regardless 
of filter) were selected and optimised regarding their contrast (command “MinMax” in 
ImageJ). 
All  images  depicting  the  BTx-stain  were  then  combined  to  a  stack  in  ImageJ, 
deblurred and registered in the correct z-location within their stack with “deblurrr 
single stack”- and “stackreg” (with “scaled rotation”)  -macros.  The  z-stacks  were 
then  combined  to  one  single  image  (command  “ZProject”)  by  summarising  the 
intensities and the background subtracted (rolling ball radius: 50) once the files had 
been converted to an 8-bit file. 2. General Materials and Methods    47 
 
Fig.7: Effects of the image-processing steps. Two images depicting the BTx-signal are 
selected and optimised regarding their contrast (step 1), then deblurred (step 2). Following 
registering  in  the  stack,  the  stacks  are  combined  to  a  single  image  (step  3)  and  the 
background  subtracted  (step  4).  (For  illustratory  purposes,  the  images  are  deblurred 
individually; this step usually is conducted once the optimised images are combined to a 
stack. Scale bars: 20 µm.) 
 
The  images  acquired  of  the  GFP  and  CFP  were  first  optimised  regarding  their 
contrast (command “MinMax” in ImageJ) and then copied to Photoshop. Here the 
corresponding BTx-signal for the NMJ was used as a matrix for correct positioning 
of the GFP/CFP-filled structures. The GFP/CFP-image with the largest amount of 
neuromuscular structures in focus was selected, superimposed on the BTx-image 
and shifted to the correct position. In the following, layers were added onto the first 
GFP/CFP-image  and  the  in-focus  areas  cloned  from  the  respective  images  and 
pasted  onto  new  layers  to  acquire  a full  GFP/CFP-image  with  clear  and  distinct 
features for the whole NMJ. As a final step, the opacity of all layers was adjusted to 
100%, the BTx-stencil was deleted and all layers were merged (command “flatten 
image”). If necessary the background of the CFP/GFP-images was subtracted in 
ImageJ (rolling ball radius: 50) once the files had been converted to an 8-bit file. 
The  scale  bars  for  images  acquired  in  vivo  were  extrapolated  from  scale  bars 
acquired from the NMJs imaged in rapid succession (within an hour) in and ex vivo. 
These “sample” scale bars where then applied to the in vivo images according to 
their rate of magnification. 
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Fig.8: Workflow for the reconstruction of images acquired in vivo. For images depicting 
the BTx-stain (orange) all steps were conducted with ImageJ, whereas for GFP/CFP images 
(green/blue) a combination of ImageJ and Photoshop was used. 
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2.3 Fixation, processing and imaging (qualitative and quantitive) of the 
SM and SH 
2.3.1 In situ fixation 
Following sacrifice of mice by CO2/pentobarbital-exposure, the SM and SH  were 
exposed  in  the  same  manner  as  for  in  vivo  imaging  and  covered  with  4% 
paraformaldehyde (PFA; see 2.10.4) for 1 hour. The muscles then were extracted, 
pinned into Sylgard-coated imaging dishes (diameter: 34 mm) and post-fixed at 4ºC 
in 4% PFA for 1 hour (SH)/ 2 hours (SM). 
 
 
2.3.2 Perfusion 
In order to gain better resolution in SH/SM-wholemount  imaging, to facilitate the 
application  of  additional  stains  to  SM/SH  and  to  acquire  SH/SM  for 
electronmicroscopic investigations (EM), mice were perfused intracardially following 
C02-exposure.  Mice  were  pinned  out  in  dorsal  recumbency  and  the  heart  was 
exposed  following  an  abdominal  incision  and  reflection  of  the  sternum  towards 
rostal.  Next, the  left  cardiac  ventricle  was  expanded  by  the  flushing  agents, the 
portal vein transected and the agents applied with moderate pressure. 
For wholemount imaging of the SH/SM, the mice were flushed with 3 ml of Ringer’s 
solution and then fixed with 10 ml of warmed 4% PFA. Following perfusion, the SM 
and SH were extracted and post-fixed at 4ºC in 4% PFA for 1 hour (SH)/ 2 hours 
(SM). 
For the acquisition of tissue processed for EM, the mice were flushed with 10 ml of 
saline and then fixed with 20 ml of “Strongfix” (see 2.10.5). Following perfusion, SH 
and SM were exposed and post-fixed in situ for 1 hour in “Strongfix”, extracted and 
transferred into “Strongfix” at 4ºC for storage until processing. 
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2.3.3 Secondary staining 
For the optional application of primary and/or secondary Abs, the SH/SM following 
their  fixation  were  thoroughly  rinsed  in  phosphate-buffered-saline  (PBS;  see 
2.10.12) for 10 minutes, incubated in 0.1M Glycine for 10 minutes and rinsed again 
in PBS for 10 minutes. Primary/secondary Abs were applied as described in the 
relevant chapters and 2.8. 
 
2.3.4 Wholemount imaging (Fig.9A) 
Pinned-out fixed muscles were thoroughly rinsed in cold PBS before transferral to a 
Zeiss AxioImager with optional Apotome function (Zeiss, Goettingen, Germany) and 
adequate filters for the detection of blue, green, red and purple fluorescence (see 
Table  3).  Imaging  was  conducted  wholemount  in  PBS  with  water-immersion 
objectives and a total magnification of x200 (NA 0.5) and x400 (NA 0.8). All images 
acquired  were  reconstructed  semi-automatically  and  processed  with  Zeiss 
Axiovision  4.7.2  imaging  software  (©  Carl  Zeiss  Imaging  Solutions  GmbH, 
Germany). 
Fluorochrome  TRITC  FITC / GFP  CFP  Cy5 
Excitation range  BP 546/12  BP 485/20  BP 436/20  BP 640/30 
Dichromatic mirror  560 nm  510 nm  455 nm  660 nm 
Emission range  BP 575-640  BP 515-565  BP 480/40  BP690/50 
 
Table 3: Filter sets for Zeiss AxioImager (ex vivo imaging). All values for bandpasses (BP) 
are given in nm. 
 
 
 
 
 
2.3.5 Quantitative imaging 
In  quantitative  assessments,  superficial  NMJs  of  the  SM/SH  were  assessed  for 
GFP/CFP overlying the BTx-signal with the Zeiss AxioImager. CFP was scored as 
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signal,  regardless  of  its  morphology,  intensity  and  extent.  GFP  was  scored  as 
“present” if any GFP-positive cell bodies were overlying the NMJ, regardless of their 
fluorescence intensity. The percentage of NMJs exhibiting CFP or GFP was then 
calculated for each muscle assessed and pooled for each group and time-point. Chi-
square tests (Excel spreadsheet; Microsoft ® Office Excel 2003) were applied to the 
mean percentages of counts for each time-point and group to determine statistical 
significances between groups (personal communications Dr. Carl Goodyear). 
In SM these investigations were conducted in pinned-out muscles, whereas in SH 
these investigations were  conducted  in  coverslipped muscles (Fig.9B). In SM  as 
many superficial NMJs were assessed as possible (minimum: 51; maximum: 95), 
whereas in SH roughly 100 superficial NMJs per muscle were assessed. 
 
 
2.3.6 Electronmicroscopic investigations 
All stages of these investigations, including the processing, cutting and staining of 
tissue  followed  by  the  imaging  of  sections,  was  very  kindly  carried  out  by  Mrs 
Jennifer Barrie. 
Briefly, the tissue blocks prepared for resin embedding were processed using a Lynx 
Tissue Processor for Microscopy (Leica, Wetzlar, Germany). The tissues were post-
fixed in 1% osmium tetraoxide, subjected to alcohols of increasing grades followed 
by  propylene  oxide  and  then  infiltrated  with  araldite  resin.  In  resin-filled  silicone 
moulds, the tissue  blocks  were  then  orientated  and  left  for  24  hours at  60ºC  to 
polymerise. One µm-thick sections were cut with an Ultracut-E ultratome (Reichert-
Jung, Vienna, Austria). These sections were mounted on cleaned glass microscopic 
slides (Menzel, Braunschweig, Germany), stained with 1% methylene blue and 1% 
azur II in 1% borax and used for orientation in light microscopy. For EM, 70 nm 
sections were cut with a diamond knife and mounted on 300-mesh copper grid with 
a diameter of 3.05 mm. Sections were stained with uranyl acetate and lead citrate 
and imaged with a CX100 electron microscope (JEOL, Watchmead, Herts, UK). 2. General Materials and Methods    52 
 
Fig.9: Ex vivo imaging.  A wholemount SM and SH; B coverslipped SH; C ribcage and 
sternum pinned out with outer side upwards and connective tissue and superficial muscles 
removed; D exposure of the left and right TS following removal of the ribs and intercostal 
muscles; E single TS-prep pinned out for Ab- and complement-incubation; F coverslipped 
TS. 
 
 
2.4 Preparation of the triangularis sterni muscle (TS) 
The TS (also M. transversarius thoracis or M. sternocostalis) is a very thin muscle, 
which consists of only two to three layers of muscle fibres and lies within the rib 
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for very good Ab-penetration whilst also facilitating imaging by allowing this muscle 
to be coverslipped. Additionally, a large number of NMJs can be examined with a 
good spatial resolution (Kerschensteiner et al., 2008). 
In the mouse, the TS has a trapezoidal shape, originates at the sternum and inserts 
on the ribs. Cranially, the TS extends to the second intercostal space, whilst the 
seventh  intercostal  space  provides  its  caudal  limit  (Kempley  &  Stolkin,  1980; 
McArdle et al., 1981). Innervation to the TS is provided by the third, fourth and fifth 
intercostal nerves (Nickel et al., 1992). 
The gain access to the TS, the entire ribcage of the mouse is extracted following 
removal of skin, overlying muscle and contents of the thoracic cavity. The ribs are 
cut as close to the vertebral column as possible and the ribcage then pinned into a 
Sylgard-lined  petridish  containing  freshly  prepared  Ringer’s  solution  (see  2.10.1) 
with the outermost side up (Fig.9C). 
Next, the intercostal muscles are carefully dissected away in the second to fourth or 
third to fifth intercostal space. The TS can be identified by its fibres running rosto-
lateral to caudo-medial, which is the opposite when compared with the intercostal 
muscles  (rostro-medial  to  caudo-lateral).  Following  clearance  of  the  intercostal 
spaces,  the  ribs  are  carefully  lifted  and  cut,  first  close  to  the  sternum  and  then 
laterally  (Fig.9D).  Connective  tissue  usually  is  removed  together  with  the  ribs. 
Severing of blood vessels, especially the paired internal thoracic arteries, leads to 
“blood-staining”  of  the  TS.  This  can  easily  be  rectified  by  gently  squirting  the 
affected  area  with  a micro-fine  syringe  (BD  Medical-Diabetes  Care,  Oxford,  UK) 
filled with Ringer’s solution. 
Cutting the sternum along the midline results in the preparation being separated into 
two  individual  TS,  and  following  trimming  of  excess  tissue  (ribs,  muscle  and 
connective tissue), these can then be pinned into Sylgard-containing wells (Fig.9E). 
Careful pinning maintains the physiological tautness of the muscle, whilst limiting the 
pins  to  bony  structures  and  tissue  outside  the  ribs  ensures  that  the TS  are  not 
subjected to artificial changes. 
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2.5 Fixation, processing and imaging of the TS 
2.5.1 Fixation and processing of TS 
Following incubations, TS were rinsed with Ringer’s solution and fixed with 4% PFA 
for  20  minutes  at  4ºC.  Following  a  thorough  rinse  with  PBS,  the  TS  was  then 
dissected away from the surrounding bony structures of the ribcage. 
In the event of further staining, TS was thoroughly rinsed in PBS for 10 minutes, 
incubated in 0.1M Glycine for 10 minutes and rinsed again in PBS for 10 minutes 
before incubation with secondary Abs as described in 2.8. This was followed by 
another thorough PBS rinse. 
For  imaging,  the  TS  were  mounted  on  conventional  glass  slides  (Menzel, 
Braunschweig, Germany) in Citifluor antifading agent (Citifluor products, Canterbury, 
UK), coverslipped and sealed (Fig.9F). These muscles were stored at -20ºC until 
required for imaging. 
 
 
2.5.2 Qualitative imaging of TS 
Qualitative imaging of the TS was conducted with a Zeiss AxioImager with optional 
Apotome function  (Zeiss,  Goettingen, Germany;  also see  Table 3).  Imaging  was 
conducted with water-immersion objectives (total magnification x200 (NA 0.5) and 
x400  (NA  0.8))  or  with  an  oil-immersion  objective  (total  magnification  x630,  NA 
1.25).  All images acquired  were reconstructed semi-automatically and  processed 
with Zeiss Axiovision 4.7.2 imaging software (© Carl Zeiss Imaging Solutions GmbH, 
Germany). 
For the assessment of NT injury, 100 superficial TS-NMJs were assessed for the 
incidence of CFP overlying the BTx-signal. CFP was scored as absent, changed or 
healthy, and data (percentages) between groups was compared with the chi-square 
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2.5.3 Semi-quantitative imaging of TS and SM/SH sections 
For  quantitative  assessments  of  IgG/complement  deposition,  TS/SM  sections/SH 
sections  were  imaged  with  a  Zeiss  LSM  5  Pascal  confocal  microscope  (Zeiss, 
Oberkochen, Germany) at a magnification of x400 (NA 1.3; oil-immersion objective) 
and using constant acquisition settings both for fluorescein isothiocyanate (FITC) 
and tetramethyl rhodamine iso-thiocyanate (TRITC). Orientation within the samples 
was  carried  out  with  fluorescent  light (FITC  filter-set:  excitation  BP  450-490  nm, 
dichromatic mirror 510 nm, emission long pass filter (LP) 515 nm; TRITC filter-set: 
excitation  BP  546  nm/12,  dichromatic  mirror  580  nm,  LP  590  nm),  whereas  for 
imaging the samples were excited with an Argon laser (488/514nm, 25 mW) and a 
Helium Neon laser (543nm, 1 mW) and emission detected with two photomultiplier 
tubes.  Imaging  was  conducted  semi-automatically  with  LSM  5  Pascal  software 
(Version  2.5,  ©  Carl  Zeiss  1986-1999,  Portions  ©  Copyright  1996.  Microsoft 
Corporation.) 
At least 150 NMJs per muscle were imaged and these images were then semi-
quantified using a macro (“FITC/TRITC-Intensity”) generated in-house by Mr Peter 
Humphreys for the ImageJ software (see Appendix for macro). In short, this macro 
identified NMJs on the basis of the conjugated (FITC- or TRITC-) BTx-staining and 
measured  the  intensity  of  FITC/TRITC-conjuated  IgG/complement  covering  the 
NMJ-area.  The  maximum value  obtainable for read-outs  amounted to 255.  Data 
then  was  analysed  with  Minitab  statistical  software  (Version  16.1,  Minitab  LTd., 
Coventry, UK) and for comparison of time-points and groups the Mann-Whitney test 
(2 groups) or the Kruskal Wallace test (> 2 groups) for non-parametrical data were 
applied.  The  measurements  themselves  are  illustrated  by  boxplots  generated  in 
Minitab (Version 16.1, Minitab LTd., Coventry, UK). In these illustrations, the box 
depicts the values for the second and third quartile, whilst the lower whisker extends 
to the lowest value within the lower limit (Q1-1.5(Q3-Q1)) and the upper whisker 
extends  to  the  highest  value  within  the  upper  limit  (Q3+1.5(Q3-Q1)).  All  outlier 
points represent one individual value. 
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2.6. Permeabilisation of wholemount muscles 
Following fixation all muscles were thoroughly rinsed in PBS for 10 minutes, then 
incubated in 0.1M Glycine for a further 10 minutes and then rinsed in PBS again. 
Depending on the level of permabilisation required and the muscle used different 
permeabilisation protocols were applied: 
 
2.6.1 Permeabilisation only at the level of the NMJ 
Triangularis sterni muscles were incubated in blocking serum II (see 2.10.6) for 30 
minutes at 4ºC. Secondary Abs was applied in blocking serum II for 16 hours at 4ºC. 
 
2.6.2 Permeabilisation of the NMJ and proximal efferents 
TS were incubated in frozen acetone for 30 minutes at -20ºC, whereas SH/SM were 
incubated in frozen acetone for 1 hour at -20ºC. Following a thorough rinse in PBS, 
TS and SH/SM were further incubated for 1 hour in blocking serum III (see 2.10.6) at 
4ºC.  Both  primary  and secondary  Abs  were  applied  in  blocking  serum  III for  20 
hours at 4ºC. 
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2.7 Anti-ganglioside Abs and α-BTx (Table 4) 
  In vivo (SM/SH)  Ex vivo (TS)  Sections 
 
Concen-
tration  Quantity  Time  Concen-
tration  Quantity  Time  Concen-
tration  Quantity  Time 
α-BTx 
2.5 
µg/ml  0.4 ml  10 
min  2 µg/ml  1.33 
µg/ml 
6h or 
16h @ 
4ºC 
TBG3 
200 
µg/ml  0.6 ml  200 
µg/ml  50 µg/ml 
300 µl 
per 
slide  2h @ 
4ºC 
EG1  1 mg/ml  120 µl 
All other 
Abs 
100 
µg/ml 
100 
µg/ml 
NHS  40% 
0.6 ml 
30 
min 
40% 
0.5 ml  30 
min 
n.a. 
 
Table 4: Application of anti-ganglioside Abs and α-BTx  
(n.a. not applicable) 
 
In in vivo experiments all agents were applied diluted in sterile Ringer’s solution. 
In ex vivo experiments (TS and sections) all agents were applied diluted in Ringer’s 
solution made up according to 2.10. 
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2.8 Tissue manipulation and staining (Table 5) 
  Wholemount SH/SM  Wholemount TS  Sections 
  Concentration  Application  Concentration  Application  Concentration  Application 
Fixation 
with PFA 
4%  1h SH, 2h 
SM @ 4ºC  4%  20 min @ 
4ºC 
1% Triton 
x100  1h @ 4ºC  0.5% or 1% 
Triton x100 
30 min or 
1h @ 4ºC  Permea-
bilisation   Frozen 
acetone 
1h @  
-20 ºC 
Frozen 
acetone 
30 min @  
-20 ºC 
NF  1:100 
Anti-rabbit  1:200 
20h @ 4ºC  1:200  20h @ 4ºC 
C5b-C9 
(MAC) 
1:40 
1h in vivo 
plus 16h @ 
4ºC 
1:40 
1h @ RT, 
3h @ 4ºC, 
plus 16h @ 
4ºC 
n.a. 
Anti-
mouse 
1:200 
1h in vivo 
plus 16h @ 
4ºC or 4h 
@ RT 
(GAP-43) 
1:200  16h @ 4ºC  1:300  6h or 16h 
@ 4ºC 
EthD-2  1:500  30 min  1:500  30 min 
Anti-GAP-
43 
1:500 to 
1:125  3d @ 4ºC  n.a. 
n.a. 
 
Table 5: Tissue manipulation and staining 
(n.a. not applicable; RT room termperature) 
 
All primary Abs  were applied diluted in Ringer’s solution for unfixed tissue and 
diluted in PBS for fixed tissue. 
All  secondary  Abs  were  applied  to  fixed  tissues  in  blocking  solution  I  for 
unpermeabilised tissue and blocking solution II or III for permeabilised tissue. 
Blocking solution II was applied if only the NMJ needed to be permeabilised and 
blocking solution III was applied if the permeabilisation extended to the proximal 
efferents. 
Between application of primary and secondary Abs all unfixed tissues were rinsed 
in Ringer’s solution and all fixed tissues were rinsed in PBS. 
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2.9 Manufacturers for reagents used (Table 6) 
Agent  Manufacturer  Localisation 
All forms of conjugated α-BTx  Molecular Probes  Eugene, OR, USA 
All forms of conjugated α-mouse 
Abs 
Southern Biotech  Birmingham, AL, USA 
All forms of conjugated α-rabbit Abs  Southern Biotech  Birmingham, AL, USA 
α-GAP-43  Sigma-Aldrich  St Louis, MO, USA 
α-human C5b-9 (MAC)  Dako  Glostrup, Denmark 
Bright cryo-m-bed  Bright Instrument Company 
Limited 
Huntingdon, UK 
Citifluor antifading agent  Citifluor Products  Canterbury, UK 
EthidiumD2  Molecular Probes  Eugene, OR, USA 
Glutaraldehyde (25%, EM grade)  Agar Scientific Ltd.  Stansted, Essex, UK 
NF-heavy (200 kDa)  Affiniti, Enzo Life Sciences  Exeter, UK 
NF-light (60 kDa)  Abcam  Cambridge, UK 
Normal goat serum (NGS)  Sigma-Aldrich  St Louis, MO, USA 
Ringer’s solution (Vetivex 9)  Dechra  Shrewsbury, UK 
Triton x100  Sigma-Aldrich  St Louis, MO, USA 
VWR International  Haasrode, Belgium 
All chemicals  Fisher Scientific  Loughborough, 
Leicestershire, UK 
 
Table 6: Manufacturers for reagents used 
 
 
2.10 Recipes for commonly used solutions 
2.10.1 Ringer’s solution 
A  10x  Ringer’s  solution  stock  (NaCl  67.79g,  KCl  3.35g,  NaHCO3  19.32g, 
NaH2PO4x2H2O 1.56g, Glucose 19.82g, 1M MgCl2 10ml added to distilled water to 
make up a total volume of 1l) was made up and stored at 4ºC. 
For use, Ringer’s solution stock was diluted in distilled water and bubbled for 5-10 
minutes with oxygen (minimum 99.5%). Two ml of 1M CaCl2 were added per 1l of 
solution  and  the  solution  brought  to  a  pH  of  7.4;  the  final  concentration  of  the 2. General Materials and Methods    60 
Ringer’s solution came to 116 mM NaCl, 4.5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 1 
mM NaH2PO4, 23 mM NaHCO3 and 11 mM glucose. 
 
2.10.2 Phosphate buffered saline (PBS) 
A 10x PBS stock (NaCl 80g, KCl 2g, KH2PO4  2g, Na2HPO4x12H2O 29g in 1l of 
distilled water) was made up and brought to a pH of 7.4. 
For use, the stock was diluted with distilled water. 
 
2.10.3 Saline solution 
Distilled water was supplemented with 0.75% of NaCl. 
 
2.10.4 Paraformaldehyde (PFA) 4% 
Distilled water equal to slightly less than 2/3 of the desired final volume was heated 
to 60ºC in a fume hood. The quantity of PFA, that will make a 4%-solution was 
weighed out and added to the water with a stir bar. The solution was maintained at 
60ºC and one drop of 2N NaOH added, which leads to clearance of the solution. 
One tenth of the volume of 10x PBS was added and the solution brought to a pH of 
7.2. Following the addition of more water to reach the final volume, the solution was 
filtered, cooled to room temperature (RT) and stored in aliquots at -20 ºC.  
 
2.10.5 “Strongfix” 
For 500 ml of “Strongfix”, 250 ml of 8% PFA (see above) were made up and mixed 
with 100 ml of 25% Glutaraldehyde and 250 mg of CaCl2 in a glass bottle on a heat-2. General Materials and Methods    61 
proof  surface.  The  solution  was  then  made  up  to  500  ml  by  adding  0.08M  Na-
cacodylate buffer and stored at 4ºC. 
 
2.10.6 Blocking sera 
Blocking serum I: PBS + 1% NGS 
Blocking serum II: PBS + 1% NGS + 0.5% Triton x100 
Blocking serum III: PBS + 1% NGS + 1% Triton x100 
 
 
2.11 Normal human serum (NHS) 
NHS, acting as a source of complement, was taken from a single donor stock and 
stored immediately after  acquisition in aliquots at -70ºC to  preserve  complement 
activity. 
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2.12 Statistics and Imaging 
The following statistical (Table 7) and imaging packages (Table 8) were applied: 
Comparison of  Statistical test  Software  Description  Application 
Percentages  Chi-square  Excel  Chapter 
2.3.5, 2.5.2 
Chapter 3.1, 
3.2, 3.5, 3.7 
Fluorescence intensity 
Mann-Whitney 
(2 groups), 
Kruskal-Wallis 
(>2 groups) 
Chapter 
2.5.3 
Chapter 3.4, 
3.5 
Scores, whole number 
counts, measurements 
2-sample t-test 
Minitab 
statistical 
software 
Chapter 3.2  Chapter 3.2 
 
Table 7: Statistical tests and packages 
 
 
 
 
 
 
 
Microscope  Software for  Details 
  Image acquisition  Image processing   
Leica DMI4000B   
(in vivo imaging) 
Leica Application Suite  ImageJ and Adobe 
Photoshop 
Chapter 2.2.2 
and 2.2.5 
Zeiss AxioImager 
(ex vivo imaging) 
Zeiss Axiovision 4.7.2  Chapter 2.3.4 
Zeiss LSM 5 Pascal 
(ex vivo imaging) 
LSM 5 Pascal software  ImageJ  Chapter 2.5.3 
 
Table 8: Microscopes, imaging and image processing software 
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3. RESULTS 
3.1 Stability of NMJs regarding their pSC number in double fluorescent 
mice 
3.1.1 Introduction 
Murine NMJs have been described as remarkably stable over longer periods of time 
(Sanes & Lichtman, 1999). Apart from the NMJs expanding in size in accordance 
with muscle fibre growth (Balice-Gordon & Lichtman, 1990), only minor changes to 
the  NT  arborisations  and  nAChR-patterns  have  been  noted  in  in  vivo  imaging 
studies conducted both in the SM and gastrocnemius muscles in mice aged three to 
18 months (Balice-Gordon & Lichtman, 1990; Lichtman, Magrassi, & Purves, 1987; 
Wigston, 1990). Interestingly, similar investigations conducted in the soleus muscle 
yielded  different  results,  with  more  frequent  changes  to  the  nAChRs  of  NMJs 
observed (Wigston, 1989).  
Specifically regarding the number of pSCs per NMJ, a short-term in vivo study in 
two- to three-month-old-mice with a maximum of one month between assessments, 
revealed no changes to the pSCs number per NMJ (O'Malley et al., 1999). Similarly, 
an in vivo study conducted in mice expressing fluorescent proteins solely in their 
SCs, revealed only minor changes to numbers and positions of SCs, with 20% of 
NMJs exhibiting an extra pSC and 10% of NMJs losing one pSCs over 30 days (Zuo 
et al., 2004). Over the time-course of more than a year (rats aged two months and 
15 months) only one or two pSCs are added to the average number of pSCs per 
NMJ (Love & Thompson, 1998). 
Since  none  of  the  studies  described  above,  however,  was  conducted  in  mice 
expressing fluorescent proteins both in the motor axons and SCs of their PNS and 
most investigations were limited to one month, the stability of NMJs regarding their 
pSC number was assessed in double-fluorescent mice aged one to twelve months, 
with a special focus on three-month-old mice as it was aspired to use these in in and 
ex vivo investigations.  
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3.1.2 Specific Materials and Methods 
3.1.2.1 Mice and procedures 
In 28 double-fluorescent WT mice (see 2.1.1) aged 1, 3, 5, 7, 9 and 12 months 
(each n=4; except 3 months, n=8), the SM were exposed for ex vivo imaging (see 
2.3.1) and incubated with rhodamine-conjugated BTx for 1 hour. Following rinsing 
with Ringer’s solution, the muscles were fixed and processed for imaging (see 2.3.1 
and 2.3.4). 
Both left and right SM-NMJs (each mouse n=2) were assessed for numbers of bright 
GFP-positive cell bodies overlying the BTx-signal. 
 
3.1.2.2 Statistics 
In each age-group the counts were combined to calculate the average number of 
pSCs overlying the NMJ. Additionally, the mice were grouped into a young group 
(1, 3 and 5 months) and an old group (7, 9 and 12 months) and the NMJs were 
grouped into NMJs with one or two pSCs, NMJs with three pSCs and NMJs with 
four or more pSCs. 
To  compare  percentages,  chi-square  tests  were  applied  to  determine  statistical 
signicant differences between groups. 
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3.1.3 Results 
A total of 6909 NMJs were assessed for their pSC numbers (Table 9). 
  Mice aged 
NMJs with  1 month  3 months  5 months  7 months  9 months  12 months 
1 pSC  66  180  93  38  49  64 
2 pSCs  484  698  341  171  194  220 
3 pSCs  460  850  398  284  299  348 
4 pSCs  126  303  172  157  181  206 
5 pSCs  21  76  46  74  78  88 
6 pSCs  2  15  7  17  30  26 
7 pSCs    4  3  3  7  12 
8 pSCs    2    5  2  8 
9 pSCs            1 
Total NMJs  1159  2128  1060  749  840  973 
pSCs per NMJ  2.62  2.75  2.78  3.19  3.21  3.21 
 
Table 9: Results for pSC counts 
 
An increase in the average number of pSCs per NMJ (Table 9) could be observed 
when comparing the different age-groups, with one-month-old mice exhibiting the 
lowest average (2.6 pSCs per NMJ) and the twelve-month-old-mice exhibiting the 
highest average (3.2 pSCs per NMJ). However, once the mice had reached an age 
of seven months the average number of pSCs remained fairly stable around 3.2 
pSCs per NMJ. In general, the younger mice (one- to five-month-old) displayed less 
variation between NMJs when when compared to the older mice (seven- to twelve-
month-old) and the variation for the pSC-distribution was very constant for all ages 
within the younger and older group, respectively (Fig.10A). 
Regarding the distribution of pSCs per NMJ (Fig.10B), all mice showed a relatively 
similar percentage of NMJs with three pSCs (min 35.6%; max 39.9%; mean 38.1%), 
and this similary remained evident when grouping the mice into younger mice and 
older mice (young: 39.3%, old 36.3%); nevertheless the difference between those 
two groups was still significant (p=0.015; chi-square test, n=56). The younger mice, 
however, had a significantly larger percentage of NMJs with only one or two pSCs 
when compared with the older mice (p<0.001; chi-square test, n=56). With the NMJs 3. Results       Stability of NMJs    66 
comprising four or more pSCs, the reverse situation could be observed (p<0.001; 
chi-square test, n=56). 
Fig.10: Results for pSCs counts per NMJ. A Boxplot for pSCs per NMJ in each age group; 
the box depicts the values for the second and third quartile, whilst the lower whisker extends 
to the lowest value within the lower limit (Q1-1.5(Q3-Q1)) and the upper whisker extends to 
the highest value within the upper limit (Q3+1.5(Q3-Q1)). All outlier points represent one 
individual value. B distribution of NMJs in relation to their number of pSCs. 3. Results       Stability of NMJs    67 
 
Fig.11: NMJs in mice of different ages. Ages in months are depicted in the left column. 
Note the increased fragmentation of the BTx-signal (circles), which is mirrored by “knobbly” 
NTs.  BTx  (orange  in  composite  images)  depicts  the  nAChRs,  CFP  (blue  in  composite 
images), the axons and GFP (green in composite images) the SCs. Scale bars: 20 µm. 3. Results       Stability of NMJs    68 
The morphology of the NMJs slightly changed once the mice had reached an age of 
approximately  seven  months.  Instead  of  the  smooth  and  continuous  BTx-signal 
(mirrored by homogenously CFP-filled  NTs) observed  at NMJs  of younger mice, 
mice in this older age group often exhibited slightly fragmented and “knobbly” BTx-
signals. These changes to the distribution of the nAChRs were mirrored by “knobbly” 
NTs, heterogenous in their diameter (Fig.11). 
 
3.1.4 Discussion 
The average number of pSCs per SM-NMJ remains fairly stable over the first year in 
the life of a mouse. Compared to the counts conducted in the SM of two- to four-
month-old mice only expressing the fluorescent protein in their SCs, which exhibited 
3.3  ±  0.5  pSCs  per  NMJ  (Zuo  et  al.,  2004),  the  average  number  in  the  counts 
described  above  were  a  little  lower.  At  the  same  time,  they  correspond  well  to 
counts conducted in the soleus muscle of two-month-old-mice (Love & Thompson, 
1998).  One  reason  for  a  relatively  lower  number  of  average  pSCs  per  NMJ 
ascertained in the same muscle and with the same kind of detection method might 
be the fact, that in the current study only the bright GFP-stained cell bodies were 
counted,  whereas  routinely  also  faint  GFP-positive  cell  bodies  are  observed  at 
NMJs. 
Over time, NMJs have been described to expand (Balice-Gordon & Lichtman, 1990) 
and since the endplate size (determined by nAChR-area) correlates with the pSC 
number (Lubischer & Bebinger, 1999), larger endplates are associated with higher 
numbers of pSCs (Love & Thompson, 1998; Zuo et al., 2004). In the SM of rats, the 
endplate  length  ceases  to  increase  at  roughly  200  days  of  age  (Courtney  & 
Steinbach, 1981), which corresponds well with a stabilisation of the pSC number at 
roughly 7 months observed in the present study. 
A relative increase of NMJs with more than four pSCs and a relative decrease of 
NMJs with one or two pSCs as observed when comparing the “old” group with the 
“young” group, probably also reflects the general tendency of larger NMJs being 
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The morphological changes to the NMJs observed in the “old” group are consistent 
with those observed previously by other authors (Balice-Gordon, 1997a; Chai et al., 
2011; Courtney & Steinbach, 1981; Li et al., 2011; Smith & Rosenheimer, 1982), 
albeit  here  the  very  subtle  changes  were  observed  many  months  earlier  than 
described  previously  (Balice-Gordon,  1997a;  Li  et  al.,  2011).  Fragmentation  of 
nAChRs and the formation of NT-varicosities also occur following insults which lead 
to necrosis/degeneration and  regeneration of  the postsynaptic muscle fibre, thus 
these age-related alterations to the NMJs-morphology are surmised to be initiated 
by changes to the postsynaptic apparatus (Li et al., 2011; also see chapter 3.2). 
 
 
3.1.5 Conclusion 
The  average  number  of  pSCs  per  NMJ  in  the  SM  of  double-fluorescent  mice 
remains very stable over the first year of life of the mouse, indicating that any shift in 
pSC numbers must be induced by pathological events. 
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3.2 In vivo imaging of the NMJ 
3.2.1 Introduction 
In vivo imaging of the NMJ was pioneered in the middle of the 1980s (Lichtman et 
al., 1987). One of the muscles most commonly used for these investigations is the 
SM (Balice-Gordon, 1997b; Zuo et al., 2004), which lies obliquely in the ventral neck 
area  and  flanks  the  sternohyoid  muscle  (SH)  (Fig.12).  For  imaging,  the  SM  is 
generally lifted by a small wire loop and flattened with a small circular coverslip. This 
set-up improves the optics, whilst stabilising the muscle and also bringing most of 
the endplate region into the same focal plane (Balice-Gordon, 1997b; de Paiva et 
al., 1999; Lichtman et al., 1987; Zuo et al., 2004). 
 
The  application  of  fluorescent  conjugates  of  α-BTx,  which  selectively  binds  the 
nAChRs  allows  for  the  detection  of  the  junctional  area  (Lu  &  Lichtman,  2007). 
Additionally, every NMJ has its own very distinct nAChR pattern which means that 
this staining helps to discriminate one NMJ from another. Keeping the concentration 
of α-BTx around 2-10 µg/ml ensures that only 10-20% of all nAChR are labelled and 
synaptic transmission is not influenced (Balice-Gordon, 1997b). Saturation of the 
nAChRs  has  been  described  following  an  incubation  of  20  minutes  at  a 
concentration of 5 µg/ml (Turney et al., 1996) or 20 µg/ml (van Mier & Lichtman, 
1994), whilst other authors claim that incubation of (frog) endplates with α-BTx at a 
concentration  of  1  µg/ml  for more  than  30 minutes  results  in  a  reduction  of  the 
miniature endplate potentials to more than one tenth (Katz & Miledi, 1973). Most in 
vivo imaging paradigms are carried out following an incubation of the muscles with 
fluorescently-labelled α-BTx at a concentration of 4-5 µg/ml for 3-5 minutes (Balice-
Gordon & Lichtman, 1993; Rich & Lichtman, 1989b, 1989c; Wigston, 1990; Zuo et 
al., 2004), which labels approximately 50% of the nAChR (Rich & Lichtman, 1989b). 
Alternatively, the application of 10 µg/ml α-BTx for 1-3 minutes labels 10% of the 
nAChRs (O'Malley et al., 1999). 
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Fig.12: Sternohyoid (SH) and sternomastoid (SM) muscles. A anatomical overview of the 
left half of the ventral neck area. B following a midline incision with the mouse is lying in 
dorsal recumbency and gentle retraction of the mandibular glands, the SH (1) and SM (2) 
become visible. 
 
 
 
3.2.2 Specific Materials and Methods  
3.2.2.1 Groups and procedures (Table 10) 
Fifty-six adult (three months to one year) male and female double-fluorescent mice 
in  five  groups  were  subjected  to  in  vivo  imaging  of  the  ventral  neck  muscles. 3. Results       In vivo imaging    72 
Anaesthesia, general approach to the muscles under investigation (approach A) and 
the set-up for the in and ex vivo imaging were as described in 2.2 and 2.3. 
 
 
Table 10: Experimental groups for in vivo imaging trials 3. Results       In vivo imaging    73 
In groups I, II, and IV, NMJs of the SM were imaged, whereas in groups III and V, 
NMJs  of  the  sternohyoid  muscle  (SH)  were  imaged.  In  groups  I  and  II  various 
different  devises  were  used  to  stabilise  the  SM  for  imaging  (Fig.13A).  These 
included  two  “lever”-like  constructions  (lever  1  and  2),  rubber  tubing  positioned 
under the SM and a suture thread looped under the SM and attached to the skin 
either side. In group IV the approach to the SM was modified in that way, that the 
neck/head of the mouse was gently turned so that the SM imaged lay uppermost 
(approach B, Fig.13B). In group V, the light intensity the muscles were exposed to 
were decreased consecutively both for the orientation and imaging step. 
 
 
 
Fig.13: In vivo imaging trials. A different stabilising devices: lever 1 (1), lever 2 (2), suture 
thread (3), rubber tubing (4); B two different approaches to the muscles imaged: approach A 
with the mouse lying flat in dorsal recumbency, approach B with the head of the mouse 
slightly twisted so that the SM imaged lies uppermost. 3. Results       In vivo imaging    74 
One mouse in group II and two mice each in groups III and IV served as α-BTx-
controls, i.e. in these mice the muscles of interest were only exposed and incubated 
with α-BTx, but not imaged or stabilised. 
A second imaging session - either in or ex vivo- was conducted between 3 days and 
5 weeks later with the aim to revisit the previously imaged NMJs. 
3.2.2.2 Scoring 
Groups  I to IV  were  assessed  regarding  the  stability  of  the muscle  imaged,  the 
images acquired in the 1
st and 2
nd imaging session and the feasibility to reimage 
individual NMJs. The images were scored with the following criteria (Table 11): 
Imaging 
session  Criteria  Minimum 
score 
Maximum 
score 
Overall detail of images  1  3 
Detail of pSCs  1  4 
1
st 
Overall score  2  7 
Percentage of NMJs revisited due to location  0  100 
Percentage of NMJs revisited due to BTx signal  0  100 
Percentage of NMJs with unchanged NTs  0  100 
2
nd 
Percentage of NMJs with unchanged pSCs  0  100 
 
Table 11: Scoring criteria for the in vivo imaging trials 
 
Additionally the scores for groups I and IV were combined in order to be able to 
compare the SH and SM muscle. 
 
3.2.2.3 Comparison of SH- and SM- NMJs regarding size and pSC number 
In  three  14-week-old  mice  the  left  and  right  SH  and  SM  (each  mouse  n=2  per 
muscle) were assessed regarding their number of pSCs per NMJ in the same way 
as described in 3.1.2.1. 3. Results       In vivo imaging    75 
Additionally, the diameter of 15 randomly selected NMJs per muscle was measured 
and the average NMJ-diameter for both SH and SM calculated. 
3.2.2.4 Statistics 
To compare scores, pSCs-counts and NMJ-diameters between muscles 2-sample t-
tests were applied, whereas to compare percentages between muscles chi-square 
tests were applied. 
 
 
 
3.2.3 Results 
3.2.3.1 Survival of mice 
Three  mice  in  group  II  and  two  mice  in  group  IV  died  due  to  anaesthetic  or 
intubation-related complications. 
 
3.2.3.2 Stability of muscle under investigation 
Stabilisation  of  the  SM  with  either  of  two  levers  resulted  in  the  muscle  being 
reasonably stable and flat for imaging. However, the positioning or rubber tubing 
beneath the SM still resulted in the SM being very wobbly; thus no good images 
could be acquired or the imaging had to be terminated early. Group II, therefore, 
was omitted from the scoring. 
Stabilisation of the SH was due to its location not possible (or even necessary). 
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3.2.3.3 Primary imaging sessions 
In both SH and SM, reasonably flat NMJs could be imaged. Subjectively, the NMJs 
of the SM appeared to be a little bit bigger and more complex than NMJs of the SH, 
thus requiring more images to be taken to acquire sufficient detail of the NMJ. With 
SH-NMJs, it was often possible to acquire a detailed and in-focus of the entire NMJ 
with one image. 
 
3.2.3.4 Secondary imaging sessions 
In general, the tissue in follow-up imaging sessions appeared to be not as clear as 
in primary imaging sessions. This was especially the case when the time-course 
between 1
st and 2
nd session was less than seven days. Macroscopically, the muscle 
subjected  to  (more)  imaging  often  appeared  to  less  pink  and  smaller  when 
compared to the not (or less) imaged contralateral muscle.  
“Murkiness” of the tissue thus contributed to the failing of reimaging individual NMJs. 
Additionally, in very many cases the morphology of the different components of the 
original NMJs had  changed. The changes could be seen  within a few days and 
seemed  to  persist,  as  ex  vivo  reimaging  at  a  later  time-point  still  revealed 
morphologically  altered  NMJs  (Figs.14,  15).  Changes  to  the  NMJ  included  a 
fragmentation of the α-BTx-signal with loss of the smooth appearance of this signal. 
This was often accompanied by a decrease of the NMJ in size. The fragmentation of 
the α-BTx-signal was mirrored by “knobbly” CFP-signal in the NT which also lost its 
smooth  appearance  and  homogenous  diameter.  The  pSCs  exhibited  increased 
numbers overlying the NMJ and frequently extended long processes towards the 
periphery,  which  could  be  accompanied  by  axonal  sprouts.  In  general,  the  area 
imaged appeared to be populated by a surplus of GFP-positive cells. 3. Results       In vivo imaging    77 
 
Fig.14: In vivo imaging trials: in vivo imaging results. Four NMJs (two each for A and B) 
are imaged (1
st) and reimaged (2
nd) in vivo. Note the general shrinkage of the NMJs (all 
images have the same magnification), fragmentation of the BTx-signals, which is mirrored by 
irregular and “knobbly” NTs (CFP) and increased numbers of pSCs (GFP in 2
nd) overlying 
the NMJ. Scale bars: 20 µm. 3. Results       In vivo imaging    78 
 
Fig.15: In vivo imaging trials: in and ex vivo imaging results. A first imaging in vivo, B 
reimaging of the same NMJ two weeks later in vivo, C reimaging of the same NMJ four 
months later ex vivo. BTx depicts the nACHRs (orange in composite image), CFP the axons 
(blue in composite image) and GFP the SCs (green in composite image).  
Note the fragmentation of the nAchRs, the muscular part of the NMJ, which is mirrored by 
irregular and “knobbly” NTs (CFP in B and C). Scale bars: 20 µm. 
 
 
 
3.2.3.5 α-BTx-controls (Fig.16) 
Incubation of the muscles with rhodamine-conjugated α-BTx at a concentration of 2 
µg/ml for 10 minutes did not lead to any changes of the neural, glial or postsynaptic 
structures of the NMJ both of the SH and SM in a time-course of four days to two 
weeks. 3. Results       In vivo imaging    79 
 
Fig.16: α-BTx-controls. A overview; B close-up of NMJs. There are no changes observed 
to the BTx-signal (which depicts the nAChRs and is orange in the composite image), the 
pSCs (GFP, green in the composite image) and the NTs (CFP, blue in the composite image). 
Scale bars: A 100 µm, B 20 µm. 
 
 
3.2.3.6 Scores for groups I, III and IV and SM versus SH (Table 12) 
Criteria  Groups  Muscle 
  I  III  IV  SM  SH  p 
Imaging 
session 
  n=10  n=10  n=10  n=20  n=10   
Overall detail of images  2.4  1.7  2.5  2.4  1.7  0.005 
Detail of pSCs  2.9  3.4  3.0  2.95  3.4  0.115 
1
st 
Overall score  5.3  5.1  5.5  5.35  5.1  0.599 
NMJs revisited  31.1%  71.9%  44.8%  38.2%  71.9%  < 0.001 
NMJs with unchanged BTx-
signal  6.8%  36.8%  2.6%  4.6%  36.8%  < 0.001 
NMJs with unchanged NTs  0.0%  21.1%  5.1%  2.6%  21.1%  < 0.001 
2
nd 
NMJs with unchanged pSCs  1.4%  29.8%  6.4%  3.9%  29.8%  < 0.001 
 
Table 12: Scores for groups I, III and IV and comparison of SM versus SH (scores: 2-
sample t-test, n=30; percentages: chi square test, n=30) 3. Results       In vivo imaging    80 
3.2.3.7 Comparison of SH- and SM-NMJs 
In each SH, 100 NMJs were assessed for the number of bright GFP-positive cell 
bodies overlying the BTx –signal, whereas in the SM between 64 and 82 NMJs were 
assessed. In the SH, an average of 1.9 pSCs per NMJ was observed, whilst in the 
SM the average lay at 2.6 pSCs per NMJ (p<0.001, 2-sample t-test, n=12). The 
NMJ-diameters measured in the SH ranged from 26.42 µm to 63.64 µm with an 
average of 45.83 µm. In the SM the minimum diameter was 48.38 µm, the maximum 
diameter  was  70.41  µm  and  the  average  diameter  was  60.38  µm  (p<0.001,  2-
sample t-test, n=30). 
 
3.2.3.8 Group V 
Decreasing  of  the fluorescent  light intensity omitted from  the bulb to 17%  whilst 
orientating in the sample and to 25% during the acquisition of images still allowed 
for  sufficient  illumination  of  the  SH;  it  was  surmised  that  these  values  could  be 
decreased even further. Additionally, the field diaphragm (diameter of light beam) of 
the  microscope  and  the  exposure  time  of  the  camera  were  decreased  (field 
diaphragm: 3; exposure time: 120 ms), whilst the optical gain was doubled. Thus the 
general exposure of the muscle to light was even more limited, whilst optimising the 
camera input. 
In this group 60.1% of the originally imaged NMJs could be revisited and more than 
half of these (31.3%) had retained their original α-BTx, NT and pSC morphology. 
No changes to the NMJs of the adjacent SMs were noted. 
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3.2.4 Discussion 
Like any in vivo procedure, in vivo imaging of NMJs is an invasive procedure and, 
therefore, can lead to changes or inhibit processes which normally occur (Balice-
Gordon, 1997b; Lichtman & Fraser, 2001). Investigator-induced changes can be due 
to surgical trauma, infection, labelling and phototoxicity (Lichtman & Fraser, 2001), 
thus adequate control groups are necessary (Balice-Gordon, 1997b). 
Overillumination  of  the  NMJs  under  investigation  induces  NT  sprouting  and 
proliferation of pSCs within three to seven days. Additionally, the loss of nAChR-
areas can be observed (O'Malley et al., 1999). Traumatic injury to the innervating 
nerve leads to denervation of the endplates. The pSCs react to this by extending 
processes,  which,  following  regeneration,  are  accompanied  by  NT  sprouts; 
alternatively,  these  can  also  arise  from  still  innervated  NMJs  (Brown  &  Ironton, 
1978; O'Malley et al., 1999; Son & Thompson, 1995a). A loss of nAChRs (Rich & 
Lichtman,  1989b)  and  increase  of  pSC  numbers  can  be  observed  (Love  & 
Thompson,  1998).  Application  of  paralyzing  agents  to  the  endplates,  such  as 
botolinum toxin, high doses of α-BTx (Love & Thompson, 1999), β-BTx or tetanus 
toxin also lead to a loss of nAChRs (Balice-Gordon & Lichtman, 1994), a reactive 
growth of pSC processes (Kang et al., 2007) and NT sprouts (de Paiva et al., 1999; 
Dixon & Harris, 1999; Duchen & Tonge, 1973), albeit in a lower magnitude when 
compared to traumatic denervation (Son & Thompson, 1995a). Following muscle 
fibre injury, also a loss of nAChRs (Rich & Lichtman, 1989a) with fragmentation of 
the nAChRs following regeneration of muscle fibres (Rich & Lichtman, 1989c; Li & 
Thompson, 2011; Li et al., 2011) and reactive sprouting of NTs both on the injured 
and neighbouring healthy muscle fibres is observed (van Mier & Lichtman, 1994). 
Also,  the  morphologic  changes  to  the  cholinesterase  pattern  of  the  NMJs  of 
regenerating muscle fibres following  muscle fibre necrosis induced by the  snake 
toxin  cardiotoxin,  closely  resemble  the  fragmented  nAChR-  and  NT-  patterns 
observed  in my mice  (Duchen  et  al.,  1974).  Thus,  in  summary,  overillumination, 
traumatic  denervation,  inactivation  of  the  NMJs  following  the  application  of 
paralyzing agents and both traumatic and toxic muscle fibre injury result in similar 
changes to the different components of the NMJ, namely reactive growing of pSC 
processes, increase of pSC numbers, extension of NT sprouts and loss of nAChR-
area, all of which were observed in the present study. Interestingly, the changes to 
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older than nine months, described in the previous chapter (3.1), further supporting 
the notion of a limited repertoire for components of the NMJ to react to associated 
degenerative changes. 
The first attempts of imaging the NMJs were carried out following descriptions on in 
vivo  imaging  of  SM-NMJs  (group  I).  However,  due  to  the  microscope  being 
equipped  with  water-immersion  objectives,  a  coverslipping  of  the  muscle  –  as 
described by other groups conducting in vivo imaging procedures in the SM (see 
3.2.1) – had to be omitted. The extensive changes observed in this group lead to the 
trial of a different device (rubber tubing or lever B) to stabilise the muscle and a 
different  approach  (approach  B)  in  the  hope  of  being  able  to  omit  a  stabilising 
device. At the same time the application of BTx was validated to investigate whether 
the application of this potentially paralyzing agent was the source of the changes 
observed. Application of rhodamine-conjugated α-BTx at a concentration of 2 µg/ml 
for 10 minutes did not lead to any changes of the different components of the NMJ 
at any time-point (four days to two weeks) observed and also was well within the 
recommended limits. As the imaged NMJs in these groups, however, remained to 
exhibit  extensive  changes,  it  was  clear  that  stabilisation  and/or  imaging  of  the 
muscles  must  be  causing  these  degenerative  changes;  thus  phototoxity  and 
traumatic  injury  to  innervating  nerve  or  muscle  imaged  remained  potential 
explanations for the changes observed. 
The  aptitude  of  the  SH  for  in  vivo  imaging  of  NMJs  was  discovered  more 
accidentally than intentionally. The SH is a flat paired muscle in the ventral neck 
area, which in the mouse originates at the sternum and inserts on the hyoid bone. It 
is  innervated  from  dorsolateral  by  the  ventral  branch  of  the  first  cervical  nerve 
(Nickel  et  al.,  1992).  Similar  to  the  SM,  the  SH  is  described  to  be  a  fast-twitch 
muscle (van Lunteren & Moyer, 2003) composed entirely of type IIb and IIx myosin 
heavy chain isoforms (Attal et al., 2000). Other investigators observed close to equal 
amounts of type IIa and IIb fibres (Yoshii et al., 2008). One of the functions of the 
SH is to contribute to dilation of the pharynx, therefore this muscle contributes to 
breathing actions (Attal et al., 2000). All SH-NMJs are confined to a single endplate 
band which arches across the middle of the muscle (Must, 1987). Location of the SH 
directly on top of the trachea and in the midline render this muscle easily accessible 
and  very  flat  at  the  same  time,  thus  making  any  stabilisation  unnecessary  and 
minimising  any  manipulation  and  the  chance  of  providing  injury  to  either  the 3. Results       In vivo imaging    83 
innervating nerve or the muscle itself. The comparatively smaller and flatter NMJs 
with less pSCs (compared to the SM) facilitate imaging, thus making it possible to 
minimise the exposure of this muscle to light. 
The last control group, therefore, focussed on the SH and aimed to determine the 
minimum amount of light required to be able to image this muscle sufficiently. Whilst 
it  was  possible  to  decrease  light  exposure  significantly,  still  a  number  of  NMJs 
exhibited the changes described above. Thus, it was aspired to decrease the light 
intensity even more in further investigations. 
 
3.2.5 Conclusion 
Considering  the  SH  did  not  require  any  manipulation  for  imaging,  the  α-BTx 
concentration  had  been validated and  the changes  observed in  imaged muscles 
most accurately resembled those seen following (traumatic or toxic) injury to the 
muscle  to  the  muscle  itself,  it  was  concluded  that  the  changes  were  due  to 
phototoxic damage of the muscle. Fragmentation of the nAChR-pattern, shrinking of 
the NMJ and the extension of short pSC processes has been described to be visible 
within  3  days  of  induction  of muscle fibre  injury  (Li  &  Thompson,  2011).  As my 
reimaging sessions were conducted after a lag phase of 3 days, it therefore should 
have  been  possible  to  pick  up  any  changes  to  the  components  of  the  NMJ. 
Furthermore, assessments of the neighbouring SM under decreased light exposure 
of the SH revealed no changes to these muscles. 
Therefore, it was concluded that conservative imaging of the SH by decreasing 
the light intensity of the microscope to 17% (or lower), the field diaphragm of the 
microscope to 3, the light intensity of camera to 25% (or lower) and the exposure 
time to 120ms should allow for in vivo investigations conducted in this muscle. A 
concomitant increase of the acquisition gain to x2 would counteract for the loss of 
fluorescence intensity observed in the images. 
In all cases, the BTx-signal would need to be closely scrutinised for changes, as 
fragmentation  of  the  BTx-signal  indicates  muscle-injury-induced  (overillumination, 
traumatic  and  toxic  injury)  changes  to  the  components  of  the  NMJ.  However, 3. Results       In vivo imaging    84 
considering that these changes appeared to be very localised (see 3.2.3.8), it still 
should be possible to extrapolate and combine findings observed on the SM to the 
SH and vice versa. 
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3.3 Anti-ganglioside antibody trials 
3.3.1 Introduction 
As  indicated  in  the  introduction  (1.1.2)  the  distribution  of  gangliosides  varies 
between  the  neural  and  glial  structures  they  are  located  on.  Anti-GM1  Abs,  for 
example, bind both peripheral motor and sensory nerves (and here also both the 
nodal axolemma and the paranodal areas of myelinating SCs), whereas anti-GD1a 
Abs preferentially bind motor nerves (Gong et al., 2002).  
Similarly,  Ab-binding  specificities  also  hold  true  for  the  NMJ.  Previous  studies 
investigating the potential neuromuscular neural and/or glial targets for the mouse 
monoclonal Abs cloned and produced in-house reached the following observations: 
In WT mice, anti-GD3 Abs preferentially induce pSC injury, whilst the application of 
anti-GT1a Abs combined with a source of complement leads to a selective injury of 
the NTs (Halstead et al., 2005b). Anti-GQ1b Abs in combination with a source of 
complement  lead  to  paralysis  of  the  muscle  under  investigation  (Bullens  et  al., 
2002), thus putatively indicating that this Ab binds and exerts its pathology at the 
NT. Other investigators have reported that anti-GM2 Abs bind both the pSCs and 
NTs in WT mice (Santafe et al., 2005). In GalNac-Transferase KOs (GM2KO; see 
Fig.1),  application  of  an  anti-GD3  Abs  combined  with  a  source  of  complement 
induce  the  same  electrophysiological  changes  at  the  NMJ  as  a  bispecific  anti-
GQ1b/anti-GD3-Abs  applied  to  a  WT  mouse  (Bullens  et  al.,  2002),  thus  also 
indicating  the  ability  of  this  Ab  to  bind  the  NT.  Finally,  in  GD3-Synthase  KOs 
(GD3KO;  see  Fig.1),  anti-GD1a  Abs  induce  axonal/NT  injury  (Goodfellow  et  al., 
2005; McGonigal et al., 2010). 
Considering the overall aim of the present study was to establish an in vivo imaging 
system in which either the neuromuscular neural or glial component or both could be 
targeted by anti-ganglioside Abs and monitored, the following investigations were 
aimed at determining suitable Abs for the specified injuries of the various structures 
of the NMJ. A number of different in house-generated mouse monoclonal Abs were 
trialled both in and ex vivo for their staining profiles and injury potential following the 
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3.2.2 Specific Materials and Methods 
3.2.2.1 Animals and general protocol 
WT,  GM2KO,  GD3KO  and  PLP-Tg  mice,  all  double-fluorescent,  were  either 
subjected to in vivo (2.2) and/or ex vivo (2.4) application of mouse monoclonal anti-
ganglioside Abs. 
 
3.2.2.2 Antibodies (Table 13) 
All  Abs  applied  were  mouse  monoclonal  Abs,  generated  and  characterised  for 
ganglioside-binding  profiles  as  described  previously  (Goodfellow  et  al.,  2005; 
Goodyear et al., 1999; Halstead et al., 2005b). 
Both for in and ex vivo investigations, the Abs were applied for 30 minutes at a 
concentration of 100 µg/ml, except for TBG3 which was applied at 200µg/ml (see 
2.7). In ex vivo investigations, the Abs were supplemented by fluorescently-labelled 
α-BTx. 
Antibody  Isotype  Mouse strain  Application  Investigation 
   
Binding 
specificity 
(ELISA) 
WT  KO  PLP
-Tg 
In 
vivo 
Ex 
vivo 
Bin-
ding 
profile 
Injury 
TBG3  GD1a, (GT1b)  √  GD3KO  √  √  √  √  √ 
EG1  GT1a, GQ1b, GD3  √  GM2KO  √  √  √  √  √ 
MOG16  GD1b, GT1b, (GD1a)  √  GM2KO  √  √  √  √  √ 
CGG3 
IgG3 
GD3  √    √    √  √   
 
Table 13: Anti-ganglioside Abs applied in the Ab-trials 
 
For the illustration of the binding profiles, ex vivo preparations were incubated 
with  the  anti-ganglioside  Ab  on  ice,  whilst  in  vivo-Ab  incubations  remained  at 
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FITC/TRITC-conjugated  secondary  Abs  were  applied  as  described  (see  2.7  and 
2.3.1, 2.3.3 and 2.5.1).  
In order to investigate the pathological potential of the Abs, tissues was further 
incubated  with  a  source  of  complement  (40%  normal  human  serum  (NHS),  see 
2.11) following their Ab-incubation and then processed for qualitative imaging (see 
2.3 and 2.5). All these incubations were conducted at 37ºC. 
 
3.2.2.3 Determination of injury to neural/glial structures of the NMJ 
The fluorescent proteins expressed in the axons and SCs of the fluorescent mice 
are  both  localised  to  the  cytosol  as  soluble  free  proteins  (Wesley  Thompson, 
personal  communications).  Following  a  loss  of  the  axolemmal/SC  membrane 
integrity, for example due to the formation of MAC pores on these, these proteins 
(presumably) diffuse out of the axon/SC. Thus a loss of CFP/GFP serves as a rapid 
and reliable indicator of complement-mediated injury to these. 
 
3.2.2.4 Additional illustration of a loss of pSC membrane integrity 
In order to further demonstrate the loss of pSC membrane integrity, NHS in many 
cases  was  supplemented  by  EthD-2  (1:500),  a  nuclear  marker,  whose  cellular 
ingress und subsequent nuclear binding indicates a loss of cell membrane integrity. 
 
3.2.2.5 Auxiliary investigations regarding the TBG3-binding profile 
TS-preparations incubated as described above were permeabilised as described in 
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Fig.17: Anti-ganglioside Ab-binding patterns at the NMJ. In A (MOG16 in WT), B (CCG3 
in PLP-Tg) and C (EG1 in PLP-Tg) the Ab-binding patterns (α-IgG3; pink in the composite 
image)  resemble  the  BTx-signal  (which  depicts  the  nAChRs;  orange  in  the  composite 
image), whereas in D (EG1 in GM2KO), E (EG1 in WT) and F (MOG16 in PLP-Tg) the Ab 
colocalises with the pSCs (GFP, green in the composite image). CFP depicts the axons, 
which are blue in the composite image. Scale bars: 20 µm. 3. Results       Anti-ganglioside antibody trials    89 
3.3.3 Results 
3.3.3.1 Binding profiles 
Depending on the ganglioside-specificity applied the staining of the secondary Abs 
either  very  much  resembled  the  nAChR-pattern  or  colocalised  with  the  pSCs 
(Fig.17). 
The binding pattern for TBG3 in WT mice was very difficult to illustrate (Fig.18A). 
Therefore,  TBG3  was  applied  to  GD3KOs  which  relatively  overexpress  the  Ab-
target. In these mice, the staining pattern for TBG3 much resembled the nAChR-
pattern (Fig.18B). In PLP-Tg mice TBG3 did not bind (Fig. 18C); this was expected 
considering  the  fact  that  the  NTs  of  these  mice  do  not  possess  any  complex 
gangliosides. Following permeabilisation both of WT- and GD3KO-tissue incubated 
with TBG3, Ab could be easily detected in both; the staining pattern now resembled 
the CFP-pattern with punctuate interspersed dense patches of Ab (Fig.18D, E). 
 
3.3.3.2 Loss of fluorescent proteins 
Following the acute topical application either in vivo or ex vivo of anti-ganglioside 
Abs no changes to the neural or glial components could be observed (Fig.19A). 
Only once NHS was applied as a source of external complement, a rapid loss of 
either GFP and/or CFP was observed. Within 15 minutes of the application of NHS 
following a  TBG3-incubation, the NTs started to bleb, exhibit constrictions and a 
local loss of CFP (Fig.19B). These changes only involved the area overlying the 
NMJ or extended proximally along the axon for a short distance (Fig.19C). 
With GFP, the loss of fluorescent protein occurred roughly within the same time-
frame and within 30 minutes of the application of complement the nuclei of injured 
pSCs were stained with EthD-2 (Figs.20, 21). 
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Fig.18:  Binding  pattern  for  TBG3  at  the  NMJ.  A,  B,  C  un-permeabilised  tisse;  D,  E 
permeabilised tisse. A, D WT-mouse, B, E GD3KO-mouse, C PLP-TG mouse. 
Note how in the WT- and PLP-Tg-mouse no Ab-binding (α-IgG3, orange in the composite 
image) can be demonstrated in unpermeabilised tissue (A and C), whereas in the GD3KO-
mouse Ab is readily shown (B). Once tissue is permeabilised, the Ab is readily visible at the 
WT-NMJ  and  colocalises  with  the  NTs  (CFP,  blue  in  the  composite  image).  However, 
following  permeabilisation  the  binding  pattern  does  not  resemble  the  BTx-signal  (which 
depicts the nAChRs and is green in the composite image) anymore (B), but follows the CFP-
signal (D, E). Scale bars: 20 µm. 
 
With  none  of  the  Abs  applied  the myelinating  SCs  surrounding  the  distal  axons 
neither  seemed  to  lose  their  fluorescence  nor  exhibited  an  uptake  of  EthD-2 
(Fig.21).  In  control  animals,  which  only  received  Ringer’s  solution  and  NHS,  no 
changes to the fluorescent proteins were noted (Fig.22). 
Depending on the Ab applied, an isolated loss of CFP could be observed, whereas 
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readily  observed,  the  changes  to  the  physiological  CFP-pattern  were  only  very 
subtle  (Fig.20),  whilst  in  other  cases  they  were  very  obvious  (Figs.21C,  23). 
Especially with EG1, the CFP-changes appeared to be concentration-dependent, 
i.e. lower concentrations of EG1 lead to less concomitant loss of CFP in addition to 
the well reproducible loss of GFP (Figs.20, 21). 
 
 
Fig.19: NT injury following the application of TBG3 and complement. A No changes to 
the  NT  (CFP)  are  observed  following  the  application  of  Ab.  Only  once  the  source  of 
complement (NHS) is applied, the NT starts to bleb and looses its fluorescence (arrow). B In 
vivo  documentation  of  injury  progression.  At  t0  the  Ab-application  is  completed  and  the 
muscle is incubated with complement. Within 15 minutes (t15, arrows) of the application of 
complement, changes to the morphology of the NT (CFP) can be observed, whereas the 
GFP-signal for the pSCs remains physiological (same as t0). The pSCs also do not exhibit 
any uptake of EthD-2 (orange in the composite image), indicating that their cell membrane 
integrity is not compromised by complement-mediated injury. C Ex vivo image of the acute 
injury following 30 minutes of incubation with Ab and complement.  
In A, B and C, BTx depicts the nAChRs (orange in the composite image), CFP the axons 
(blue in the composite images) and GFP the SCs (green in the composite images). Scale 
bars: 20 µm. 3. Results       Anti-ganglioside antibody trials    92 
 
Fig.20: pSC injury in WT-mouse following the application of EG1 and complement. The 
GFP-positive cell bodies are replaced by EthD-2 stained nuclei (orange in the composite 
image). Note the  very  subtle  changes  to the  circled NTs  (CFP),  wherase the  other  NTs 
remain healthy.  
BTx  depicts  the  nAChRs  (pink  in  the  composite  image),  CFP  the  axons  (blue  in  the 
composite image) and GFP the SCs (green in the composite image). Scale bar: 20 µm. 
 
 
 
 
Fig.21:  Examination  of  myelinating  SCs  and  dose-dependant  injury  of  the  NTs 
following the application of EG1 and complement. No loss of GFP or uptake of EthD-2 3. Results       Anti-ganglioside antibody trials    93 
(orange in the composite images) in the myelinating SCs in A NT injury, B predominant pSC 
injury  following  the  application  of  EG1  at  50  µg/ml  (half  the  usual  concentration)  and  C 
combined  NT  and  pSC  injury  following  the  application  of  EG1  at  100  µg/ml  (usual 
concentration). 
BTx  depicts  the  nAChRs  (pink  in  the  composite  image),  CFP  the  axons  (blue  in  the 
composite image) and GFP the SCs (green in the composite image). Scale bars: 100 µm. 
 
 
 
 
 
 
 
Fig.22: Control muscles (incubated with Ringer’s solution followed by complement.)  
A in vivo application and imaging; B ex vivo application and imaging. No changes to the 
fluorescent proteins are noted. 
BTx  depicts  the  nAChRs  (orange  in  the  composite  image),  CFP  the  axons  (blue  in  the 
composite image) and GFP the SCs (green in the composite image). Scale bars: A 20 µm, B 
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3.3.3.3 Summary of results (Table 14) 
In and ex vivo application of anti-ganglioside Abs in conjunction with a source of 
complement  revealed  the  following  binding  profiles  and  injury  specificities. 
Antibodies  with  a  binding  profile  resembling  the  nAChR-pattern  corresponded  to 
selective NT-injuries, whereas Abs which exhibited a binding profile colocalising with 
pSCs, resulted in pSC injuries and NT changes of varying degree. 
 
Mouse strain 
WT  GD3KO  GM2KO  PLP-Tg 
Antibody 
binding  injury  binding  injury  binding  injury  binding  injury 
TBG3  NT  NT  NT  NT  n.i.  n.i.  –  – 
EG1  pSC  pSC + NT  n.i.  n.i.  pSC  pSC + NT  NT  NT 
MOG16  NT  NT  n.i.  n.i.  –  –  pSC  pSC + NT 
CGG3  pSC  n.i.  n.i.  n.i.  n.i.  n.i.  NT  NT 
 
Table 14: Results for anti-ganglioside Ab-binding and –injury trials  
(n.i. not investigated) 
 
 
Fig.23: Application of MOG16 in PLP-Tg mice. Despite this Ab exhibiting a pSC staining 
pattern (see Fig.17), a loss of CFP (blue in the composite images) overlying the NMJ (BTx, 
orange in the composite images) can be observed, indicating that the NTs are injured in 
addition to the pSCs (GFP, green in the composite images). Scale bars: A 100 µm, B 20 µm. 3. Results       Anti-ganglioside antibody trials    95 
3.3.4 Discussion 
Similar to previous investigations conducted in WT and KO non-fluorescent mice, 
the  application  of  anti-ganglioside  Abs  with  varying  affinities  to  the  different 
gangliosides and a source of complement resulted in selective injuries to the neural 
and/or glial components of the NMJ depending on the affinity of the Ab applied. 
An injury specifically to the NTs in WT mice was elicited following the application of 
anti-GD1a-,  anti-GD1b-  and  anti-GT1b-Abs.  This  corresponds  well  to  previous 
investigations (Halstead et al., 2005b) and clinical studies, where anti-GM1 and anti-
GD1a Abs are predominantly found in patients suffering from acute motor axonal 
forms of GBS (Kaida et al., 2000; Press et al., 2001). Also, the fact that anti-GD1a 
Abs bind at lower levels (i.e. are harder to demonstrate) in WT mice when compared 
to GD3KO-mice, correlates well with the literature (Goodfellow et al., 2005). The 
rather unexpected and highly interesting finding, that TBG3, the anti-GD1a Ab, could 
readily  be  demonstrated  at  the  NT  of  WT  following  permeabilisation  of  these 
structures, indicates that this Ab must be internalised rapidly in this area and lead to 
a side-study exploring this phenomenon (see 3.5). Additionally, this finding then also 
explains why in previous studies WT-NMJs appeared to be relatively refractory to 
anti-GD1a  Ab-mediated  injury  at  the  standard  concentration  of  100  µg/ml 
(Goodfellow et al., 2005). In the current settings anti-GD1a Ab (TBG3) was applied 
at  double  the  concentration  (200  µg/ml)  and  a  shorter  incubation  period,  thus 
increasing the Ab-load and limiting the time available for uptake into the NT. 
Rather  unexpectedly,  however,  and  contrary  to  previous  observations,  it  did  not 
seem to be possible to elicit a selective injury to the pSCs in WT fluorescent mice. 
Previous  investigations  had  indicated  that  pSC  injury  in  these  mice  is  relatively 
associated with a GD3-reactivity of Abs (Halstead et al., 2005b); at the same time it 
was surmised that variations in Ab-concentration and exposure times could result in 
a broadening of the target structures (Halstead et al., 2005b). In the current study, 
both the application of EG1 and CGG3 in WT mice resulted in combined pSC and 
NT  injuries,  however,  especially for EG1 a  dose-dependant target shift  could be 
observed, with lower concentrations (50 µg/ml) resulting primary in injuries to the 
pSCs (albeit at a lower overall frequency) and regular concentrations (100 µg/ml) 
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The application of EG1 and complement in GM2KO mice resulted in a combined 
pSC  and  NT  injury.  This  potentially  can  be  explained  by  the  knockout  of  the 
GalNacTransferase in these mice which leads to the NTs expressing GD3 instead of 
complex gangliosides. Thus an Ab targeting GD3 binds both pSCs and NTs and 
results in a complement-mediated injury to both of these. This Ab therefore could 
not contribute to explaining the background behind the contradictory observations 
described above. 
At this point it might be worthwhile mentioning the efficacy of binding patterns. The 
binding pattern of Abs which in conjunction with complement lead to injury of the 
NTs, closely resemble the staining pattern for nAChRs (BTx) (Fig. 17). This staining 
pattern on the other hand is also very similar to that shown for acetylcholineesterase 
(Rich & Lichtman, 1989c), glycoproteins of the synaptic basal lamina stained with L-
VVA (O'Malley et al., 1999) or following the application of RH795 (Balice-Gordon & 
Lichtman,  1993),  a  dye  used  for  the  functional  imaging  of  neurons  (product 
information,  Molecular  Probes).  The  analogy  of  staining  patterns  observed  for 
muscular,  basal  membranous  and  neural  structures  of  the  NMJ  presumably 
indicates the close proximity of these structures to one another, especially for when 
Abs applied can only bind the synaptic (abglial) side of the NTs. In stark contrast to 
this, the binding patterns for pSCs are very distinct due to colocalisation with GFP-
filled cell bodies overlying the NMJS in these mice (Fig.17). At the same time, it is 
not clear to what extent pSC binding patterns mask NT binding patterns due to the 
relation of these structures to one another. The pSCs processes precisely align with 
the NTs, thus making it difficult to discern whether the Abs actually are binding the 
NTs, the pSC processes or both.  
Thus, there are three potential explanations, why all  Abs which exhibited a pSC 
binding  profile  induced  both  a  pSC  and  NT  injury  following  the  application  of 
complement (Table 14): a) the Ab binds to both the pSCs and NTs and the NT-
binding is masked by the pSC-binding, b) the NT-injury is a bystander (friendly fire) 
injury following a severe complement activation on the pSCs or c) the NTs show 
changes  to  their  morphology  as  a  result  of  the  injury  to  their  pSC.  As  briefly 
indicated above, b) and c) lie in direct contrast to previous investigations where the 
short-term  ablation  of  the  pSCs  did  not  lead  to  any  ultrastructural  or  functional 
changes of the NTs (Halstead et al., 2005b). A caveat to the previous investigations, 
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and the subtle changes to the CFP observed in the present study might not have 
been discernible in ultrastructural and electrophysiological investigations conducted 
in the previous investigations. 
The application of MOG16 in PLP-Tg mice provided some help in elucidating this 
question. In ELISAs, MOG16 binds the complex gangliosides GD1b and GT1b. In 
WT-muscles, this Ab exhibits a binding pattern similar to the BTx-signal and induces 
a selective injury to the NTs. In PLP-Tg mice, however, this Ab colocalises with the 
pSCs and, following the application of complement, results in a very pronounced 
pSC  injury  which  is  accompanied  by  obvious  changes  to  the  NTs  (Fig.23). 
Technically, PLP-Tg mice only express complex gangliosides in the SCs of their 
PNS,  as  the  promoter  (PLP)  for  the  enzyme  required  to  synthesise  complex 
gangliosides  is  only  found  in  certain  glial  cells,  such  as  SC  precursors, 
oligodendrocytes and olfactory ensheating cells, and some non-glial cells (Griffiths 
et al., 1998). However, recent publications have indicated a possibility of neuronal 
expression of PLP in mice (Miller et al., 2009; Sarret et al., 2010) with research 
specifically showing the embryonic expression of soma-restricted products of the 
PLP gene in motor neurons of the PNS (Jacobs et al., 2004). This would mean that 
depending on the life of the enzyme and the rate of ganglioside turnover at the NT, 
PLP-Tg  mice  potentially  could  possess  complex  gangliosides  on  their  NTs 
(confirmed by personal communications with Wendy Macklin, supplier of the PLP-
promoter).  However,  if  the  neural  structures  in  these  mice  do  possess  complex 
gangliosides,  they  should  also  be  vulnerable  to  the  application  of  TBG3  and 
complement, which in WT mice leads to a very reliable NT-injury. In PLP-Tg-mice, 
however, TBG3 does not bind and the application of TBG3 and complement does 
not lead any changes to the NTs; therefore, PLP-Tg neural structures do not contain 
any complex gangliosides, and potential explanation a) (the masking of a NT binding 
pattern by a pSC binding pattern) cannot apply to these mice. When comparing pSC 
binding profiles for PLP and WT mice no obvious differences can be observed. This, 
together with the fact that an Ab which definitely only binds the pSCs leads to a 
combined pSC and NT injury in the PLP-Tg mouse, indicates that the concomitant 
injury of the NTs with the pSC injury in the WT mouse most likely is the result of a 
bystander injury (explanation b)) or reactive changes of the NT following the pSC 
injury  (explanation  c)).  Further  investigations  are  warranted  to  provide  a  definite 
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In addition to raising a number of questions, the binding and injury profiles, however, 
also resulted in the very interesting observation, namely that the reintroduction of 
the GalNac-Transferase in PLP-Tg mice via the PLP-promotor resulted in a changed 
ganglioside profile of the  pSCs  of these mice. Instead  of the simple  ganglioside 
GD3, the pSCs of these mice now express the complex gangliosides GD1b and/or 
GT1b. The switch seems to be complete as both EG1 and CGG3, Abs which both 
bind GD3, exhibit a NT binding profile and induce a selective NT-injury in these mice 
(Fig.17). 
 
 
3.3.5 Conclusion 
Despite raising a number of questions, the investigations described in this chapter 
indicate that for WT mice, a selective and reliable injury to the NTs can be induced 
following  the  application  of  TBG3.  The  concentration  of  this  Ab  needs  to  be 
increased and the exposure time decreased to be able to compensate for the rapid 
internalisation of this Ab at the NT. A reliable combined injury to NTs and pSCs can 
be achieved by applying both TBG3 and EG1 simultaneously. 
Currently, no selective injury to pSCs can be elicited in fluorescent mice. 
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3.4 Comparison of SM and SH regarding Ab-binding, NT sprouting and 
pSC process extension 
3.4.1 Introduction 
Previous  investigations  conducted  in  the  murine  model  for  GBS  have  revealed 
differences  in  the  strain  susceptibility  to  Ab-mediated  injury.  NIH(s)  mice,  which 
were  used  in  the  earliest  investigations,  seemed  relatively  refractory  to  Ab-  and 
complement-mediated  of  pSCs  when  compared  to  Balb/c  and  C57Bl/6  mice 
(Halstead et al., 2004, 2005b). This appears to be due to a difference in the level of 
anti-ganglioside Ab-binding (unpublished data). 
The homozygous strain of double-fluorescent mice was outbred with DBA females 
to acquire bigger litters and thus increase the availability of mice. As it was intended 
to make use of all stocks (both homozygous and heterozygous male and female 
mice) the following investigations were aimed at determining whether the Ab-binding 
level for the Ab in mind to create in vivo NT-injuries was equal for all muscles under 
investigation in both homozygous and heterozygous male and female mice. The Ab-
binding levels were determined semi-quantitatively by assessing the fluorescence 
intensity of secondary Abs overlying the NMJ (briefly described in 2.5.3), a method 
repeatedly published in previous instances (Goodfellow et al., 2005; Greenshields et 
al., 2009; Halstead et al., 2004). Obviously, this methodology does not allow for 
determining the exact amount of Ab bound at the NMJ. However, as all staining runs 
are carried out in parallel and with the same agents, it does allow for the relative 
comparison of the level of Ab bound in the muscles under investigation. 
On an entirely different note, research has indicated that the ability and rate of NTs 
to  sprout  following  traumatic  denervation  of  the  NMJ  or  toxin-induced  paralysis 
differs  between  fast-  and  slow-twitch  muscles,  with  NTs  of  slow-twitch-muscles 
exhibiting a greater capacity and/or faster NT sprouting (Brown et al., 1980; Duchen, 
1970; Duchen & Tonge, 1973; Frey et al., 2000; Hopkins et al., 1986). As indicated 
in the introduction (1.3.3.3), NT sprouts follow extended pSC processes and can be 
induced  by  these  (Son  &  Thompson,  1995a);  both  the  axonal  sprouts  and  the 
reactive  pSCs  extending  processes  are  GAP-43  positive  (Woolf  et  al.,  1992). 
Considering  the  SM  and  SH,  the  muscles  aspired  to  be  used  in  the  in  vivo 
investigations, are predominantly fast-twitch (d'Albis et al., 1988; Kemp et al., 2009; 3. Results       Validation of SM and SH    100 
van Lunteren & Moyer, 2003), the ability of these muscles to exhibit pSC processes 
and NT sprouts following (traumatic) denervation of the NMJs was examined. 
 
 
3.4.2 Specific Materials and Methods 
3.4.2.1 Antibody-binding capacity 
The  SM,  SH  and  TS  of  four  age-matched  (10  to  12  weeks)  homozygous  and 
heterozygous double-fluourescent WT mice (one male and one female each) were 
extracted and snap-frozen at -80ºC. 
Muscles  were  mounted  on  blocks  of  embedding  compound  (Bright  cryo-m-bed, 
Bright Instrument Company Limited, Huntingdon, UK), sectioned longitudinally at 8 
µm with a cryostat (Bright Company Limited, Huntingdon, UK) and transferred to 
glass slides (Menzel, Braunschweig, Germany). 
Two  samples  per muscle  per  animal  were  incubated  with  TBG3  (50µg/ml) for  2 
hours at 4ºC, rinsed in PBS and further incubated with TRITC-conjugated α-m-IgG3 
(1:300 in PBS) and FITC-conjugated BTx (1.3 µg/ml) for 6 hours at 4ºC (see also 
2.7 and 2.8). Slides were washed in PBS, mounted in Citifluor anti-fading agent 
(Citifluor products, Canterbury, UK), coverslipped and sealed. 
The  Ab-deposit overlying  the NMJ  was  determined  and  semi-quantified for  each 
muscle section as described in 2.5.3 and muscles/lines/sexes were compared using 
the Mann-Whitney test for non-parametrical data. 
 
3.4.2.2 Nerve terminal sprouting and pSC process extension capacity 
In twelve heterozygous double-fluorescent WT mice the SM and SH were exposed 
as described in 2.2.1. Then the left CNXI was crushed at the point of appearance 
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entrance into the SM) and the left innervating nerve to the SH was crushed directly 
at its entrance into the SH. The mice were recovered and sacrificed after four (n=3), 
seven (n=3) and 14 days (n=6). For qualitative assessments (n=3 for each time-
point) the SM and SH were processed and imaged as described in 2.3.1 and 2.3.4 
The remaining three mice (14 days of regeneration) were perfused as described in 
2.3.2 and the SM permeabilised as described in 2.6.2. Anti-GAP-43 was applied in 
blocking serum III (2.10) at a concentration of 1:500, 1:250 and 1:125 for 3 days at 
4ºC,  followed  by  a  PBS  wash  and  an  incubation  with  secondary  Ab  (TRITC-
conjugated anti-m-IgG2a, 1:100) and Cy5-conjugated BTx (1:500) for 4h at RT. SM 
were imaged as described in 2.3.4. 
 
 
3.4.3 Results 
3.4.3.1 Antibody-binding capacity 
In total 1867 NMJs (minimum 82 NMJs, maximum 262 NMJs per muscle, sex and 
strain) were imaged. 
The Ab-binding capacity were similar for all muscles in male and female homo- and 
heterozygous  double-fluorescent  mice  with  the  SH  in  male  heterozygous  TS 
exhibiting  the  highest  levels  and  the  homozygous  TS  (both  male  and  female) 
exhibiting the lowest levels (Fig.24A). 
In  statistical  analyses,  no  significant  differences  were  observed  between 
homozygous and heterozygous SH (p=0.812; Mann-Whitney test, n=830) and SM 
(p=0.565; Mann-Whitney test, n=433) with the SM generally exhibiting lower levels 
of Ab-deposit when compared to the SH. A significant difference in the levels of Ab-
binding  was  observed  when  comparing  homozygous  and  heterozygous  TS 
(p<0.001; Mann Whitney test, n=604; Fig.24B). 3. Results       Validation of SM and SH    102 
 
 
Fig.24: TBG3-binding at SH-, SM- and TS-NMJs of female and male double-fluorescent 
mice. A overview of binding values for all muscle sections; B comparison of the different 
muscles  in  heterozygous  and  homozygous  double-fluorescent  mice.  Mann-Whitney  test; 
n=830 (SH), n=433 (SM) and n=604 (TS). Each point represents one measurement. The 
maximum value obtainable for a measurement is 255. 3. Results       Validation of SM and SH    103 
When combining all three muscles and comparing male and female heterozygous or 
homozygous  mice,  a  slight  (however  significant  (p=0.021;  Mann-Whitney  test; 
n=1037))  difference  was  noted  between  male  and  female  heterozygous  mice, 
however,  there  was  no  difference  between  male  and  female  homozygous  mice 
(p=0.189; Mann-Whitney test, n=830; Fig.25). 
 
 
Fig.25:  Comparison  of  TBG3-binding  capacity  between  the  female  and  male 
individuals of each strain. Mann-Whitney test, n=1037 (het) and n=830 (hom). Each point 
represents one measurement. The maximum value obtainable for a measurement is 255. 
 
 
Pooling  all  three  muscles  and  both  sexes  and  comparing  heterozygous  and 
homozygous  mice,  a  significant  difference  between  the  two  strains  of  mice  was 
observed (p<0.001; Mann-Whitney test, n=1867; Fig.26A). This however, is due to 
the difference of Ab-deposit in the TS between the two strains, as the exclusion of 
this muscle lead to no significant difference being observed between homozygous 
and heterozygous double-fluorescent mice (p=0.853; Mann-Whitney test, n=1263; 
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Fig.26:  Comparison  of  the  TBG3-binding  capacity  between  heterozygous  and 
homozygous  double-fluorescent  mice.  A  all  muscles;  B  TS  excluded.  Statistics  were 
conducted  with  Mann-Whitney  tests;  n=1867  (A),  n=1263(B).  Each  point  represents  one 
measurement. The maximum value obtainable for a measurement is 255. 
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3.4.3.2 Nerve terminal sprouting and pSC process extension in SM and SH following 
traumatic denervation 
Following four days of regeneration, many NMJs of the left SH already exhibited 
CFP overlying the NMJ. The presence of CFP occurred in a latero-medial fashion. 
Also,  GFP-positive  processes  and  axonal  sprouts  extending  from  CFP-positive 
NMJs were observed (Fig.27A). In general, there seemed to be a surplus of GFP-
positive cells. At this time-point, the SM exhibited no CFP, whatsoever. In some 
areas of the SM, GFP-positive networks were observed, whereas in other areas, the 
pSCs and myelinating SCs only extended very tentative processes (Fig.27B). 
 
Fig.27: Sternohyoid (A) and SM (B) muscles 
four  days  after  crush  of  the  innervating 
nerve. Note the lack of axons (CFP) in the SM. 
The reinnervated SH-NMJ extends a NT sprout 
(CFP in A, arrow) and a pSC process (GFP in 
A, arrow) whilst the SH-NMJ to the right of the 
innervated  NMJ  exhibits  a  surplus  of  GFP-
positive cells on its efferent axon (asterisk). The 
close-up  of  the  SM-pSCs  (GFP  in  B)  also 
shows  pSC  processes  (arrows).  BTx  depicts 
the nAChRs (orange in the composite images), 
CFP the axons (blue in the composite images) 
and  GFP  the  SCs  (green  in  the  composite 
images). Scale bars: A 20 µm, B 100 µm. 3. Results       Validation of SM and SH    106 
At  seven  days  of  regeneration,  all  SH-NMJs  exhibited  CFP  overlying  their  BTx-
signal and very many NMJs exhibited processes extending from GFP-positive cells 
and NT sprouts (Fig.28A). The SM was in the process of reinnervation, with some 
NTs exhibiting short sprouts. Here, a surplus of GFP-positive cells was observed 
which formed extensive networks. These often bridged individual NMJs (Fig.28B) A 
further seven days later, the SH closely resembled the control muscles, with only 
very few and distinct processes extending from GFP-positive cells and one or two 
NT sprouts to be seen (Fig.28C). The SM also exhibited CFP overlying all its NMJs, 
however, nearly every NMJ exhibited NT sprouts and extensive networks of GFP-
positive  cells  could  be  observed,  of  which  there  was  still  a  surplus.  In  many 
occasions  both  CFP-  and  GFP-positive  processes  bridged  individual  NMJs 
(Fig.28D) 
Control SM and SH did not exhibit any changes to their fluorescent proteins; this 
includes pSCs processes or NT sprouts (Fig.28E).  
The anti-GAP-43 stain predominantly colocalised with GFP-positive structures. Here 
both the cell bodies and processes were stained (Fig.29). Only very occasionally 
axonal structures were stained. 
 
Fig. 28 see overleaf 
 
 
Fig.29:  GAP-43-stain  at  regenerating  NMJs.  GAP-43  (orange  in  the  composite  image) 
colocalises mainly with the GFP-signal for the pSC cell bodies and processes. BTx depicts 
the nAChRs (pink in the composite image), CFP the axons (blue in the composite image) 
and GFP the SCs (green in the composite image). Scale bar: 20 µm. 3. Results       Validation of SM and SH    107 
 
Fig.28: Recovery of the SH and SM from crush of the innervating nerve. A, B 7 days 
after crush. C, D 14 days after crush. E control NMJ. 
A note the long pSC process (GFP) and NT sprout (CFP) extending to the right in the NMJ. 
The efferent axon is on the left. B networks of GFP-positive cells and return of some CFP to 
all three NMJs; the NMJ at the top (arrow) exhibits the most complete reinnervation. C the 
SH-NMJs exhibit a physiological morphology, D two SM-NMJs are bridged both by axons 
(CFP) and pSC processes (GFP). 
BTx depicts the nAChRs (orange in the composite images), CFP the axons (blue in the 
composite images) and GFP the SCs (green in the composite images). Scale bars: A, B 100 
µm, C-E 20 µm. 
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3.4.4 Discussion and Conclusion 
3.4.4.1 Antibody-binding capacity 
Differences in the ganglioside distribution in the same species have been reported 
for various areas of the central nervous system and these also seem to undergo 
changes during maturation of the animal (Bhargava et al., 1984). Similar findings 
were  made  when  comparing  human  extraocular  and  limb/axial  muscles.  Here  a 
difference in the neuromuscular staining was observed, with the extraocular NMJs 
exhibiting a stronger binding for anti-GQ1b, -GT1a and –GD1b Abs when compared 
to the limb and axial muscles (Liu et al., 2009). 
The  results  described  above  reveal  no  major  differences  in  the  ganglioside 
distribution at NTs for the two predominantly fast-twitch muscles, SH (van Lunteren 
&  Moyer,  2003)  and  SM  (Kemp  et  al.,  2009)  both  in  homo-  and  heterozygous 
double-fluorescent mice. In both strains lower Ab-deposits were observed in the SM 
when compared to the SH, which means potentially that the SH-NTs are slightly 
more  susceptible  to  anti-ganglioside  Ab  and  complement-mediated  injury. 
Nevertheless,  it  should  be  feasible  to  extrapolate  data  acquired  both  from 
homozygous and heterozygous mice for these two muscles. 
Interestingly, the homozygous predominantly slow-twitch TS (Baxter et al., 2008) 
exhibited a much reduced Ab-binding capacity when compared to the heterozygous 
TS.  The  reason  behind  this  remains  to  be  elucidated.  Therefore,  at  this  point  – 
considering the heterozygous TS exhibited Ab-binding levels similar to SH and SM – 
further  investigations  should  exclude  the  homozygous  TS  and  only  utilise 
heterozygous TS. 
 
3.4.4.2 Nerve terminal sprouting and pSC process extension 
Many investigations assessing pSC process extension and associated NT sprouting 
following  traumatic  denervation  of  the  NMJ  have  been  conducted  in  the  soleus 
muscle (Brown & Holland, 1979; Love & Thompson, 1999; Reynolds & Woolf, 1992; 
Son  &  Thompson  1995a,  1995b),  which  predominantly  is  a  slow-twitch  muscle 3. Results       Validation of SM and SH    109 
(d'Albis  et  al.,  1988;  Kemp  et  al.,  2009).  At  the  same  time,  a  difference  in  the 
capacity NTs to produce axonal sprouts has been reported with NTs from slow-
twitch muscles exhibiting a greater capacity for this behaviour when compared to 
NTs located on fast-twitch muscles (Brown et al., 1980; Duchen & Tonge, 1973; 
Frey  et  al.,  2000;  Hopkins  et  al.,  1986).  This  might  be  due  to  the  fact  that 
Semaphorin 3A, a growth-cone collapse inducing factor and therefore inhibitory for 
the growth of neurites, is selectively expressed in pSCs of fast-twitch (IIb/x) muscle 
fibres  following  denervation  or  toxin-induced  paralysis  (De  Winter  et  al.,  2006). 
Interestingly, however, other investigators have reported that following paralysis of 
muscles with botulinum toxin the morphology and actual period of nerve growth (four 
weeks) both in slow- and fast-twitch muscles is very similar. The principal difference 
is  at  what  rate  these  changes  occur.  In  slow-twitch  muscles  these  changes  are 
observed roughly two to three weeks earlier than in fast-twitch muscles (Duchen, 
1970). 
In general, and as briefly introduced in the introduction (1.3.3.3), following crush 
injuries  to  the  innervating  nerve,  pSCs  of  denervated  NMJs  extend  processes 
towards the periphery in the aim of reaching another NMJ; preferentially these pSCs 
bridges are formed between innervated and denervated NMJs (in contrast to two 
denervated  NMJs)  (Love  &  Thompson,  1999).  In  the  event  of  contacting  an 
innervated NMJ, the pSCs then induce the NT to sprout and guide it back to their 
own NMJ to regain innervation (Son & Thompson, 1995a). In regenerating muscles, 
the  NMJs  therefore  are  cross-linked  by  pSC-processes  and  axonal  sprouts,  and 
following regeneration “escaping”/overshooting axons which follow pSC processes 
extending  towards the  periphery can  be  observed (O'Malley  et al., 1999; Son & 
Thompson 1995a, 1995b; Son et al., 1996). 
The results described above, clearly indicate that the SM and SH, which both are 
predominantly  fast-twitch-muscles  (d'Albis  et  al.,  1988;  Kemp  et  al.,  2009;  van 
Lunteren  &  Moyer,  2003),  exhibit  pSC  processes  and  NT  sprouts  during  their 
reinnervation period after a crush injury to their innervating nerve. 
In the early stages after nerve injury, only few pSC processes were observed. In the 
SM,  however,  these  soon  extended  and resulted  in  extensive  networks  of  GFP-
positive  cells,  which  could  still  be  seen  at  the  time-point  when  most  NMJs  had 
recovered their CFP-signal (NTs). In the SH, many pSC processes were noted, too, 3. Results       Validation of SM and SH    110 
these however, did not form extensive networks. Within seven to ten days following 
reinnervation,  the  SH-pSCs  had  returned  to  control  morphology.  During  and 
following the reinnervation period, the rate of NT sprouts increased until close to all 
NMJs  exhibited  sprouts.  These  then  persisted  for  a  while,  in  their  time-course 
presumably mirroring the pSC processes. The occurrence and resolution of pSC 
processes  and  NT  sprouts  observed  in  the  present  study  were  similar  to  those 
described in the soleus muscle following crush injury to the sciatic nerve (Reynolds 
& Woolf, 1992), whilst the rate of the changes observed corresponded well to crush 
injuries to the SM-innervation carried out in other groups, albeit in closer location to 
the muscle (Marques et al., 2006). 
The GAP-43 stain confirmed the presence of activated pSCs (Woolf et al., 1992). 
Unfortunately,  it  proved  very  problematic  to  stain  the  axonal  sprouts.  This  most 
probably is due to technical difficulties as most protocols apply this stain in sections 
and not wholemount tissue. 
Nevertheless, the results acquired in this chapter indicate that following traumatic 
denervation of their NMJs, the pSCs and NTs of the SM and SH are capable of 
exhibiting  the  characteristic  changes  observed  in  other  muscles  following 
denervation or paralysis of those. 
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3.5  Antibody  internalisation  at  the  motor  NT  and  protection  from 
complement-mediated injury 
3.5.1 Introduction 
Previous studies investigating the application of anti-GD1a Abs in WT and GD3KO 
mice, have revealed the WT mice as relatively resistant to NT-injury following Ab- 
and complement-application. Additionally, the WT mice exhibited significantly lower 
levels  of  IgG  and  complement  deposition  when  compared  to  the  GD3KO  mice 
(Goodfellow et al., 2005). This was attributed to the lower expression of the target 
ganglioside GD1a in WT compared to the GD3KO mouse (Goodfellow et al., 2005), 
as in the latter the a-series gangliosides are relatively overexpressed (Kawai et al., 
2001;  Okada  et  al.,  2002).  Investigations  described  in  a  previous  chapter  (3.3) 
revealed that anti-GD1a Abs are rapidly internalised in the WT mice, whereas in 
GD3KO mice these Abs can still demonstrated on the terminal axolemma following 
identical incubation times.  
Thus, the following study was aimed at determining the rate of Ab-uptake at the NT 
in WT mice and how this potentially can protect the NT from complement-mediated 
injury. The amount of Ab and complement overlying the NMJ were determined semi-
quantitively, in exactly the same way as described and discussed in the previous 
chapter  (see  3.4.1)  and  published  on  previous  occasions  (Bullens  et  al.,  2002; 
Goodfellow et al., 2005; Greenshields et al., 2009, Halstead et al., 2004, 2005a, 
2008b). 
 
 
3.5.2 Specific Materials and Methods 
3.5.2.1 Antibody-binding and -uptake 
Twelve TS preparations (see 2.4) of heterozygous double-fluorescent WT mice were 
incubated  with 0.5 ml  of TBG3 (100  µg/ml, supplemented  by FITC-labelled-BTx) 
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·  30 minutes on ice (termed 0 min),  
·  30 minutes at 37° C (termed 30 min)  
·  30 minutes at 37° C followed by 60 minutes with Ringer’s solution (2.10.1) 
(termed 90 min)  
·  30 minutes with Ringer’s solution on ice (control) 
Following these incubations the muscles were rinsed, fixed and further processed 
for  Ab-detection  as  described  in  2.5.1.  Semi-quantification  of  Ab-deposit  was 
conducted  and  measurements  illustrated  as  described  in  2.5.3.  Groups  were 
compared with the Mann-Whitney test (2 groups) and the Kruskal-Wallis test (>2 
groups) for non-parametrical data. 
After  the  first  set  of  quantitative  imaging,  the  muscles  were  rinsed  in  PBS, 
permeabilised for the level of the NMJ as described in 2.6.1 and reprocessed for Ab-
detection in the same way as the primary event. The second set of imaging was 
conducted  with  the  same  settings  for  FITC  and  TRITC  as  the  first  set  and 
processing of the measurements was also identical to that of the primary event. 
 
3.5.2.2 Ex vivo assessment of complement deposition and NT injury 
Twelve TS preparations (see 2.4) of heterozygous single - (only CFP) or double-
fluorescent  WT  mice  were  incubated  at  37° C  with  0.5   ml  of  TBG3  (200  µg/ml, 
supplemented by FITC-labelled-BTx) and 0.5 ml of 40% NHS with the following four 
incubation protocols (each n=3):  
·  TBG3 and NHS together for 30 minutes (termed 0 min) 
·  TBG3 for 30 minutes followed by NHS for 30 min (termed 30 min)  
·  TBG3 for 30 minutes, followed by Ringer’s solution for 60 min and NHS for 
30 min (termed 90 min)  
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The  TS  were  rinsed  five  times  with  Ringer’s  solution  between  the  individual 
solutions.  
Following the incubations, all TS were rinsed and incubated with α-C5-9 (1:40 and 
FITC-BTx (2 µg/ml) in Ringer’s solution) for 1 hour at room temperature and 3 hours 
at 4° C, then fixed with 4% PFA for 20 minutes, rins ed with PBS and 0.1M Glycine in 
PBS,  incubated  further  with  α-C5b-9  (1:40  in  PBS)  overnight  at  4° C  and  with 
secondary  AB  (TRITC-α-m-IgG2a  1:200)  for  7  hours  at  4° C,  and  processed  a s 
above. 
Following the quantitative analyses of complement deposition (see 2.5.3), 100 NMJs 
per  TS were  assessed for  CFP overlying the BTx-signal. To be able to conduct 
these investigations in a blinded fashion, the labels of the slides were obscured and 
samples coded by an independent colleague. CFP was scored as absent, changed 
or  normal  (Fig.30)  and  percentages  of  NMJs  calculated  for  absent,  changed  or 
normal  CFP.  Groups  were  compared  with  the  Kruskal-Wallis  test  for  non-
parametrical  data  (measurements)  and  chi-square  tests  (percentages  calculated 
from counts). 
 
 
3.5.2.3 In vivo assessment of NT injury 
In twelve heterozygous double-fluorescent WT mice, the SM were exposed in vivo 
as described in 2.2.1 and incubated with 0.6 ml TBG3 (200 µg/ml) and 0.6 ml of 
40% NHS with the following four incubation protocols (each n=3): 
·  TBG3 and NHS together for 30 minutes (termed 0 min)  
·  TBG3 for 30 min followed by NHS for 30 minutes (termed 30 min)  
·  TBG3 for 30 min, followed by sterile Ringer’s solution for 60 minutes and 
NHS for 30 minutes (termed 90 min).  
·  either Ringer’s solution instead of TBG3 or heat-inactivated NHS (control). 3. Results       Antibody internalisation at the NT   114 
 
Fig.30: Assessment of NTs (CFP). A CFP absent, B CFP changed, C CFP normal. Note 
the blebbing of the NT (CFP) in B. 
BTx depicts the nAChRs (orange in the composite images), CFP the axons (blue in the 
composite images) and GFP the SCs (green in the composite images). Scale bars: 20 µm. 
 
 
 
 
 
The surgical site was rinsed five times with sterile Ringer’s solution between the 
individual solutions. Following the incubations, the mice were immediately sacrificed 
and the SM processed for wholemount imaging and imaged as described in 2.3.1 
and 2.3.5. 
For the quantitative analysis of the injury, the superficial NMJs of the extracted SM 
were  assessed  for  CFP  overlying  the  BTx  signal.  CFP  was  scored  as  absent, 
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3.5.3 Results 
3.5.3.1 Antibody-binding and -uptake (Fig.31) 
A total of 2722 NMJs and 3043 NMJs were assessed in non-permeabilised and 
permeabilised tissue, respectively. 
In  non-permeabilised  tissue  a  significant  loss  of  superficial  IgG-deposit  could  be 
observed between the NMJs incubated on ice (0 min) and at 37ºC for 30 minutes 
(p<0.001; Mann-Whitney test, n=1645). Following an additional hour of incubation at 
37ºC  with  Ringer’s  solution,  the  values  for  IgG-deposition  further  decreased 
(p<0.001; Mann-Whitney test, n=1381). 
In  contrast  to  this,  following  permeabilisation  of  the  tissue,  only  very  slight  (yet 
significant) differences between the IgG-content (both superficial and internalised) 
were observed between tissue incubated on ice or at 37ºC (p<0.001; Mann-Whitney 
text, n=1663), whereas following a further one hour incubation with Ringer’s solution 
the IgG-content decreased dramatically (p<0.001; Mann-Whitney test; n=1557). 
In controls, no superficial or internalised Ab was detected. 
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Fig.31: Antibody-binding and -uptake. The level of Ab bound to the surface of the NT 
(non-permeabilised  tissue)  decreases  with  an  increase  in  incubation  time  and  there  is  a 
statistically significant difference between all time-points assessed (p<0.001; Kruskal-Wallis 
test, n=2722). Following permeabilisation of the tissue, Ab lying within the NT can also be 
visualised, thus the measurements depict the summary of superficial and internalised Ab. 
Here the level also decreases after a prolonged incubation period (90 min) and statistically 
significant different values are observed between all time-points and control tissue (p<0.001; 
Kruskal-Wallis test; n=3043).  
Each  outlier  point  represents  one  measurement.  The  maximum  value  obtainable  for  a 
measurement is 255. 
 
 
 
3.5.3.2 Complement deposition and ex vivo NT injury 
Here a total of 3552 NMJs were assessed for complement deposition. 
Concomitant incubation of tissue with anti-ganglioside Ab and complement resulted 
in the highest values for MAC-deposition. The later complement was applied, the 
less MAC-deposits  were observed at the NMJ, with an incubation gap (in which 
Ringer’s solution was applied for 1h) resulting in the same MAC-deposits as control 
tissue (Fig.32). 3. Results       Antibody internalisation at the NT   117 
 
Fig.32: Complement deposition and ex vivo NT injury. 
A The more time elapses between Ab-incubation and application of complement, the less 
MAC-deposition is observed at the NMJ (p<0.001; Kruskal-Wallis test, n=3552) Each point 
represents one measurement. The maximum value obtainable for a measurement was 255. 
B Example images for MAC deposition (red in the composite images) at the different time-
points. Note the CFP-loss at 0 min and 30 min, which represents NT injury, and coincides 
with MAC-deposition. 
BTx depicts  the  nAChRs  and  GFP the  SCs (both green in  the  composite images),  CFP 
depicts the axons (blue in the composite images). Scale bars: 20 µm. 3. Results       Antibody internalisation at the NT   118 
The results of the MAC-deposition were mirrored in assessments for NT injury. The 
simultaneous application of Ab and complement resulted in the highest score for 
unhealthy (CFP absent or changed) NMJs. This score continuously decreased the 
later complement was applied and statistically, no difference was observed between 
tissue with the incubation gap (90min) and the control tissue (p=0.737; chi-square 
test, n=12; Fig.33A). This corresponds directly with the results of the complement 
depositions. 
Interestingly,  the  main  category  contributing  to  the  most  detrimental  effect  of 
applying Ab and complement simultaneously was the amount of NTs where the CFP 
could  not be visualised  anymore  (absent), indicating the severity of the injury in 
these muscles. 
 
3.5.3.3 In vivo NT injury (Fig.34) 
Nerve  terminal  injury  following  the  in  vivo  application  of  Ab  and  complement 
mirrored that of ex vivo incubations. Here also the concomitant application of Ab and 
complement  resulted  in  the  highest  counts  for  non-healthy  NTs  (CFP  absent  or 
changed).  The  later  complement  was  applied  the  less  NTs  were  injured  and  in 
controls all NTs remained healthy. 
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Fig.33: Ex vivo NT injury. A Assessment of NT injury through examination of the CFP-
signal. B examples for NT injury at the different time-points. Note the increase in amount of 
healthy NTs (CFP; arrows in 30 min) with an increase in the time between Ab-incubation and 
application of complement. 
BTx depicts the nAChRs (green in the composite images) and CFP the axons (blue in the 
composite images). Scale bars: 100 µm. 3. Results       Antibody internalisation at the NT   120 
 
Fig.34: In vivo NT  injury.  A Assessment of NT injury through examination of the  CFP-
signal. B examples for NT injury at the different time-points. Arrows in 30 min and 90 min 
depict healthy NTs (CFP). 
BTx depicts the nAChRs (orange in the composite images), CFP the axons (blue in the 
composite images) and GFP the SCs (green in the composite images). Scale bars: 100 µm. 
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3.5.4 Discussion 
Anti-ganglioside Ab is taken up rapidly at the motor NT, which results in a protection 
of the NT from complement-mediated injury. These findings explain why in previous 
investigations,  the  NTs  of  WT  mice  appeared  to  be  relatively  resistant  to  anti-
ganglioside Ab- and complement-mediated injury (Goodfellow et al., 2005). At the 
same time, the findings, however, also indicate that an increase of Ab-concentration 
and a decrease in the protraction time until application of complement result in this 
phenomenon  being  overcome,  presumably  by  saturation  of  the  internalisation 
pathways. A saturation of the internalisation pathway presumably also accounts for 
the  increased  vulnerability  and  higher  MAC  deposits  observed  in  GD3KO  mice 
(Goodfellow et al., 2005). 
Following a prolonged incubation of TS, the total amount of Ab (both internalised 
and  superficial)  found  at  the  NT  decreases  which  indicates  either  a  local 
degradation or a transport of the Ab to a more proximal location. 
There  are  other  macromolecules  such  as  cholera,  tetanus  and  botulinum  toxin, 
which also bind to the gangliosides located on the NT (Helting et al., 1977; van 
Heyningen, 1974). Cholera toxin very selectively binds GM1 (Singh et al., 2000; van 
Heyningen, 1974), whilst both tetanus and botulinum toxin bind GD1b, GT1b and 
GQ1b (Schwab & Thoenen, 1978; Singh et al., 2000). Following their binding, both 
cholera and tetanus toxin are taken up into the NT and undergo retrograde transport 
in  membrane-bound  compartments  to  the  cell  body  at  a  velocity  of  7.5  mm/h 
(Schwab & Thoenen, 1978). In the case of cholera toxin, this phenomenon is widely 
exploited in research be coupling this toxin with fluorescent proteins and using it as 
a retrograde tracer. Botulinum toxin on the other hand is not transported, but locally 
undergoes  conformational  changes  to  be  able  to  exert  its  pathological  actions 
directly  at  the  NT  (Foran  et  al.,  2003).  Dopamine-β-hydrolase  Abs,  which 
presumably bind to dopamine-β-hydrolases at adrenergic NTs, also are taken up 
and  undergo  retrograde  transport;  this  selectively  takes  place  in  axons  of  the 
sympathetic nervous system (Fillenz et al., 1976). Thus, both the possibilities for 
local  degradation  or  retrograde  transport  have  been  demonstrated  for 
macromolecules binding gangliosides and being taken up in the NT. The fate for the 
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3.5.5 Conclusion 
The rapid uptake of anti-ganglioside Abs into the motor NT can protect this structure 
from  complement-mediated  injury. In order  to overcome this phenomenon in  the 
experimental setting, an increased Ab-concentration - preferentially combined with a 
decreased  protraction  period  for  the  incubation  with  complement  -  needs  to  be 
applied.  Unfortunately,  no  comment  can  be  made  in  regards  to  how  the  Ab-
concentrations  applied  in  current  investigations  relate  to  the  clinical  situation,  as 
unlike  for  example  Myasthenia  gravis  (Rǿdgaard  et  al.,  1987)  the  serum  Ab-
concentrations  in  relation  to  disease  occurance  and  disease  severity  remain 
unknown. 
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3.6 Auxiliary investigations associated with the loss of CFP at the NT 
3.6.1 Introduction  
Mice expressing fluorescent proteins in the axons  of their peripheral and central 
nervous system due to the Thy1.2 gene regulatory elements have been used to 
investigate a number of developmental, degenerative and regenerative questions 
(Lichtman & Sanes, 2003; Magill et al., 2008; Misgeld, 2005), such as axonal branch 
removal  at  developing  synapses  (Bishop  et  al.,  2004)  and  axonal  de-  and 
regeneration  in  the  central  nervous  system  (Dratviman-Storobinsky  et  al.,  2008; 
Kerschensteiner et al., 2005) and PNS (Beirowski et al., 2005; Hayashi et al., 2007, 
2008; Koob et al., 2007; Magill et al., 2007 ;Nguyen et al., 2002; Pan et al. 2003) 
following traumatic nerve injury. The advantages of these mice - especially when 
compared to carrying out intravital staining of axons - are multiple and include the 
fact that the fluorescent proteins diffuse or are transported along the entire axon. 
Therefore the entire NT is labelled, including tiny axonal sprouts. Also, there is no 
obvious difference in the staining intensity between distal and proximal portions of 
peripheral  nerves,  the  fluorescence  remains  stable  even  following  numerous 
imaging  sessions,  in  many  mouse  lines  the  motor  axons  start  exhibiting 
fluorescence by embryonic day 13 and the fluorescent proteins do not induce any 
(toxic) changes to the motor axons (Feng et al., 2000). 
Considering all these investigations are purely based on the incidence or absence of 
intracytosolic fluorescent proteins in the axons, it is crucial to determine to which 
(commonly  investigated)  histological  changes  the  loss  of  fluorescent  proteins 
correspond. Three studies have investigated the relationship between the loss of 
intraaxonal cytosolic proteins and electronmicroscopy (EM) of corresponding nerve 
sections following traumatic injury of the peripheral and central nerves (Beirowski et 
al., 2004, 2010; Wang, Hamm, & Povlishock, 2011). Both in and ex vivo lesioning of 
fluorescent optic, spinal cord and cerebral axons leads to swelling and beading of 
these  in  a  proximo-distal  fashion.  The  velocity  of  the  occurrence  of  these 
morphological changes roughly corresponds to the velocity of slow axonal transport 
(Beirowski  et  al.,  2010).  Fragmentation  of  the  fluorescent  signal  correlates  with 
breakdown of the axon (spheroid formation) (Beirowski et al., 2004), which is one of 
the  first  changes  observed  in  Wallerian  degeneration  (Stoll  et  al.,  2002;  Stoll  & 
Muller, 1999). Up to 48 hours after induction of the injury these spheroids contain 3. Results       Auxiliary investigations    124 
accumulations  of  multivesicular  bodies,  intact  or  dilated  mitochondria  and 
disorganised  cytoskeletal  elements,  whereas  at  later  time-points  the  spheroids 
appear to be empty or are only filled with floccular material. At early time-points (10-
24  hours after  induction of the injury), the spheroids  stain for anti-neurofilament, 
anti-neuronal βIII-tubulin and anti-tau Abs and also for makers of impaired axonal 
transport, such as β-amyloid precursor protein and synatophysin (Beirowski et al., 
2010).  Quantitative  analyses  of  preservation  rates  for  peripheral  axons  following 
traumatic  injury  were  conducted  both  with  fluorescence  and  conventional  light 
microscopy/EM.  No  significant  difference  was  observed  between  the  method  of 
evaluation at any time-point scrutinised (Beirowski et al., 2004). Percussion injury of 
the optic nerve also results in the area of focal loss of fluorescent proteins in the 
area where the force is applied. Here, EM investigations revealed highly vacuolated 
and organelle-devoid axonal cylinders, whereas the proximal and distal swellings 
contain  disorganised  axonal  skeletal  proteins.  The  distal  swellings  are  further 
characterised by dilated mitochondria and also contain autophagic vacuoles at later 
time-points (Wang et al., 2011). 
In the following, similar investigations to those described above were carried out in 
the  murine  model  of  GBS  to  investigate  the  significance,  nature  and  presumed 
mode for loss of the intraaxonal fluorescent protein following induction of an anti-
ganglioside Ab and complement-mediated injury to the motor NT. 
 
 
3.6.2 Specific Materials and Methods 
3.6.2.1 Ex vivo preparations 
Triangularis  sterni  preparations  (see  2.4)  of  WT  double-fluorescent  and  single-
fluorescent (only CFP) mice were incubated at 37ºC with TBG3 followed by NHS as 
described  in  2.7.  On  one  occasion,  tissue  was  further  incubated  with  Ringer’s 
solution for 4 hours at 37 ºC after the NHS incubation. In control tissue, TBG3 was 
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Following the incubations, the tissue was processed for Ab-deposition (see 2.5.1) or 
for  permeabilisation  of  the  NMJ  and  proximal  efferents  as  described  in  2.6.2. 
Primary Abs for neurofilament (NF) light (70kDa) and heavy (200 kDa) were applied 
at concentration of 1:200 in blocking serum III (see 2.10.6) for 20 hours at 4ºC (see 
2.7). Following a rinse in PBS, secondary fluorescence-conjugated goat-anti rabbit-
IgG was applied, also at a concentration of 1:200 in blocking serum III (see 2.10.6) 
for 20 hours at 4ºC. Then tissue was processed for imaging as described in 2.5.1. 
For  each  type  of  NF,  100  NMJs  per  TS  and  condition  were  assessed  for  the 
incidence of the physiological appearance of NF and CFP overlying the BTx-signal. 
To assess the contribution of calpain to NT injury and loss of CFP, AK 295 (200 mM, 
provided by Dr. J. Glass (Atlanta, GA, USA), which strongly inhibits both calpain I 
and II and to a lesser degree also cathepsin B (Li et al., 1996; Wang et al., 2004) 
was added to NHS and the tissue was processed for NF heavy as described above. 
 
3.6.2.2 In vivo preparations 
The SH and SM of double-fluorescent mice were subjected to in vivo application 
(see 2.2.1) of TBG3 followed by NHS as described in 2.7. Then α-IgG3 (1:200) and 
α-C5b-9 (1:40) were applied in vivo for 1 hour, before SM and SH were processed 
as described in 2.3.1 and 2.3.2. Anti-IgG3 and α-C5b-9 were then reapplied at the 
same concentrations overnight at 4ºC. Following a PBS rinse, the secondary Ab for 
MAC-deposition  (TRITC-α-m-IgG2a; 1:200) was  applied in blocking  serum I (see 
2.10.6) for 7 hours at 4° C (see 2.7). 
To assess the complete loss of NF light and heavy immuno-reactivity at 24 hours 
after induction of the injury, mice were recovered following the in vivo application of 
TBG3 and NHS and sacrificed one day later. Then SM and SH were processed for 
permeabilisation of the NMJs and proximal efferents as described in 2.6.2, and α-
NF-Abs (1:100) were applied in blocking serum III for 20 hours at 4ºC, followed by 
incubation with secondary Ab (fluorescence-conjugated goat anti-rabbit IgG; 1:200) 
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3.6.2.3 Electronmicroscopic investigations 
To acquire tissue for EM, mice subjected to in vivo application of TGB3 or Ringer’s 
solution  followed  by  NHS  (see  2.2.1  and  2.7).  The  mice  were  recovered  after 
checking the SH/SM in vivo for completeness of the injury and then sacrificed within 
the next hour or after 24 hours. Sternomastoid muscles/SH were processed for EM 
and imaged by Mrs Jennifer Barrie as described in 2.3.6. 
 
 
3.6.3 Results 
3.6.3.1 Ex vivo preparations 
In  all  control  preparations,  smooth  and regular  CFP  was  observed  overlying  the 
BTx-signal (Fig.35A). Acutely, following the induction of an anti-ganglioside Ab and 
complement-mediated  injury,  a  change  to  the  physiological  appearance  of  CFP 
overlying the BTx-signal could be observed (also see chapter 3.3). The CFP either 
was confined to blebs overlying the NMJ (Fig.35B) or no CFP could be observed 
anymore (Fig.35C). 
 
3.6.3.1.1 Antibody-deposition 
Following induction of anti-ganglioside Ab and complement-mediated injury to the 
NT, it was still possible to illustrate the Ab-binding pattern at the NMJ. The pattern of 
Ab-binding  was  very  punctate  (Fig.35D)  and  exhibited  a  similiar  pattern  to  Ab 
applied to NMJs without the ensuing application of complement (Fig. 35E). 
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Fig.35: Ex vivo TBG3 and complement application. A control NMJs with no changes to 
the  fluorescent proteins,  B  blebbing NTs  (circles in  CFP),  C  no  CFP  overlying  the  BTx-
signal, D superficial Ab-deposit (α-IgG3) at NMJs, which exhibit injured NTs (loss of CFP), E 
Ab-binding at the NMJ without the application of complement. 
A, B, C: BTx depicts the nAChRs (orange in the composite images), CFP the axons (blue in 
the composite images) and GFP the SCs (green in the composite images). D, E: BTx depicts 
the nAChRs (green in the composite images), CFP the axons (blue in the composite images) 
and α-IgG3 the Ab-deposit (pink/orange in the composite images). Scale bars: 20 µm. 
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3.6.3.1.2 Neurofilament immunoreactivity at the NMJ 
In all control  preparations, the  NF  immunostaining, both for  NF  heavy and  light, 
exhibited  a  very  crisp  and  distinct  signal  extending  along  the  motor  axons  and 
spreading into the NMJ (Fig.36A, C, E; Fig.37A). 
 
 
Fig.36: Neurofilament immunoreactivity (orange in the composite images) at the NMJ. 
A, C, E control tissue; B, D, F tissue exposed to TBG3 and complement. A, B NF heavy 
acutely; C, D NF light acutely; E, F NF light after prolonged incubation times. 
Note the very distinct and clear signal both for NF heavy (A) and NF light (C, E) in control 
situations. Acutely following the application of TBG3 and compliment, a loss of CFP-signal 
(B, D) and loss of the immunoreactivity for NF heavy (B) is observed. The NF light-staining 
exhibits a spongy appearance (D; compare to the crisp signal in C). Following a prolonged 
incubation time, the immunoreactivity for NF light also is lost (F). 
BTx depicts the nAChRs and GFP the SCs (both green in the composite images) and CFP 
depicts the axons (blue in the composite images) and GFP the SCs. Scale bars: 20 µm. 3. Results       Auxiliary investigations    129 
In preparations subjected to anti-ganglioside Ab and complement, the changes to 
the physiological appearance of CFP at the NMJ were accompanied by changes to 
the  NF-immunoreactivity.  Neurofilament  heavy  could  not  be  stained  for  anymore 
(Fig.36B), whereas the NF light stain exhibited a swollen and spongy appearance 
(Fig.36D). However, following an additional incubation for four hours with Ringer’s 
solution at 37ºC the immunostaining for NF light also disappeared (Fig.36F). 
These qualitative observations were confirmed in counts assessing the occurrence 
or absence of a physiological CFP- and NF-signal overlying the BTx-signal (Table 
15). 
Neurofilament 
  Condition  NMJs 
CFP 
abnormal or 
gone  normal  swollen  gone  total 
abnormal 
Ab+NHS  100  97  2  9  89  98  NF heavy 
acute  Ringer’s+NHS  100  1  94  1  5  6 
Ab+NHS  100  97  5  90  5  95  NF light 
acute  Ringer’s+NHS  100  1  100  0  0  0 
Ab+NHS  100  98  2  6  92  98 
NF light 4h 
Ringer’s+NHS  100  2  97  2  1  3 
 
Table 15: Occurrence and absence of NF heavy and light at the NMJ following the 
application of TBG3 and complement 
 
 
3.6.3.1.3 Application of calpain-inhibitors 
Applying the calpain-inhibitor AK295 together with the source of complement (NHS), 
resulted in NF heavy immunoreactivity remaining, whilst CFP at the NMJ still was 
lost (Fig.37B). However, in comparison to the very sharply demarcated loss of CFP 
observed  predominantly  at  the  NMJ  in  muscles  where  anti-ganglioside  Ab  and 
complement were applied, the additional application of AK295 resulted in a more 
generalised loss of CFP, with the individual axon branches exhibiting a decrease of 
fluorescence  intensity  and  occasionally  even  the  fluorescence  of  axons  in  small 
nerve bundles appearing faint (Fig.37C). 3. Results       Auxiliary investigations    130 
 
Fig.37: Application of the calpain-inhibitor AK295 together with complement following 
the  TBG3-incubation.  A  CFP  and  NF  heavy  at  healthy  NMJs,  B  localised  and  sharply 
demarked loss of CFP and NF heavy following the application of TBG3 and complement. C 
generalised decrease of CFP-fluorescence intensity (asterisk) and preservation of NF heavy 
(arrowheads) following the inhibition of calpain after the application of TBG3, AK295 and 
complement. 
BTx depicts  the  nAChRs  and  GFP the  SCs (both green in  the  composite images),  CFP 
depicts the axons (blue in the composite images). The NF immunoreactivity is orange in the 
composite images. Scale bars: 100 µm. 
 3. Results       Auxiliary investigations    131 
3.6.3.2 In vivo preparations 
At NMJs where CFP was lost or blebbing, MAC deposition was observed (Fig.38B); 
Ab-deposition could not be demonstrated. 
 
Fig.38: MAC-deposition (orange in the composite images) at NMJs following the in 
vivo application of TBG3 and complement. A no MAC-deposition at a healthy NT (smooth 
CFP), B MAC-deposition at an injured NT (only CFP-blobs). 
BTx depicts the nAChRs (pink in the composite images) and CFP depicts the axons (blue in 
the composite images). Scale bars: 20 µm. 
 
 
Twenty-four hours following the induction of anti-ganglioside Ab and complement-
mediated injury, neither NF light (Fig.39A) nor heavy (Fig.39C) could be stained for 
at NMJs which did not exhibit any CFP anymore. 
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Fig.39: Absence of NF (orange in composite images) at NTs exhibiting no CFP at 24h 
after the application of TBG3 and complement. A, B NF light, C, D NF heavy. B and D 
are on the contralateral side (underside) of the muscles which did not receive any Ab and 
complement and therefore serve as an internal control. 
BTx  depicts  the  nAChRs  (pink  in  the  composite  images),  GFP  the  SCs  (green  in  the 
composite images) and CFP the axons (blue in the composite images). Scale bars: 20 µm. 3. Results       Auxiliary investigations    133 
3.6.3.3 Electronmicroscopy of representative tissue 
Ultrastructural investigations of tissue processed for EM directly after subjecting the 
muscles to anti-ganglioside Ab and complement-mediated injury revealed electron 
lucent  NTs,  some  of  which  were  wrapped/engulfed  by  the  overlying  pSCs  or 
segregated into smaller membrane-bound compartments. Most NTs were devoid of 
vesicles and filaments; some of them did, however, exhibit swollen mitochondria. No 
changes to the muscular components of the NMJs were observed. 
At 24h after induction of the injury, the NTs were difficult do address. In many cases 
they seem to have decreased in volume and compacted their contents. 
Control  NMJs  exhibited  well  addressable  spherical  NTs  containing  numerous 
filaments, synaptic vesicles and a few mitochondria. In some NTs a relative paucity 
of synaptic vesicles was observed. 
 
Fig. 40 see overleaf 
 
Fig.41: Electronmicrosopic images of control NMJs. Note the well addressable spherical 
NTs filled with filaments, synaptic vesicles and mitochondria. Scale bar: 2 µm. 3. Results       Auxiliary investigations    134 
 
Fig. 40: Electronmicroscopic images of injured NTs. A acute injury. The left NT (asterisk) 
is engulfed (presumably) by a pSC, whereas the right NT (arrowhead) is fragmented into a 
number of membrane-bound compartments. Note the paucity of filaments, mitochondria and 
synaptic vesicles. B 24h after induction of the injury it is very difficult to address the original 
NT, which appears to be filled with debris (arrowhead). Scale bars: 2 µm. 
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3.6.4 Discussion 
3.6.4.1 CFP loss – mode and extent 
Immune-mediated  injury  to  the  NTs  at  the  NMJ  results  in  a  change  of  the 
morphology or loss of the intracytosolic NT-marker (CFP) overlying the NMJ. The 
morphological  changes  comprise  localised  swelling  and  blebbing  of  CFP. 
Investigations described in the previous chapter (3.5) indicate that the severity of the 
injury might correlate to the morphological changes. Milder injuries result in local 
swelling and blebbing, whereas more severe injuries seem to be associated with a 
rapid  and  complete  loss  of  CFP  overlying  the  NMJ.  In  general,  incidence  and 
absence of CFP is sharply demarcated which indicates that the residual fluorescent 
marker must be contained within some kind of membranous structure (similar to the 
axolemma which provides a diffusion barrier under physiological circumstances). 
Antibody-mediated  injury  leads  to  the  formation  of  a  MAC-complex  on  the 
axolemmal  surface  (Halstead  et  al.,  2004)  (see  1.1.5),  which  also  could  be 
demonstrated following the in vivo application of Ab and complement. In contrast to 
this, Ab-deposits could not be shown following the in vivo induction of the injury. 
However, considering the challenges in demonstrating the Ab-deposit in WT-mice 
described  in  a  previous  chapter  (3.2)  and  the notorious  difficulty  in  staining  and 
obtaining sufficient resolution when imaging relatively thick and previously in vivo 
imaged wholemount tissue, this result is not entirely surprising and does not reliably 
indicate that the injured NTs were not bound by Ab. 
The  formation  of  MAC-complexes  on  the  axolemmal  surface  results  in  an 
uncontrolled influx of ions, small molecules and water into the NT along the diffusion 
gradient  and  specifically  a  massive  increase  of  intraaxonal  Ca
2+  (Morgan  et  al., 
1986).  This,  in  turn  and  amongst  other  consequences,  leads  to  Ca
2+-dependant 
proteases, such as calpain, being activated. One of the major substrates for calpain 
is neurofilament (Chan & Mattson, 1999), one of the axonal cytoskeletal proteins 
(Schlaepfer,  1987).  This  explains  the  loss  of  the  NF  heavy  overlying  the  NMJ 
observed in the current and also previous investigations (Goodfellow et al., 2005; 
O'Hanlon et al., 2003). The relative preservation of NF light acutely, however with a 
very different morphology when compared to the physiological situation, presumably 
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the axonal core (Fuchs & Cleveland, 1998), and thus may be less readily accessible 
for calpain-mediated cleavage. Further incubation of the ex vivo preparations for 
four  hours  in  Ringer’s  solution  and  investigations  conducted  at  24  hours  after 
induction  of  the  injury  readily  show  that  at  these  later  time-points  NF  light  also 
cannot be stained for anymore. This further supports the hypothesis that due to its 
location in the axon, NF light requires more time to be degraded when compared to 
NF heavy. Similar results were observed following induction of a (traumatic) stretch 
injury to the optic nerve. Here the levels for NF heavy decreased acutely (within 30 
minutes) following induction of the traumatic axonal injury, whilst the levels for NF 
light exhibited a progressive decrease over the first 24 hours (Serbest et al., 2007). 
Generally, both following diffuse axonal injury and nerve transection, a loss of NF is 
observed  (Donat  &  Wisniewski,  1973)  in  areas  of  axonal  swelling  (Martinez  & 
Friede, 1970; Maxwell & Graham, 1997). The localised loss of NF overlying the NMJ 
observed in the present study corresponds well with observations made at NMJs 
following the in vivo application of α-latrotoxin in mice (Duchen et al., 1981; Robbins 
et al., 1990) and of β-BTx in rats (Dixon & Harris, 1999). 
Application of the calpain-inhibitor AK295 both in previous (McGonigal et al., 2010; 
O'Hanlon et al., 2003) and current investigations resulted in the preservation of NF 
heavy whilst a loss of CFP at the NMJ is still observed. This finding both confirms 
that injury to the architectural structures of the NT in the current model occurs in a 
calpain-dependent fashion, whilst at the same time also indicating that CFP is not a 
calpain-substrate. 
Therefore, the acute CFP-loss of the NT in the present study must be due to a) 
either  the  CFP  diffusing  from  the  NT-cytosol  into  the  periphery  via  MAC  pores 
located on the NT or b) the CFP being degraded locally by a different protease. 
Depending on the severity of the injury, blobs of CFP overlying the NMJ – at early 
time-points often associated with pSC cell bodies - can still be observed. At NMJs 
where  CFP-blobs  are  evident,  it  was  still  possible  to  illustrate  Ab-deposit.  This 
indicates that the axolemmal membrane must acutely persist following induction of 
the injury, even if it may be broken up into small sections filled with CFP or even be 
riddled with MAC-pores. 
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3.6.4.2 Events in the proximal efferents following the acute NT-injury 
Proximal to the injured NT small bead-like axonal compartments filled with CFP are 
observed,  which  probably  correspond  to the  blebbing  observed  acutely  after  the 
transection  of  nerve;  this  is  thought  to  signify  temporary  events  of  membrane 
resealing  (David  et  al.,  1997;  Xie  &  Barrett,  1991).  Fragmentation  of  the 
intracytosolic  fluorescent  signal  in  axons  following  sciatic  nerve  transection  has 
been shown to correlate well with ovoid bodies (and signifies the axoplasmic content 
of  those  (Pan  et  al.,  2003))  formed  in  the  course  of  Wallerian  degeneration 
(Beirowski et al., 2004). It is preceded by cytoplasmic constrictions in Wld
s mice 
(Beirowski et al., 2005). Both the removal of Ca
2+ and the application of calpain-
inhibitors from optic nerve explants result in a massive reduction of the formation of 
axonal  spheroids,  indicating  a  role  for  Ca
2+-induced  calpains  in  this  process 
(Beirowski  et  al.,  2010)  and  supporting  that  fact  that  Wallerian  degeneration  is 
largely dependent on the influx of extracellular Ca
2+ and the activation of calpains 
(George et al., 1995). 
A morphologically similar process to the proceedings observed at the NT following 
anti-ganglioside Ab and complement-mediated injury also seems to occur in acute 
axonal  degeneration,  which  has  been  observed  peracutely  following  nerve 
transection  in  the  spinal  cord.  Acute  axonal  degeneration  develops  very  rapidly 
(within 10 to 20 minutes after induction of the lesion), is restricted to a small part of 
the axon (200-300 µm), takes place both proximal and distal to the lesion and only 
lasts for about 5 min (Kerschensteiner et al., 2005). In regards to its morphology and 
dynamics (Ca
2+- and calpain-dependant) it is very similar to Wallerian degeneration 
(Kerschensteiner et al., 2005; Misgeld, 2005). Combining these observations with 
the fact that the NT/axonal degeneration in the current setting also is Ca
2+- and 
calpain-dependant (Halstead et al., 2004; O'Hanlon et al., 2003), indicate that anti-
ganglioside Ab-mediated injury to the NTs possibly shares similar mechanisms with 
those  taking  place  directly  at  the  lesioned  site  early  in  Wallerian  degeneration, 
however more rapid in their execution and self-limitating, and therefore very similar 
to the acute axonal degeneration described above. This is in line with the hypothesis 
that many  types  of  nerve  injuries  including  metabolic,  inflammatory,  mechanical, 
heritable,  toxic  and  ischemic  insults  share  a  similar  sequence  of  degenerative 
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(Coleman, 2005) and originate in the disruption of the physiological axoplasmic Na
+, 
K
+ and Ca
2+ concentration (LoPachin & Lehning, 1997; Stoll et al., 2002). 
Interestingly  and  further  supporting  the  resealing  hypothesis,  following  the 
application of AK295, a decreased intensity of CFP-fluorescence proximal to the 
NMJ and even in small nerve bundles was observed. Calpain has been reported to 
play a role in axolemmal resealing following the transection of spinal nerve roots 
(Howard et al., 1999) or neuronal processes (Xie & Barrett, 1991), a process which 
clearly appears to take place in the current investigations when viewing the sharply 
demarcated  loss  of  CFP  under  those  experimental  situations  where  no  calpain-
inhibition  was  carried  out.  Following  the  application  of  AK295  the  resealing 
potentially  is  hindered,  which  then  leads  to  a  greater  leakage  (or  a  more  wide-
spread digestion) of the cytosolic CFP and results in a more generalised loss of 
fluorescence. An exacerbated loss of ion homeostasis would then also explain why 
the application of AK295 – despite preventing the destruction of the architectural 
structure and the nodal proteins  in single fibres  and small bundles  following  the 
application of anti-ganglioside Ab and complement – did not preserve the perineural 
electrophysiological properties in previous investigations (McGonigal et al., 2010).   
Regardless of the reason behind the CFP-loss, one important corollary to take from 
these observations is that the absence of disappearance of cytosolic CFP cannot 
simply be equated to an absence or destruction of the axon, but in these mice rather 
needs to be interpreted in the pathophysiological context in which it is occurring, i.e. 
in our case as a breach of the axolemmal integrity  with all its associated (intra-
axonal) consequences. The additional use of transgenic mice exhibiting membrane-
associated fluorescent proteins (De Paola et al., 2003) might be able to contribute to 
elucidate questions specifically associated  with the fate of the axonal membrane 
following the breaching of its integrity. 
 
3.6.4.3  Ultrastructural  changes  to  the  NT  following  anti-ganglioside  Ab  and 
complement-mediated injury 
Electronmicroscopic  investigations  of  NTs  directly  after  subjecting  them  to  anti-
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of vesicles and filaments and containing abnormal mitochondria or no mitochondria 
at  all.  These  NTs  sometimes  were  segregated  into  smaller  compartments  or 
“wrapped” by the overlying pSCs. These observations correspond well to previous 
investigations conducted in the same model (Goodfellow et al., 2005; Halstead et 
al., 2005b; O'Hanlon et al., 2001). An additional 24 hours later, the NTs seemed to 
be more difficult to address due to an overall decrease in volume and a compaction 
of any remaining contents. 
Ultrastructural investigations of motor NTs following proximal axotomy of the efferent 
nerve  (Gillingwater  &  Ribchester,  2001;  Manolov,  1974:  Miledi  &  Slater,  1970; 
Winlow & Usherwood, 1975) or the in vivo application of presynaptic neurotoxins, 
such as β-BTx (Dixon & Harris, 1999), crotoxin (Gopalakrishnakone & Hawgood, 
1984), α-latrotoxin (Duchen et al., 1981), taipoxin and notexin (Cull-Candy et al., 
1976)  result  in  the  same  changes  to  the  NT  as  observed  following  an  anti-
ganglioside Ab and complement-mediated injury to the NT. Following proximal nerve 
section the endplates remain unchanged for eight to twelve hours. After this lag 
phase,  the  NT  breaks  up  into  smaller  fragments,  which  contain  abnormal 
mitochondria,  honeycomb  structures,  bags  of  glycogen  particles  and  exhibit  a 
decrease of synaptic vesicles. The pSC processes protrude into the synaptic cleft 
and engulf NT-fragments (Manolov, 1974; Winlow & Usherwood, 1975). Finally, the 
pSC  takes  the  place  of  the  NT  at  the  NMJ  (Gillingwater  &  Ribchester,  2001; 
Manolov, 1974; Miledi & Slater, 1970), which can also be observed following the 
applicaton of β-BTx (Abe et al., 1976). 
The  only  caveat  in  the  current  observations  is  the  relative  paucity  of  synaptic 
vesicles observed in some control NMJs (Manolov, 1974; Miledi & Slater, 1970). 
However, considering the control muscles were harvested from mice exposed to an 
in  vivo  topical  application  of  complement  under  general  anaesthesia  it  could  be 
surmised  that  manipulations  to  the  muscles  might  have  lead  to  an  increased 
expenditure  of  synaptic  vesicles.  Poor  fixation  or  fixation  artefacts  should  be 
associated with more wide-spread changes to the neuromuscular structures. 
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3.6.5 Conclusion 
Following anti-ganglioside Ab and complement-mediated injury to the NTs acutely a 
sharply  demarcated  blebbing  and/or  loss  of  CFP  overlying  the  NMJ  can  be 
observed. These changes correspond to a loss of the axonal skeletal proteins, NF 
light  and  heavy.  The  application  of  calpain-inhibitors  results  in  a  preservation  of 
skeletal  proteins,  whilst  the  loss  of  CFP  seems  to  be  even  more  pronounced 
indicating that the events are calpain-dependant and also heavily rely on resealing 
processes. 
Similar morphological characteristics in fluorescence microscopic investigations and 
pathophysiolocial dynamics are noted when comparing the immune-mediated injury 
to  the  NT  with  acute  events  in  the  Wallerian  degeneration  of  axons  following 
traumatic  injury.  Presumably  (as  discussed  above)  both  events  are  the 
consequence  of  the  same  mechanisms,  and  a  based  on  the  disruption  of  the 
physiological axonal ion homeostasis. Additionally, ultrastructural investigations of 
the  NT  following  anti-ganglioside  Ab  and  complement-mediated  injury  closely 
resemble those of NTs undergoing degeneration following proximal axotomy of the 
efferent nerve. 
Combining all these observations it is surmised that following an anti-ganglioside Ab 
and  complement-mediated  injury  the  NTs  degenerate.  This  then  in  the  following 
implicates  that  these  structures  need  to  undergo  regeneration  to  restore  their 
physiological state. 
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3.7 Rate of motor NT regeneration following a single anti-ganglioside 
Ab and complement-mediated injury 
3.7.1 Introduction 
Anti-GM1 and anti-GD1a Abs are the circulating Abs predominantly found in patients 
suffering  from  the  motor  axonal  forms  of  GBS  (acute  motor  axonal  neuropathy, 
AMAN)  (Kaida  et  al.,  2000;  Press  et  al.,  2001;  Willison,  2005).  As  described  in 
1.1.3.1, AMAN patients clinically exhibit paralysis, which may require the patients to 
be  ventilated  artificially  (McKhann  et  al.,  1993).  Necropsies  conducted  these 
patients  reveal  Wallerian-like  degeneration  of  the  motor  nerve  fibres.  As  the 
degenerative changes are more pronounced in the ventral roots than the peripheral 
nerves,  it  is  surmised  that  the  initial  lesion  is  to  be  found  in  the  spinal  roots. 
Occasionally,  however,  only  very  few  pathological  changes  are  observed  in  the 
ventral roots and these are not compatible with the degree of paralysis observed 
(Griffin et al., 1995;  McKhann  et al., 1993). At the same time, some necropsies 
exhibit very extensive motor fibre degeneration, which is not commensurate with the 
rapid recovery (Griffin et al., 1995; Ho et al., 1997b) occurring in some patients. The 
convalescence of AMAN-patients has been described to occur in two subgroups: 
one group which exhibits a rapid improvement within the first two to four weeks after 
onset  of  disease,  and  the  other  group,  in  which  recovery  is  prolonged  and  the 
patients are unable to walk independently at six months after disease onset (Hiraga 
et al., 2005; Kuwabara et al., 1998a). The explanations for a rapid recovery include 
a) distal demyelination, b) a reversible conduction-block along motor axons and c) 
degeneration restricted to the very distal motor nerve (Griffin et al., 1995; Ho et al., 
1997b;  Kuwabara  et  al.,  1998a).  The  investigation  of  muscle-nerve  biopsies 
obtained  from  a rapidly recovering AMAN-patient provides  evidence for  the  third 
hypothesis (Ho et al., 1997a). Since the neuromuscular junction (NMJ) lies outside 
the BNB (Olsson, 1968), the motor NTs – also under clinical circumstances – are 
readily available for Ab-binding (Ho et al., 1997a; Plomp & Willison, 2009). 
Thus, the first set of investigations conducted in this chapter aims at determining the 
rate of NT recovery following a single anti-ganglioside Ab and complement-mediated 
injury. In a second step, a concomitant injury to the pSCs is elicited. Since these 
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it is surmised that a concomitant injury of these should result in decreasing the rate 
of NT regeneration. 
 
 
3.7.2 Specific Materials and Methods 
3.7.2.1 Groups and study set-up 
Forty-five homozygous and heterozygous double-fluorescent mice were assigned to 
three groups (each n=15). 
Group A: NT injury  Group B: NT and pSC injury  Group C: control  Survival 
times 
TBG3 + NHS  TBG3 + EG1 + NHS  Ringer’s + NHS 
0d  3  3  3 
1d  3  3  3 
2d  3  3  3 
3d  3  3  3 
5d  3  3  3 
 
Table 16: Experimental groups for the NT regeneration study 
 
Investigations described in chapter 3.3 revealed that the application of TBG3 and a 
source of complement in WT mice leads to a selective injury of the NTs, whereas 
the application of EG1 is primarily associated with an injury to the pSCs, however 
also has a NT-injury component (see 3.3.4). Therefore, to obtain a reliable injury 
both the NTs and pSCs, TBG3 and EG1 were applied in combination. 
All mice were subjected to a primary in vivo imaging investigation during which the 
injury was induced and documented, and a secondary ex vivo imaging investigation 
(Fig.42). The ex vivo investigations were carried out immediately after the in vivo 
investigations to acquire more information on the acute state and extent of injury, or 
after  1,  2,  3  or  5  days  to  gain  insights  into  the  rate  of  regeneration  and  the 
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Fig.42: Flowchart for the in and ex vivo NT-regeneration study. 
 
 
 
3.7.2.2 In vivo procedures (see 2.2) 
In all mice, the SM and SH muscles were exposed and incubated with rhodamine-
conjugated  BTx  as  described  in  2.2.1.  The  following  microscope  and  camera 
settings were applied: field diaphragm: 3, light emission during orientation in the 
sample: 10%, light emission during image acquisition: 20%, exposure time during 
image  acquisition:  120  ms;  gain:  x2.  Following  a  preliminary  imaging  session  in 
which the healthy state of three NMJs was documented, Abs and NHS were applied 
topically. In groups A and B, all mice received 0.6 ml of TBG3 (200 µg/ml) followed 
by 0.6 ml of 40% NHS (see 2.7). In group B, the NHS was supplemented by 120 µl 
of  EG1  (1  mg/ml).  Control  mice  (group  C)  received  0.6  ml  of  Ringer’s  solution 
followed  by  NHS.  After  the  incubations,  the  muscles  were  rinsed  with  Ringer’s 
solution  and  the  three  originally  imaged  NMJs  were  reimaged  to  document  the 
injury. Then SH and SM were assessed for completeness of the injury, and the mice 
either sacrificed (see 2.2.4) or recovered (see 2.2.3). 
In  some  of  the  mice  sacrificed  immediately,  the  NHS  was  supplemented  by 
rhodamine-conjugated EthD-2 (see 2.7), a nuclear marker whose cellular ingress 
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3.7.2.3 Ex vivo procedures 
For  ex  vivo  imaging,  the  muscles  were  processed  and  subjected  both  to 
wholemount  and  quantitative  imaging  as  described  in  2.3.  Here  also  the  three 
originally imaged NMJs were revisited and imaged. 
 
3.7.2.4 Additional investigations associated with the return of CFP 
In additional heterozygous double-flourescent mice, SM and SH were processed for 
NF  heavy  immunoreactivity  and  EM  investigations  following  five  days  of 
regeneration as described in 3.6.2.3 and 2.3.6. 
 
 
3.7.3 Results 
3.7.3.1 In vivo investigations 
In groups A and B, the application of TBG3 alone did not lead to any changes at the 
NMJ (Figs.43A, B); however, once the source of complement (NHS) was applied, a 
very rapid deterioration of the NTs could be seen (Fig.44A). These changes only 
involved the area overlying the NMJ or extended proximally along the axon for a 
short distance. A sharp line demarcated the presence and absence of CFP. 
In  group  A,  the  pSCs  were  entirely  unaffected;  in  all  cases  they  retained  their 
fluorescence and in no cases was any uptake of EthD2 demonstrable (Fig.43A). In 
group B, many pSCs lost their fluorescence and their cell body profiles (now devoid 
of  GFP)  were  replaced  by  EthD-2-stained  nuclei  (Fig.43B).  In  both  groups,  the 
myelinated  Schwann  cells  surrounding  the  distal  axons  neither  lost  their 
fluorescence nor exhibited an uptake of EthD-2 (Figs.45A, C). 
In the control mice (group C), no changes to any of the fluorescent proteins were 
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Fig.43:  In  vivo  images  of  the  acute  anti-ganglioside  Ab  and  complement-mediated 
injury. A, B evolution of the injury: application of complement (NHS) is required to induce an 
injury; there are no changes to the NMJs after sole application of the Ab (images for before 
and after TBG3 are the same). A group A: selective injury of the NTs (CFP; arrowhead); the 
pSCs (GFP) remain bright and there is no uptake of EthD-2 in these cells. B group B: injury 
of both the NTs (CFP) and the pSCs (GFP); the EthD-2 staining (arrows) correlates with the 
former pSC cell bodies.  
BTx depicts  the  nAChRs  (orange  in  the composite  images),  GFP  the  SCs  (green in  the 
composite images) and CFP the axons (blue in the composite images). Scale bars: 20 µm. 3. Results       NT regeneration    146 
 
 
Fig.44: In vivo images of control tissue and evolution of the NT injury. A rapid evolution 
of the injury; within 15 minutes of application of complement the NTs (CFP) start to bleb and 
loose their fluorescence (NMJ from group A). There are no changes to the pSCs (GFP). B 
group C: negative control; application of Ringer’s solution and NHS does not lead to any 
changes at the NMJ. 
BTx depicts  the  nAChRs  (orange  in  the composite  images),  GFP  the  SCs  (green in  the 
composite images) and CFP the axons (blue in the composite images). Scale bars: 20 µm. 
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Fig.45: Ex vivo images of the extent of injury acutely and after 24h. A, B group A (NT 
injury), C, D group B (NT and pSC injury), E, F group C (control). Acutely (A, C, E), the loss 
of CFP (NTs) only affects the NMJ. After 24h (B, D, F), however, this loss extends further 
proximally (groups A and B). In all groups, the myelinating Schwann cells (arrows) remain 
fluorescent and do not exhibit any uptake of EthD-2 (orange in composite images), indicating 
that they are not injured. 
BTx depicts  the  nAChRs  (orange  in  the composite  images),  GFP  the  SCs  (green  in  the 
composite images) and CFP the axons (blue in the composite images). Scale bars: 100 µm. 3. Results       NT regeneration    148 
3.7.3.2 Ex vivo investigations 
3.7.3.2.1 Group A 
Following the acute injury (day 0), approximately 6% (5.7%) of the superficial SH-
NMJs still exhibited CFP overlying their BTx-signal. After one day of regeneration, 
this  percentage  remained  unchanged  (5.8%,  p=0.932;  chi-square  test,  n=12; 
Fig.46); however, at many NTs the injury had extended more proximally, with the 
CFP appearing fragmented or absent up to 150-200 µm into the distal axon. This 
often  coincided  with  the  site  at  which  the  individual  axons  coalesce  into  small 
bundles (Fig.45B). A recovery of the CFP-signal at the superficial SH-NMJs could 
be demonstrated over the next few days with 93.5% of the NMJs exhibiting CFP 
overlying their BTx–signal by day 5 (Fig.46); a precise alignment of the CFP and 
BTx-signal could be shown, both of which exhibited the same morphology as the 
pre-injury  state (Fig.47). At earlier time-points  (days  2 and 3), NTs only  partially 
covering the BTx-signal could be observed (Fig.48A). At these time-points the NTs 
also often exhibited an irregular axonal diameter (Figs.47, 48B).  
The  pSCs  were  not  compromised  at  any  time-point  and their  cell-bodies  always 
assumed their originally imaged position (Fig.47). On days 3 and 5, a number of 
pSCs  extended  processes  beyond  the  NMJ-boundaries,  which  were  often 
accompanied  by  short  axonal  sprouts  (Figs.48C,  D).  Furthermore,  many  NMJs 
exhibited  increased  numbers  of  GFP-positive  cells  (Figs.48B,  C,  D)  and  very 
occasionally the bridging of two neighbouring NMJs by pSC-processes and axons 
was observed (Fig. 48E). 
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Fig.46: Recovery of CFP overlying the NMJ.  There is a  significant difference between 
groups A (NT injury) and B (NT and pSC injury) on all days (p<0.001; chi-square test, n=12 
for each time-point) except day 5 (p=0.739, chi-square test, n=12). In group C (control) there 
is no difference between all different time-points assessed (p=0.076, chi-square test, n=30). 
Error bars depict standard deviations. 
 
Fig.47: Regeneration of individual NMJs in group A (NT injury). On day 1, there are no 
changes to the NMJs when compared to the acute state of injury (post-injury). On day 3, the 
NT  (CFP)  of  this  specific  NMJ  has  recovered,  but  exhibits  a  slightly  irregular  diameter 
(arrow),  whilst  the  NMJ  examined  after  5  days  of  regeneration  exhibits  a  physiological 
morphology.  Note  that  the  pSCs  (GFP)  of  all  NMJs  all  remain  in  same  location  when 
compared to the pre-injury state. 
BTx depicts  the  nAChRs  (orange  in  the composite  images),  GFP  the  SCs  (green  in  the 
composite images) and CFP the axons (blue in the composite images). Scale bars: 20 µm. 3. Results       NT regeneration    150 
 
Fig.48: Features of regeneration in group A (NT injury). A the NT (CFP) only partially 
covers the NMJ on day 2. B irregular NT-diameter (CFP) and increased numbers of GFP-
positive  cells at the NMJ on day  3. C,  D increased numbers of GFP-positive cells, pSC 
processes and  small terminal sprouts (arrows) on day 3. E bridging of two neighbouring 
NMJs with pSC processes and axonal sprouts (arrowheads) on day 5. 
BTx depicts  the  nAChRs  (orange  in  the composite  images),  GFP  the  SCs  (green in  the 
composite images) and CFP the axons (blue in the composite images). Scale bars: 20 µm. 
 
3.7.3.2.2 Group B 
Following the acute injury, 11.8% of the NMJs examined exhibited CFP overlying 
their BTx-signal and 25.0% of the NMJs had overlying GFP-positive cells (Figs.46, 
49). In most instances the previously GFP-positive cell profiles were replaced by 
EthD2-stained nuclei. At day 1, the percentage of NMJs exhibiting CFP remained at 
the same value as with the acute injury (11.8%, p=0.774; chi-square test, n=12; Figs 3. Results       NT regeneration    151 
45,  48),  whilst  for  the  GFP-signal  a  slight  (however,  not  significant)  further 
deterioration was observed (22.6%, p=0.462; chi-square test, n=12). Both the CFP- 
and GFP-signals overlying the NMJ returned during the regeneration phase, with 
94.0% of the NMJs examined expressing CFP and 98.7% expressing GFP at day 5 
(Figs.46,  49).  As  seen  in  group  A,  the  loss  of  CFP  extended  further  proximally 
between  day  0  and  day  1  (Fig.45D)  and  precisely  aligned  with  the  BTx-signal 
following  recovery.  Both  the  BTx-  and  the  CFP-signal  exhibited  the  same 
morphology as the pre-injury state (Fig.50). At all time-points, the return of GFP-
positive structures to the NMJ appeared to precede the return of CFP (Figs.49, 50, 
51). 
 
Fig.49: Incidence of CFP and GFP overlying the NMJ in group B (NT and pSC injury). 
The return of CFP overlying the NMJ is preceded by a return of GFP. There is a significant 
difference between CFP and GFP at all time-points investigated (p<0.001; chi-square test, 
n=12 for each time-point). 
 
At days 1 and 2 the GFP-positive cells mostly exhibited a spindly morphology with 
only faint fluorescence (Figs.50, 51A, B), whilst by day 5 they had a prominent and 
brightly  fluorescent  cell  body  (Figs.50,  51),  similar  to  GFP-positive  cells  in  the 
control situation. The GFP-positive cells did not always assume exactly the same 
location  with  respect  to  the  BTx-signal  when  compared  to  the  pre-injury  state 
(Figs.50, 52), and often an increased number (compared to the physiological state) 
of GFP-positive cells could be observed overlying the regenerating NT (Fig.51). As 3. Results       NT regeneration    152 
seen in group A at days 3 and 5, the GFP-positive cells often extended processes 
beyond  the  original  NMJ-boundary,  occasionally  accompanied  by  axonal  sprouts 
(Figs.51E, F, G). Also, the bridging of neighbouring NMJs both by pSCs processes 
and nerve terminals could occasionally be observed (Fig.51H) and on day 5, the 
nerve terminals, albeit filled with bright CFP, often exhibited an irregular diameter 
(Figs.51E, F, G). 
 
 
 
Fig.50: Regeneration of individual NMJs in group B (NT and pSC injury). On day 1, 
there are no changes to the NMJs when compared to the acute state of injury (post-injury). 
On day 3, the efferent axon has only reached the NMJ, but is not covering it yet (asterisk). 
The NMJ itself is covered by spindly and faintly fluorescent GFP-positive cells (arrowheads). 
On day 5, the NT (CFP) has also recovered and exhibits an irregular appearance (arrow). 
The pSCs on this NMJ do not lie in same location when compared to the pre-injury state. 
BTx depicts  the  nAChRs  (orange  in  the composite  images),  GFP  the  SCs  (green in  the 
composite images) and CFP the axons (blue in the composite images). Scale bars: 20 µm. 
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Fig.51: Features of regeneration in group B (NT and pSC injury). A the NMJ exhibits no 
CFP (NTs) and is only partly covered by spindly and only faintly GFP-positive structures on 
day 1. B, C, D day 2; B the NMJ has partially recovered both GFP and CFP (NT). C, D all 
NMJs exhibit GFP-positive cells, which however, in comparison to the myelinating SCs and 
the pSCs on the healthy looking NMJ (arrows) are less intense in fluorescence. Not all NMJs 
exhibit CFP (NTs). E, F, G pSC processes (GFP; arrowheads) and short axonal sprouts 
(CFP; arrows) extend from NMJs on days 3 and 5. In all three images the NTs (CFP) exhibit 
irregular diameters. H two neighbouring NMJs are bridged by both pSC processes (GFP, 
arrowhead) and axonal sprouts (CFP, arrow) on day 5. Note the increased numbers of GFP-
positive cells overlying the NMJ in E-H. 
BTx depicts  the  nAChRs  (orange  in  the composite  images),  GFP  the  SCs  (green in  the 
composite images) and CFP the axons (blue in the composite images). Scale bars: 20 µm. 3. Results       NT regeneration    154 
 
Fig.52:  Regeneration  of  individual  NMJs  in  group  B  (NT  and  pSC  injury)  – 
investigation of pSCs. A 3 days, B 5 days. Following regeneration in many cases, but not 
all,  the  GFP-positive  cells  occupy  the  same  areas  as  originally  inhabited  by  the  pSCs 
(arrows indicate alignment). 
BTx depicts  the  nAChRs  (orange  in  the composite  images),  GFP  the  SCs  (green in  the 
composite images) and CFP the axons (blue in the composite images). Scale bars: 20 µm. 3. Results       NT regeneration    155 
3.7.3.2.3 Group C  
In all control mice, no changes to the fluorescent proteins were noted (Figs.44B, 
45E, F; 53, 54) and no pSCs demonstrated any uptake of EthD-2. At each time-
point, between 95.8% and 98.5% of the NMJs assessed exhibited clearly visible 
CFP overlying the BTx-signal (p=0.076; chi-square test, n=30; Fig.46). On day 5, a 
few NMJs with increased numbers of GFP-positive cell bodies could be observed. 
Also, very occasionally, the pSCs exhibited short processes extending beyond the 
NMJ-boundaries; these, however, were never accompanied by axonal sprouts. 
 
 
 
 
Fig.53: Overviews for group C (negative control). A day 2, B day 3, C day 5. No changes 
to the fluorescent proteins are noted. 
BTx depicts  the  nAChRs  (orange  in  the composite  images),  GFP  the  SCs  (green in  the 
composite images) and CFP the axons (blue in the composite images). Scale bars: 100 µm. 
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Fig.54: Revisiting individual NMJs over time in group C (negative control). No changes 
to the fluorescent proteins are noted.  
BTx depicts  the  nAChRs  (orange  in  the composite  images),  GFP  the  SCs  (green in  the 
composite images) and CFP the axons (blue in the composite images). Scale bars: 20 µm. 
 
 
 
 
3.7.3.3 Auxiliary investigations 
Following five days of regeneration, both NF heavy and a return of CFP could be 
demonstrated  at  NMJs,  which  acutely  (following  the  in  vivo  application  of  anti-
ganglioside  Ab  and  complement)  had  shown  a  loss  of  CFP  overlying  the  NMJ 
(Fig.55). 
 
Fig.55: Recovery of CFP and NF heavy (orange in the composite image) following 5 
days of regeneration. 
BTx  depicts  the  nAChRs  (pink  in  the  composite  image),  GFP  the  SCs  (green  in  the 
composite image) and CFP the axons (blue in the composite image). Scale bars: 20 µm. 3. Results       NT regeneration    157 
Electronmicroscopic imaging of muscles five days after induction of anti-ganglioside 
Ab and complement-mediated injury revealed easily identifiable spherical NTs filled 
with  synaptic  vesicles,  filaments  and  a  few  mitochondria.  These  lay  in  direct 
apposition to the synaptic folds (Fig.56). 
 
 
 
 
 
Fig.56: Electronmicroscopic images of NMJs 5 days after induction of the injury. The 
NTs  exhibit  a  physiological  morphology  and  are  filled  with  synaptic  vesicles  and 
mitochondria. Scale bars: 2 µm. 
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3.7.4 Discussion 
3.7.4.1 Regeneration of motor nerve terminals 
Following  five  days  of  regeneration,  the  axolemmal  integrity  (determined  by 
containment  of  CFP)  was  restored  in  nearly  all  NTs  examined,  regardless  of 
whether the pSCs had undergone concomitant injury or not. No obvious difference 
in the rate of recovery between the groups with and without concomitant injury to the 
pSCs was observed. At the recovering NTs the CFP- (and the BTx-) signal equalled 
the pre-injury state and the return of CFP corresponded to a reconstitution of NF-
heavy.  
The observation, that the status of NT integrity in both the acute state after induction 
of the injury and following one day of regeneration were identical, corresponds with 
the initial lag phase observed in rodents following traumatic injury to their nerves 
(Forman & Berenberg, 1978). During this lag phase the injury, acutely confined to 
the area of the NMJ, extended proximally towards the nerve bundles for a maximum 
of  200  µm.  The  ensuing  rapid  recovery  of  the  physiological  NT-morphology 
(including  the  ultrastructural  morphology  (Manolov,  1974;  Winlow  &  Usherwood, 
1975)) also correlates well to the rates of axonal regeneration observed in rodents 
after traumatic denervation (Forman & Berenberg, 1978; Pan et al., 2003; Pestronk 
et al., 1980) or the NT recovery following in vivo applications of β-BTx or α-latrotoxin 
(Dixon  &  Harris,  1999; Duchen  et al., 1981; Robbins et al., 1990).  Some  of the 
regenerated  NTs  examined  exhibited  a  slightly  irregular  diameter  of  their  CFP-
signal. Considering NF determines the axonal calibre (Schlaepfer, 1987), it is quite 
possible  that  the  irregular  diameter  reflects  (temporary)  irregularities  in  the  NF-
reassembly. Regenerating axons of a smaller diameter and a “wispy” appearance 
are also observed following the application of β-BTx (Dixon & Harris, 1999). 
Nerve terminal sprouts (always in association with pSCs processes) were observed 
during  the  second  half  of  the  regeneration  period.  Occasionally,  these  could  be 
shown to interconnect neighbouring NMJs, however, more regularly they were quite 
short and did not venture more than 20 µm from the NMJ-boundaries. In general, 
NT  sprouts  have  been  shown  to  be  a  regular  hallmark  of  NMJs  following  both 
traumatic and neurotoxin mediated injuries (Dixon & Harris, 1999; Duchen et al., 
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with and dependency of pSCs processes, the occurrence of these will be discussed 
in greater detail below. 
As all axons contained the same colour of fluorescence (CFP), no assumptions can 
be made to whether the individual NMJs were “reinnervated” by their original NTs. 
However,  taking  into  account  that  the  injury  did  not  extend  more  than  200  µm 
proximal and the myelinating Schwann cell tube seemed to persist, it seems very 
likely that all axons reoccupied their original endplate sites. 
 
3.7.4.2 Role of the perisynaptic Schwann cells 
For group A, the intracytosolic marker (GFP) for the pSCs remained stable at all 
times and an uptake of EthD-2 into these cells could not be demonstrated in any 
instance. This indicates that these cells were not affected by the local application of 
anti-GD1a-/anti-GT1b-Ab and complement. In group B, however, the pSCs exhibited 
a loss of their intracytosolic fluorophore and an uptake of EthD-2, which indicates a 
loss of their cell membrane integrity consistent with the formation of MAC pores 
known  to  occur  in  this  injury  model.  EthD-2-uptake  usually  is  equated  with  cell 
death;  however,  it  is  not  clear  whether  the  pSCs  in  this  model  experienced  a 
sublethal  injury  and  recovered,  whether  they  underwent  degeneration,  or  a 
combination of both. One clue to this might lie in the observations regarding the 
exact location of the pSCs with respect to their NMJ. In group A, the pSCs never 
moved  from  their  assigned  place  at  the  NMJ  regardless  of  their  NT  undergoing 
degeneration, whereas in group B, some of the recovering/returning GFP-positive 
cells were found in a different position at the NMJ when compared to the pre-injury 
state. Considering the relative loyalty of the pSCs to their exact location on the NMJ, 
the finding of pSCs at a different position potentially indicates that these have newly 
migrated or divided, which then means that the complement-mediated injury was at 
both a sublethal and lethal level. In group B, many GFP-positive cells overlying the 
NMJs at days 2 and 3 of regeneration exhibited a very spindly morphology with only 
faint green fluorescence. A lower expression of S100 has been reported in immature 
Schwann cells or their precursors (Jessen & Mirsky, 1999) and diminished levels of 
GFP-intensity have been proposed to represent a dedifferentiation of these cells into 
a more immature phenotype that does not express S100 as robustly (Magill et al., 3. Results       NT regeneration    160 
2007).  This  then  either  indicates  a)  a  dedifferentiation  of  the  pSCs  following 
complement-mediated  injury  into  a  morphologically  different  and  more  immature 
phenotype or b) that many pSCs were killed and were replaced by morphologically 
different pSC precursors. Also, increased numbers of GFP-positive cells overlying 
the regenerated NTs were regularly observed at the later time-points in both groups, 
corresponding  to  observations  made  following  reinnervation  of  traumatically 
denervated NMJs (Love & Thompson, 1998).  
Following the immune-mediated destruction of the NTs, both the pSCs of groups A 
and  B,  however,  did  exhibit  behaviour  similar  to  pSCs  challenged  by  traumatic 
denervation  of  their  NMJ.  As  demonstrated  in  the  second  part  of  chapter  3.4, 
following crush injuries to the innervating nerve, pSCs of denervated NMJs extend 
processes towards the periphery in the aim of reaching another NMJ. These then 
form extensive networks between individual NMJs. In the event of contacting an 
innervated NMJ, the pSCs then induce the NT to sprout and guide it back to their 
own NMJ to regain innervation (Son & Thompson, 1995a). In regenerating muscles, 
the  NMJs  therefore  are  cross-linked  by  pSC-processes  and  axonal  sprouts,  and 
following regeneration “escaping”/overshooting axons which follow pSC processes 
extending  towards the  periphery can  be  observed (O'Malley  et al., 1999; Son & 
Thompson 1995a, 1995b; Son et al., 1996). These could also demonstrated in the 
SM following two weeks of regeneration after a crush injury to the innervating nerve 
(see  3.4.3.2).  Interestingly,  following  the  anti-ganglioside  Ab  and  complement-
mediated injury, such changes were not observed at the magnitude expected. The 
fact that in this specific model axonal/NT regeneration occurred at such a rapid rate 
might explain the relative paucity of pSC processes and axonal sprouts observed, 
especially when considering that crush injury to innervating nerve of the SH – which 
was carried out a lot closer to the muscle when compared to the SM – resulted in 
less extensive changes regarding pSC processes and NT sprouts when compared 
to the crush injury of the innervating nerve of the SM. 
Intriguingly, the rate of NT restoration was not dependant on healthy and mature 
pSCs overlying the NMJ. The reasons for this can only be surmised and include the 
fact that the axonal injury in itself was very small and the myelinated SCs did not 
seem to be compromised. However, the return of CFP at the NMJ always seemed to 
be preceded by faint GFP-positive cells covering the area; these might be sufficient 
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positive cells overlying the NMJ seemed to slightly precede the NT restoration at all 
time-points investigated either reflects the smaller loss of GFP-positive cells at the 
NMJ in comparison to the CFP-loss acutely following the induction of the injury and 
a  comparable  rate  of  restoration  for  both,  or  provides  further  evidence  for  the 
supporting  role  of  these  cells  in  the  event  of  axonal/NT  regeneration  (Griffin  & 
Thompson, 2008).  
 
 
3.7.5 Conclusion 
The  results  described  in  this  chapter  demonstrate  that  following  a  single  anti-
ganglioside Ab-  and complement-mediated  injury to the motor NTs and the very 
distal parts of the motor axons a fast recovery of the NT axolemma, the axonal 
architectural structures and the NT ultrastructure can be observed. These results 
support  the  hypothesis  that  the  rapid  recovery  from  paralysis  observed  in  some 
AMAN-patients is due to the anti-ganglioside Ab-mediated injury being concentrated 
to the very distal ends of the motor nerves, while the ventral nerve roots and more 
proximal axons remain unaffected – or are only injured at a level not sufficiently 
contributing to chronic clinical changes. 
A  concomitant  injury  to  the  pSCs  did  not  affect  the  rate  of  NT  regeneration, 
indicating that the NT regeneration in the current setting occurred independent from 
the incidence of healthy and mature pSCs overlying the NMJ. 
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4. CONCLUSIONS 
The aim  of my  PhD project was  to combine the  already  well-established mouse 
model of GBS with an in and ex vivo imaging system of the murine NMJ and exploit 
this investigatory paradigm to examine acute injury and regeneration of neural and 
glial structures targeted in GBS. 
A number of conclusions were reached. 
 
4.1 Stability of NMJs in double-fluorescent mice 
As  it  was  aspired  to  conduct  all  investigations  in  mice  expression  fluorescent 
proteins  in  the  axons  (CFP)  and  SCs  (GFP)  of  their  PNS,  the  first  set  of 
investigations examined the NMJs of these mice regarding their stability over time. 
The  main  focus  was  concerned  with  the  number  of  pSCs  per  NMJ,  and  these 
investigations were conducted in one of the muscles traditionally used for in vivo 
imaging investigations (Balice-Gordon, 1997b). 
Counts of pSCs overlying the NMJ revealed that the average number of pSCs per 
NMJ only increased from 2.6 pSCs per NMJ in one-month-old mice to 3.2 pSCs per 
NMJ in twelve-month-old mice, thus indicating that this parameter is fairly stable. 
Especially once the mice had reached an age of seven months, no differences in the 
counts could be observed anymore. Regarding the appearance of the nAChRs and 
NTs in the fluorescent mice, minor changes were observed in the same time-frame. 
Here, the mice older than seven months often exhibited slightly fragmented BTx-
signals, which were mirrored by “knobbly” CFP-filled NTs, irregular in their diameter. 
These results correspond well with previous investigations examining the number of 
pSCs per NMJ (Love & Thompson, 1998; Zuo et al., 2004), general stability (Balice-
Gordon  &  Lichtman,  1990;  Lichtman  et  al.,  1987)  and  aging  of  NMJs  (Balice-
Gordon, 1997a; Chai et al., 2011; Courtney & Steinbach, 1981; Li et al., 2011) in 
rodents, thus indicating that the double-fluorescent mice can be used for extended 
in vivo investigations and any prominent changes in pSC numbers must be induced 
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4.2 Minimalising the illumination facilitates in vivo imaging of the SH (and SM) 
Like any in vivo procedure, in vivo imaging of NMJs is an invasive procedure and 
thus  can  result  in  changes  of  the  structures  imaged  or  inhibit  processes  which 
normally  occur  (Balice-Gordon,  1997b;  Lichtman  &  Fraser,  2001).  Investigator-
induced changes can be due to surgical trauma, infection, labelling and phototoxicity 
(Lichtman & Fraser, 2001). Therefore, adequate control groups and an optimisation 
of the techniques applied are mandatory. 
Overillumination,  traumatic  denervation,  inactivation  of  NMJs  following  the 
application of paralyzing agents and both traumatic and toxic muscle fibre injury all 
induce  similar  changes  to  the  different  components  of  the  NMJ.  These  include 
reactive  growing  of  pSC-processes,  increase  of  pSC  numbers,  extension  of  NT 
sprouts and loss of nAChR-area. All of these changes were observed in the first two 
imaging control groups which focused on the SM, the muscle traditionally used for in 
vivo imaging procedures.  
Control animals validated the concentration and incubation time of the potentially 
paralysing agent α-BTx, which was applied to selectively label the nAChRs and be 
able to discriminate one NMJ from another. Imaging of NMJs of the SH muscle, a 
flat muscle located in the midline directly on top of the trachea (if the mouse lies in 
dorsal recumbancy) and therefore requires no manipulation for imaging whatsoever, 
further indicated that the changes observed at the previously imaged NMJs were 
due to traumatic or phototoxic injury of the muscle. In the following, the light intensity 
for  imaging  was  decreased  substantially,  which  resulted  in  higher  percentage  of 
NMJs retaining their physiological appearance after in vivo imaging. 
It  was  concluded  that  conservative  imaging  of  the  SH  by  decreasing  the  light 
intensity of the microscope to 17% (or lower), the field diaphragm of the microscope 
to 3, the light intensity of camera to 25% (or lower) and the exposure time to 120ms 
should  allow  for  in  vivo  investigations  conducted  in  this  muscle.  A  concomitant 
increase of the acquisition gain to x2 would counteract for the loss of fluorescence 
intensity observed in the images. Nevertheless, the BTx-signal would need to be 
scrutinised closely as an indicator for any muscle-injury (i.e. light-) induced changes 
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4.3 Specificity of the anti-ganglioside Abs applied determines whether neural 
or glial components of the NMJ are injured 
The distribution of gangliosides varies between the neural and glial structures they 
are located on. Previous investigations conduced in the murine model of GBS have 
revealed that in WT mice anti-GD3-Abs preferentially induce pSC-injury, whilst anti-
GD1a-Abs combined with a source of complement lead to a selective injury of the 
NTs (Halstead et al., 2005b). 
Four anti-ganglioside Abs with varying binding affinities to both simple and complex 
gangliosides were applied to WT, GM2KO, GD3KO and PLP-Tg mice to determine 
binding and injury profiles. 
In WT double-fluorescent mice, previously observed ganglioside specificities for the 
NTs  were  confirmed.  However,  it  seems  advantageous  to  increase  the  Ab-
concentration  for  TBG3  to  200µg/ml  and  a  decrease  the  incubation  time  to  30 
minutes to be able to compensate for the rapid internalisation of Ab observed at the 
NT. A reliable injury to both NTs and pSCs can be achieved by applying both TBG3 
and EG1 simultaneously. 
Interestingly,  no  selective  injury  to  pSCs  could  be  elicited  in  double-fluorescent 
mice,  neither  in  WT  nor  PLP-Tg  mice,  which  selectively  express  complex 
gangliosides in glial cells via  the PLP-gene regulatory element. This finding  was 
rather unexpected and lay in contrast to previous investigations conducted in non-
fluorescent  WT  mice  (Halstead  et  al.,  2005b).  Following  the  examination  of  the 
binding  and  injury  patterns  of  the  different  Abs,  it  was  concluded  that  the 
concomitant NT-injury observed in both mice strains was either due to a) the NT-
injury being a bystander injury following severe complement activation of pSCs or b) 
the  NTs  acutely  exhibit  changes  following  the  injury  of  “their”  pSC.  Further 
investigations are warranted to elucidate this rather intriguing finding. 
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4.4  Ab-binding  levels in  SM,  SH  and  TS  of  homozygous  and  heterozygous 
double-fluorescent mice correspond well to eachother 
Previous  investigations  conducted  in  the  murine  model  for  GBS  have  revealed 
differences in the strain susceptibility to Ab-mediated injury. This appears to be due 
to a difference in the level of anti-ganglioside Ab-binding (unpublished data). Thus, 
the different muscles used for all my investigations (SM, SH and TS) and the both 
male and female homozygous and heterozygous mice were assessed for the level 
of TBG3-binding, the Ab aspired to apply for in vivo NT injury investigations. 
For the Ab-deposits no significant differences were observed between homozygous 
and heterozygous SH and SM, with the SM in both cases exhibiting a lower level of 
Ab-binding  when  compared  to  the  SH,  indicating  potentially  a  slightly  higher 
susceptibility  of  the  SH-NTs  to  Ab-  and  complement-mediated  injury.  Combining 
these  two  muscles  no  significant  differences  between  the  homozygous  and 
heterozygous  double-fluorescent  mouse  strains  could  be  observed.  There  was 
however, a significant difference when comparing homozygous and heterozygous 
TS, with the homozygous TS exhibiting very low Ab-binding levels, indicating that 
this muscle  should  be excluded  from  being  used  in  any  investigations. With  the 
heterozygous TS, the binding levels were similar to the SM and SH. No (or only very 
slight) differences were observed between the muscles of male and female mice of 
each strain. 
 
 
4.5 Both SH- and SM-NMJs react to traumatic denervation with the extension 
of pSC processes and axonal sprouts 
The ability or rate of NTs to sprout following traumatic denervation of the NMJ or 
toxin-induced  paralysis  has  been  shown  to  differ  between  fast-  and  slow-twitch 
muscles, with NTs of slow-twitch-muscles exhibiting a greater capacity and/or faster 
NT sprouting (Brown et al., 1980; Duchen, 1970; Duchen & Tonge, 1973; Frey et al., 
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investigations were predominantly fast-twitch muscles, their ability to produce pSC 
processes and NT sprouts following traumatic denervation was examined. 
Both SM and SH exhibited pSC processes and NT sprouts following crush injuries to 
their innervating nerves. These were more extensive in the SM, probably reflecting 
the fact that the crush of the innervating nerve was carried out at a further distance 
to the muscle when compared to the SH and therefore resulting in the SM requiring 
more time to regain innervation. Both the rate of the process extensions and the 
mode in which the changes occurred, correlated well with the literature (Marques et 
al., 2006; Reynolds & Woolf, 1992), indicating the capability of the SM and SH to 
show the changes expected and further validating these two muscles for the in vivo 
anti-ganglioside Ab and complement-mediated NT-injury. 
 
 
4.6  Anti-ganglioside  Ab  is  rapidly  internalised  at  the  NT;  this  mechanism 
protects the NT from complement-mediated injury 
Investigations associated with the validation of anti-ganglioside Abs for the specific 
injury of NTs in WT mice, indicated that TBG3, the Ab of choice, is internalised 
rapidly at the NT. This raised the question whether this interesting observation could 
help protect the NTs from anti-ganglioside Ab and complement-mediated injury. 
In ex vivo TS-preparations it could be shown that an increase of incubation times at 
37ºC resulted in Ab being internalised and subsequently removed from the NT. This 
was accompanied by decreased MAC-deposition and lower rates of NT-injury. In 
vivo investigations confirmed these observations. In summary, it could be shown 
that rapid uptake of anti-ganglioside Ab into the motor NT can protect this structure 
from complement-mediated injury.  
In  order  to  overcome  this  phenomenon  (in  the  experimental  setting),  the  Ab-
concentration needs to be increased, whilst a decrease of the protraction period for 
the incubation with complement further facilitates the induction of a NT-injury. 4. Conclusions    167 
4.7 Loss of CFP at the NT corresponds with a loss of physiological axonal 
architectural and ultrastructural properties 
The present study and also numerous other studies investigating developmental, 
degenerative and also regenerative questions of the PNS and CNS have and are 
being conducted in mice expressing fluorescent proteins in their axons. Only very 
few investigations have been carried out to assess which conventional observations 
(EM) the loss of fluorescent proteins in these structures corresponds to. None of 
these investigations were conducted at the NMJ. 
The loss or abnormal morphology of CFP overlying the NMJ corresponds well with a 
loss of the axonal architectural proteins NF light and heavy. The immunoreactivity 
for  NF  light  persisted  longer  than  that  for  NF  heavy,  albeit  with  a  changed 
morphology; which presumably reflects the localisation of the different NFs within 
the axon (Fuchs & Cleveland, 1998) and corresponds well to the literature (Serbest 
et al., 2007). Application of a calpain-inhibitor resulted in NF heavy being rescued 
from degradation, whilst an increased loss of CFP was observed. This observation 
indicates  that  both  resealing  events  (which  are  calpain-dependant)  and  calpain-
mediated  destruction  of  the  architectural  proteins  are  occurring  in  this  model. 
Additionally,  the  Ca
2+-dependency  of  the  process,  in  combination  with  the 
morphology of  the loss of  the axonal fluorescent proteins and EM investigations 
conducted at the NMJ, surmise that degenerative events similar to those observed 
acutely in axons following the induction of Wallerian degeneration take place at the 
NT  following  anti-ganglioside  Ab  and  complement-mediated  injury.  Injured  NTs, 
therefore,  need  to  undergo  regenerative  processes  in  order  to  regain  their 
physiological morphology. 
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4.8  Rapid  motor  NT  regeneration  following  anti-ganglioside  Ab-  and 
complement-mediated injury; the rate of NT regeneration is not affected by a 
concomitant injury to the pSCs 
Following  a  single anti-ganglioside  Ab and complement-mediated injury, the NTs 
exhibit a rapid loss of intracytosolic fluorescent protein (CFP), which corresponds to 
both a loss of the axonal architectural structures and the physiological ultrastructure 
(see 3.6). In the NT-regeneration study the incidence of CFP overlying the NMJ-
area was used as an indicator of NT-regeneration. 
Acutely after an in vivo induction of the injury and at 24h, roughly 6% of all NMJs 
exhibited CFP overlying their BTx-signal. Over the next four days, CFP returned with 
close to all NMJs (93.5%) exhibiting CFP by day five. A concomitant injury to the 
pSCs did not decrease the rate of NT regeneration. No differences between the 
extent of NT regeneration on day 5 were observed between the two groups with and 
without concomitant injury to the pSCs. However in the group subjected to both NT- 
and pSC-injury, the return of CFP was preceded by a return of GFP-positive cells 
overlying the NMJ.  
In both groups, some pSCs extended processes beyond the physiological boundary 
of the  NMJ, which  occasionally  were  accompanied by axonal sprouts. Thus, the 
changes  observed  following  Ab-mediated  injury  were  similar  to  those  of  NMJs 
subjected to traumatic denervation, albeit at a lower magnitude; this is presumably 
due to very rapid time-course of reinnervation. In the control group, no changes to 
the fluorescent proteins were noted.  
Auxiliary investigations revealed that following five days of regeneration both the 
axolemmal integrity and the architectural integrity of the NTs were re-established, 
and the physiological ultrastructural characterists of NMJs are observed once again. 
This data supports the notion that an equivalent mechanism may account for the 
rapid recovery seen in some clinical cases of AMAN. 
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5. SUMMARY and OUTLOOK 
In summary, the aim of my thesis-project was achieved.  
I managed to successfully combine the murine model of GBS with in vivo and ex 
vivo imaging of the murine NMJ and exploit this system to investigate acute injury 
and regeneration of neural and glial structures targeted in GBS. 
In  the  in  vivo  imaging  system,  it  was  possible  to  document  the  integrity  of  the 
structures  under  investigation  under  physiological  circumstances.  Following 
induction of an anti-ganglioside Ab and complement-mediated injury, this system 
then also allowed to monitor and image the degenerative changes to the structures 
under attack. 
The in vivo imaging system was combined with ex vivo imaging of the same site, 
which allowed to track the degeneration and regeneration of individual NMJs over 
time, thus decreasing the amount of research subjects required for these kinds of 
investigations.  Quantitative  assessments  complemented  the  qualitative  imaging 
sessions to determine the acute extent of distal motor nerve and NT degeneration 
and  also  the  rate  of  regeneration  following  a  single  anti-ganglioside  Ab  and 
complement-mediated injury. 
Both  qualitative  and  quantitative  imaging  confirmed  that  following  an  anti-
ganglioside Ab and complement-mediated injury, the NT degenerates very quickly. 
Regeneration occurs within five days. This rapid rate of regeneration corresponds 
well to rates of NT regeneration observed following the application of snake and 
spider toxins which mediate selective injury to the NT. However, the observations 
described here are the first investigation of the rate of NT regeneration following Ab- 
and complement-mediated injury to this structure. 
Furthermore,  this  study  directly  confirms  the  hypothesis  that  in  some  patients 
suffering from the motor axonal forms of GBS only the very distal motor nerves and 
NTs are injured, and that these can recover within a short time-frame. 
A concomitant injury applied to pSCs in this injury paradigm revealed that (in this 
setting) successful NT-regeneration is not dependant on mature and healthy pSCs 5. Summary and Outlook    170 
situated  at  the  NMJ.  Nevertheless,  a  return  of  GFP-positive  structures  (pSCs) 
overlying  the  NMJs  preceded  the  restoration  of  the  CFP-filled  NTs,  thus  further 
supporting the notion of a dependency of the NTs on the glial structures of the NMJ. 
The very interesting observation that anti-ganglioside Ab physiologically can rapidly 
be internalised at the NT was further explored in a side-study. Investigations showed 
that  the  removal  of  anti-ganglioside  Ab  from  the  axolemmal  surface  and 
internalisation into the NT is associated with a decrease of complement deposition 
on the axolemmal surface. This in turn correlates with a decrease in the rate of NT 
injury observed. Thus, NTs can also be protected from complement-mediated injury 
by internalisation of antiganglioside Ab bound to the axolemma. In what way these 
observations  correspond  to  physiological  circumstances  in  the  GBS-patients 
remains open, as to date the concentrations of circulating anti-ganglioside Abs in 
GBS-patients  have  not  been  determined  and  internalization  rates  for  NTs  also 
remain to be investigated. 
However, in addition to being able to provide some answers - in the very nature of 
science - my examinations also raised a number of queries which warrant further 
investigation. 
These include  
·  the observation that in the mice expressing fluorescent proteins in the neural 
and glial structures of their PNS no selective injuries to the pSCs could be 
elicited. This is contradictory to previous  investigations  conducted  in  non-
fluorescent mice. The results of my investigations indicate that the NTs either 
are  injured  in  a  bystander  fashion  following  an  extensive  complement 
activation on the pSCs or undergo rapid reactive changes following injury to 
“their” pSC.  
·  the fate of the anti-ganglioside Ab once taken up at the NT. Quantitative 
investigations revealed a decrease of internatised Ab over time, pointing to 
either a local degradation or retrograde transport. 
·  the origin and nature  of  the surplus of  GFP-positive cells  at regenerative 
time-points following immune-mediated or traumatic denervation of the NMJ. 5. Summary and Outlook    171 
·  the fate of the pSCs following anti-ganglioside Ab and complement-mediated 
injury. Can these cells recover, or do they regenerate and are replaced by 
newly generated pSCs? If the latter is the case, where are the progenitors of 
these new pSCs located and do these also differentiate into the surplus of 
GFP-positive  cells  overlying  the  NMJ  and  observed  at  regenerative  time-
points following neuromuscular denervation? 
Nevertheless,  the  use  of  a  combined  in  and  ex  vivo  imaging  approach  in  mice 
expressing fluorescent proteins in the neural and glial structures of their PNS proved 
to be useful and informative for the investigation both of the acute degenerative and 
also the regenerative changes to these structures following an anti-ganglioside Ab 
and complement-mediated injury. 
Future  investigations  based  on  (repeated)  in  vivo  imaging  investigations,  if 
necessary combined with ex vivo imaging sessions, are numerous and include: 
·  the  chronic  effect  of  circulating  anti-ganglioside  Abs  (without  the  external 
application  of  complement)  following  repeated  passive  immunisations  or 
active immunisation of immune-responsive mice 
·  the  extent  of  regeneration  observed  in  chronic  anti-ganglioside  Ab  and 
complement-mediated injuries 
·  the regenerative capacities of the ganglioside-KO vs WT mice following both 
immune-mediated and traumatic denervation of the NMJ 
·  the effects of resealing components, such as tri-block copolymers (Borgens 
et al. 2004; Kilinc, Gallo, & Barbee 2007), in complement-mediated injury 
·  the effects of complement-and calpain-inhibitors in a chronic setting of anti-
ganglioside Ab and complement-application. 
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Appendix: Commands for macros generated in-house 
macro "MinMax" 
{run("Set Measurements...", "  min display redirect=None decimal=0"); 
run("Measure");   
min = getResult("Min") 
max = getResult("Max") 
run("Select None"); 
    setMinAndMax(min,max); 
run("Apply LUT"); 
run("Clear Results");} 
 
 
macro "Deblurrr single stack" 
{type = 1 
rename ("original"); 
run("8-bit"); 
run("Duplicate...", "title=[blur] duplicate"); 
run("Gaussian Blur...", "radius=30 stack"); 
run("Gamma...", "stack value=1.25"); 
imageCalculator("Subtract create stack", "original", "blur" ); 
//run("Enhance Contrast", "saturated=0 normalize normalize_all"); 
selectWindow("blur"); 
close();} 
 
 
macro "Intensity (Red BTx)" 
{type = 1 
 dir = getDirectory("Choose Image Folder"); 
 list = getFileList(dir); 
 setBatchMode(true); 
  for (i=0; i<list.length; i++){ 
       path = dir+list[i]; 
  if (endsWith(path, ".lsm")){ 
    open(path); 
if (nImages==2) { 
title=list[i] + " Channel : Ch2-T2"; 
title2 =list[i] + " Channel : Ch1-T1"; 
selectWindow(title2); 
rename("red"); 
selectWindow(title); 
rename(list[i]); 
run("Set Measurements...", "area mean display redirect="+list[i] ); 
selectWindow("red"); 
setThreshold(50, 255); 
run("Analyze  Particles...",  "size=10-1000  circularity=0.00-1.00  show=Nothing 
display"); 
close(); 
close();} 
else  
{close();} 
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macro "Intensity (Green BTx)" 
{type = 1 
 dir = getDirectory("Choose Image Folder"); 
 list = getFileList(dir); 
 setBatchMode(true); 
  for (i=0; i<list.length; i++){ 
       path = dir+list[i]; 
  if (endsWith(path, ".lsm")){ 
    open(path); 
if (nImages==2) { 
title=list[i] + " Channel : Ch2-T2"; 
title2 =list[i] + " Channel : Ch1-T1"; 
selectWindow(title); 
rename("green"); 
selectWindow(title2); 
rename(list[i]); 
run("Set Measurements...", "area mean display redirect="+list[i] ); 
selectWindow("green"); 
setThreshold(50, 255); 
run("Analyze  Particles...",  "size=10-1000  circularity=0.00-1.00  show=Nothing 
display"); 
close(); 
close();} 
else 
{close();} 
 
 
 196 
Publications linked to this thesis: 
a.) Experimental Neurology 233 (2012): 836-848 
b.) The Journal of Clinical Investigation 122 (2012): 1037-1061 
 